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Abstract
The gradual accretion of fibrillar protein deposits in a tissue or organ is 
a hallmark of all amyloidogenic diseases. These deposits accumulate as senile 
plaques and cerebrovascular deposits in the brain and are characteristics of 
Alzheimer's disease. A majority of the brain amyloid deposits consist of a 40 
amino acid protein, the Alzheimer G-protein, AGP, which in a soluble form is 
ubiquitous in biological tissues. In order to provide a more detailed 
understanding of the structural transformations of soluble AGP, sequence 
analogs derived from G1-40, and having His -  Arg, and L-Asp -  D-Asp 
substitutions were synthesized.
The kinetic variations of G1-40 and G6-25 were studied using amide 
circular dichroism spectroscopy by monitoring ellipticity changes of the peptide
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
backbone. In both peptides, the gradual loss of secondary structure was a 
multiphasic process which was also dependent on concentration. The circular 
dichroism titrations with metal ions revealed the involvement of at least two ions 
in the conformational transitions of 131-40 and 136-25. The association of Al(lll) 
with L-Asp -  D-Asp derived analogs caused surprising conformational changes 
in (36-25, which were distinct from 131-40. Microheterogeneous products 
corresponding to AI(lll)-bound peptide species were resolvable on the reversed- 
phase surface. The association of aluminum was investigated by low field 27AI 
nuclear magnetic resonance spectroscopy. The signal corresponding to Al(lll)- 
bound peptide species revealed that at least four Al(lll) ions were bound to 
(31-40 and (36-25 between pH 5 and 6 . Moreover, (31-40 effectively competed 
with EDTA to bind with Al(lll).
This study also describes a strategy which resolved the band 
broadening in reversed-phase high-performance liquid chromatography of (31-40 
and derived analogs. Chromatographic parameters related to interactive contact 
area of (31-40 and derived analogs were determined on reversed-phase matrix. 
The peptides were bound to the reversed-phase surface in their monomeric form. 
Slow partition kinetics appear to contribute to significant band broadening, which 
suggests a secondary retention effect -  indicating a conformational change due 
to unfolding on the stationary phase surface.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Dedication
To
my sister Minu, and 
CV
in knowing whom, I discovered 
that they are the salt-bridges of 
my ionic life...
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table of Contents
Abstract .............................................................................................................. iii
Dedication ..............................................................................................................v
Table of Contents............................................................................................... vi
List of F igures.....................................................................................................  xi
List of Tables .....................................................................................................xviii
List of Abbreviations.............................................................................................xx
Acknowledgements............................................................................................. xxii
Chapter 1 
Introduction
The Generation of Am ylo id....................................................................................3
Identification of A m y lo id ............................................................................... 5
The Alzheimer's S-Protein ................................................................................... 6
The Alzheimer Precursor P ro te in .......................................................................10
Intrinsic Factors for ASP Deposition...................................................................14
Putative Salt-bridges in AGP ..................................................................... 14
Mutations in ASP of Different O rig ins........................................................ 15
Hydrophobicity and Solub ility ..................................................................... 17
Membrane Anchoring Site ......................................................................... 20
Secondary Structure of ASP Variants........................................................21
Post-translational Modifications in A S P ................................................... 23
Extrinsic Facto rs ...................................................................................................24
The Role of Aluminum ............................................................................... 25
The Presence of Other Peptides and Prote ins.........................................26
O bjectives............................................................................................................. 27
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 2
Materials and Methods
Introduction.........................................................................................................30
Problems and Strategies in Solid Phase Peptide Synthesis of (31-40 .........33
Solvation of Solid-Phase .........................................................................34
Side-Chain Protection in Fmoc-Amino A c id s .........................................35
Activation of Fmoc-Amino Acid E s te rs ................................................... 37
General Procedures for Synthesis and Purification of 131 -40 and Derived
Analogs .....................................................................................................38
Stepwise Synthesis of Protected Peptides.............................................44
Cleavage and Deprotection M ethods..................................................... 47
Evaluation of the Stepwise Solid-Phase Syntheses.............................. 54
Purification using reverse-phase chromatography ........................54
Amino acid sequence analyses during synthesis ..........................61
Post-synthesis sequence ana lyses................................................. 62
Cleavage by Trypsin and C N B r........................................................62
Amino Acid Analysis .........................................................................64
Peptide Concentration Determination ................................................... 65
Spectroscopic Methods for Structural S tud ie s ................................................67
Circular Dichroic Spectroscopy .............................................................. 68
Nuclear Magnetic Resonance Spectroscopy......................................... 70
Strategies in Peptide Sequencing .................................................................. 72
D-amino acids ................................................................................... 72
Metal-bound peptides .......................................................................73
M ateria ls..............................................................................................................73
Chapter 3
High Performance Liquid Chromatography Studies of AI3P and Derived Analogs
Introduction.........................................................................................................75
Reversed-Phase High Performance Liquid Chromatography of 131-40 and
Derived A na logs........................................................................................80
Experimental Chromatographic Behavior of (31-40 and Derived Analogs . . 83 
Determination of the oligomeric form of peptides during RP-HPLC
and SEC ............................................................................................ 83
Equilibrating oligomers of 1322-35 during chromatography .......... 92
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Evaluation of Chromatographic Behavior of 131-40 and Derived Analogs
During RP-H PLC ................................................................................. 96
Determination of chromatographic parameters as a function of
organic solvent concentration ............................................................97
Dependence of S and log k0 on temperature.................................... 99
Evaluation of Band Broadening of 131-40 by Gradient Elution
RP-HPLC ...................................................................................................103
Changes in Band Shape as a Function of Organic Modifier
Concentration............................................................................................ 105
Rate Constants of Bandwidth Increase for 131-40 During RP-HPLC . 109
Bandwidth Relationships ......................................................................... 115
Resolving a Typical Mixture of Synthesis-fragments ............................ 116
Effects of Extrinsic Factors............................................................................... 118
Ionic Strength Effects on Retention Times and Recovery of
Peptides.............................................................................................. 119
Exogenous Peptides..................................................................................120
Incubation in Solution: (31-40 with (326-40 and (38-40 .........................  120
Kinetic Studies: (326-40 with (31-40 and (38-40 ...................................... 122
Discussion ......................................................................................................... 132
Chapter 4
Conformational Transitions of A(3P - A Far UV/CD Spectroscopy Study
Introduction......................................................................................................... 138
Secondary Structure via Far UV Amide Circular D ichro ism ..........................140
Secondary Structure Studies of 131-40 and Derived Analogs in
Aqueous S o lu tions....................................................................................142
Analyses of secondary structural components from CD spectra . 146 
Concentration-dependent conformational changes for (31-40 . . .  150
pH dependence of CD for (31-40 and [Arg](31-40 ana logs 152
Variation in Ellipticity: Secondary Structure Transformational Analysis . . .  159 
Correlating elution behavior of (31-40 solutions as a function of
time .....................................................................................................163
Kinetic difference CD analysis for (31-40: time e ffec ts ................... 172
Kinetic difference CD of (31-40 - concentration effects...................173
Kinetic Variation in CD for (36-25 and [D-Asp] Derived Analogs 174
Elution behavior of (36-25 as a function of t im e .............................. 179
Equilibrium CD spectra of [D-Asp](36-25 analogs ..........................180
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Effect of Alternative Reference S pectra ........................................................187
Discussion ......................................................................................................... 191
Chapter 5
Interaction of Aluminum(lll) with A(3P and Derived Analogs in Aqueous Solutions
Introduction......................................................................................................... 200
Al(lll) and 131-40 Derived Analogs: Chromatographic Analysis ................... 208
Incubation of Al(lll) and Fe(lll) with 131-40: Time-dependency..................... 208
Verification of chromatographically pure Al(lll)-f31 -40 peptide
fra c tions .............................................................................................. 209
Effect of pH on Microheterogeneity Production .................................... 214
Temperature E ffects..................................................................................215
Kinetics of Microheterogeneity of Al(lll) incubations with 131-40 and
Derived A na logs........................................................................................217
Discussion .................................................................................................219
Al(lll) and 131-40 Analogs: 27AI NMR Examination .........................................232
27AI Interaction with 131-40 in Aqueous Media .......................................235
Relative Intensity of the AI(lll)-l31-40 Resonance ..........................237
EDTA titration of Al(lll)-f31 -40 ........................................................  238
Al(lll) Interaction with 136-25 in Aqueous M e d ia .....................................244
pH Titration of AI(lll)-l36-25 Species ............................................... 245
27AI NMR of Chromatographically-pure AI(lll)-bound Peptides ...........247
Discussion .................................................................................................253
Al(lll), 131-40 and 136-25: Circular Dichroic Spectroscopy..............................257
Effect of Al(lll) on CD of 131-40 .......................................................................  259
Effect of Al(lll) on CD for [D-Asp] Analogs of 131-40 ...................... 261
Effect of Al(lll) on (36-25 and Derived Analogs.......................................269
Effect of Al(lll) on [D-Asp] Analogs of (36-25 ................................  270
Effect of Fe(lll) on (31-40 and (36-25 ......................................................  270
Discussion .................................................................................................271
Summary ........................................................................................................... 283
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix A
Evaluation of Interactive Chromatographic Parameters During Gradient
Elution RP-HPLC ..................................................................................... 290
Appendix B
Decomposition Procedures for Secondary Structure Transitions from Amide
Circular Dichroism Spectroscopy of 131-40 and Derived Analogs . . . 295
Appendix C
Concentration of Aqueous Aluminum(lll): Metal-ion Buffers........................ 298
Appendix D
Characterization of Mg 2+, Zn 2+ and Ca 2+ Incubations with (31-40 and
Derived A na logs........................................................................................300
B ib liography...................................................................................................... 302
x
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Figures
Fig. 1.1 Possible mechanisms for the generation of amyloid..........................4
Fig. 1.2 Schematic representation of cross-(3 sheet formation....................... 7
Fig. 1.3 The schematic of the full-length Alzheimer Precursor
Protein, APP, isoforms APP695, APP751 and APP770...................... 1 1
Fig. 1.4 Primary sequence of human Alzheimer 13-protein, AI3P,
indicating the proteolytic sites..........................................................13
Fig. 1.5 The hypothetical aggregation model for (31 -40 based on
putative intersheet electrostatic interaction between 
His13-Asp23......................................................................................... 16
Fig. 1.6 Primary sequence analyses of secondary structure and
hydrophilicity of (31-40...................................................................... 19
Fig. 2.1 Side-chain esters in aspartate and glutamate residues
form cyclized derivatives.................................................................. 40
Fig. 2.2 Self-racemization in histidyl residues - differentiation of
p- and f-derivatized histidine residues............................................ 41
Fig. 2.3 Cyclization in the arginyl guanidine group; lactam
formation from activated carboxyl....................................................42
xi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 2.4 Pentafluorophenyl (OPfp) and 3,4-dihydro-4- 
oxobenzotriazin-3-y! (ODhbt) esters of fmoc-amino 
acids................................................................................................... 43
Fig. 2.5 General scheme for the total synthesis of 131-40 and
derived analogs by SPPS................................................................. 50
Fig. 2.6 Cleavage, deprotection and isolation schemes for the
A(3P fragments................................................................................... 51
Fig. 2.7 Analytical RP-HPLC elution profiles of crude (31-40 as a
time-dependent function of cleaving mixtures................................ 57
Fig. 2.8 Analytical RP-HPLC profile of a representative impure
synthesis of (31-40 showing the elution of (326-40 and 
(38-40 synthesis-fragments............................................................... 58
Fig. 2.9 Analytical RP-HPLC elution profiles for crude (36-25,
[Arg13](36-25, and [Arg(Mtr)](36-25..................................................  59
Fig. 3.1 RP-HPLC strategy for on-column incubation
experiments........................................................................................87
Fig. 3.2 HPLC of (31-40 and derived analogs on reversed-phase
surface octadecyl matrix................................................................... 88
Fig. 3.3 Comparison of RP-HPLC behavior of singly loaded
peptides between C8 and C18 matrices............................................89
Fig. 3.4 Comparison of RP-HPLC behavior as a function of
mobile phase; MeCN and TFE.........................................................90
Fig. 3.5 Verification of monomeric nature of (31-40 and derived
analogs in solution by SEC...............................................................91
Fig. 3.6 Characterizing oligomerization of (322-35 in solution.
........................................................................................................... 94
xii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 3.7 Elution profiles of 1322-35 oligomers on reversed-phase
and size exclusion chromatography................................................ 95
Fig. 3.8 Plots of log k* versus ^*fo r 131-40 and derived analogs
on C18 at 22°C..................................................................................101
Fig. 3.9 Plots of S (A) and log kQ (B) versus temperature for (31­
40 and derived analogs, angiotensin III and N- 
acetylphenylalanine methyl ester eluted from Vydac C18 
 102
Fig. 3.10 Elution profiles of (31-40 as a function of on-column
incubation and organic modifier..................................................... 108
Fig. 3.11 First-order kinetic plots of rate constant of band 
broadening of (31-40 on varying column temperatures as 
function of on-column incubation time, t........................................113
Fig. 3.12 Plot of peak capacity as a function of flow rate for (31 -40 
and derived analogs at a constant gradient time of 60 
min.
......................................................................................................... 123
Fig. 3.13 Resolution of synthesis-fragments (326-40 and (38-40
from a typical (31-40 synthesis....................................................... 124
Fig. 3.14 Plot of elution behavior as a function of mobile phase 
ionic strength, p, for (31-40 and derived analogs on 
reversed-phase column C8........................................................... 126
Fig. 3.15 RP-HPLC behavior of incubating equimolar (31-40 with
(326-40, and with (38-40 in-solution on Vydac C18....................... 127
Fig. 3.16 RP-HPLC profiles of the pooled fractions of (31-40
incubation with (326-40 and (38-40...............................................  129
Fig. 3.17 Kinetic profiles for solution-incubation of (326-40 with 
f38-40 (A) and (31-40 (B) over 168 hours expressed as 
normalized mass of the heterogenous product........................... 130
xiii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 3.18 The rate constant dependence of RP-HPLC-determined
association of (326-40 with (31-40 and (38-40.............................. 131
Fig. 4.1 Circular dichroism spectra of 250 pM synthetic (31 -40 in
H20  at pH 7.5, in 40% MeCN at pH 7.1 and 40% TFE at 
pH 7.2............................................................................................. 143
Fig. 4.2 CD spectra of 131 -40 as a function of concentration................... 155
Fig. 4.3 Variation in ellipticity for (31-40 as a function of
concentration................................................................................. 156
Fig. 4.4 Spectral decompositions for concentration dependence
of CD for (31-40 - Analyses using Varselec (top panel) 
and CCA (bottom panel)...............................................................157
Fig. 4.5 Circular dichroism spectra of 325 pM (31-40 solution as
a function of pH............................................................................. 158
Fig. 4.6 Circular dichroism spectra of a 320 pM (31-40 solution,
pH 7.5, taken over a period of 168 hours................................... 164
Fig. 4.7 Variation in ellipticity for a 320 pM (31 -40 solution at 215
nm as a function of time............................................................... 165
Fig. 4.8 Variation in ellipticity monitored at 210 nm for 320 pM
(31-40 as a function of time...........................................................167
Fig. 4.9 Variation in ellipticity monitored at 220 nm for 320 pM
(31 -40 as a function of time...........................................................168
Fig. 4.10 Residual plots for a two- and three-exponential fit of
kinetic data for 320 pM (31-40 at 210, 215 and 
220 nm............................................................................................170
Fig. 4.11 Characterizing (31-40 solution as a function of time by
RP-HPLC........................................................................................171
xiv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 4.12 Kinetic difference CD spectra for the three phases of
ellipticity change for 320 pM 131-40 solution at pH 7.5..............175
Fig. 4.13 Kinetics of ellipticity variation at 210, 215 and 220 nm as
a function of 131-40 concentration................................................ 177
Fig. 4.14 CD spectra of 0.4 mM (36-25 as a function of time.......................181
Fig. 4.15 Variation in ellipticity at 215 nm for (36-25 as a function
of time.............................................................................................182
Fig. 4.16 Kinetic difference CD spectra for the two phases of
ellipticity variation for 136-25.........................................................  184
Fig. 4.17 Change in chromatographic parameters of (36-25
solutions as a function of time......................................................185
Fig. 4.18 Circular dichroism spectra for (36-25 and its [D-Asp]
derived analogs.............................................................................186
Fig. 4.19 Kinetic difference CD spectra for the three phases of
ellipticity variation of (31-40 based on alternate reference 
CD spectra..................................................................................... 192
Fig. 4.20 Kinetic difference CD spectra for the two phases of
ellipticity variation for (36-25 based on alternate 
reference CD spectra....................................................................193
Fig. 5.1 RP-HPLC of (31-40 incubation with Al(lll), as a function
of time............................................................................................. 210
Fig. 5.2 RP-HPLC elution profiles of Fe(lll) incubation with (31-40
as a function of time......................................................................220
Fig. 5.3 RP-HPLC elution profiles of Al(lll) and 131-40: effect of
incubation-pH................................................................................ 221
xv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 5.4 RP-HPLC elution profiles for 131-40 and Al(lll) incubation
as a function of buffer.....................................................................222
Fig. 5.5 RP-HPLC elution profiles for Al(ill) and Fe(lll)
incubations with (36-25, (31 -28, and f38-40 after 120 
hours................................................................................................ 223
Fig. 5.6 RP-HPLC of AI(lll):l31-40 as a function of incubation-
temperature at a mole ratio 10:1....................................................224
Fig. 5.7 RP-HPLC of Al(lll) incubations with (38-40, (31-28 and
(36-25 after 24 hours at 45°C and mole ratio 10:1.......................225
Fig. 5.8 Kinetic profiles for microheterogeneity production on
incubation of Al(lll) with (31-40, 8-40, (31-28 and (36-25 
by varying metal:peptide mole ratio.............................................. 228
Fig. 5.9 Summary of yields for chromatographically-pure Al(lll)
associated pooled peptide fractions..............................................229
Fig. 5.10 27AI NMR spectra of Al(lll) binding to synthetic (31-40................  239
Fig. 5.11 Relative intensity of the 27AI NMR resonance for Al(lll)-
(31-40 as a function of Al(lll):(31 -40 mole ratio............................. 240
Fig. 5.12 Evolution of 27AI NMR spectra for a 10 mM solution of
Al(lll)-(31 -40 on addition of equimolar EDTA................................ 242
Fig. 5.13 27AI NMR spectra for Al(lll) binding to 10 mM (36-25
solution at pH 6.0............................................................................248
Fig. 5.14 Relative intensity of the AI(lll)-(36-25 resonance as a
function of [Al(lll)]..........................................................................249
Fig. 5.15 27AI NMR spectra of Al(lll) binding to 10 mM f36-25
solution as a function of pH......................................................... 250
Fig. 5.16 Plot of linewidth change for [ A l^ O y 3* and AI(lll)-(36-25
as a function of pH........................................................................251
xvi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 5.17 27AI NMR of chromatographically-pure AI(lll)-bound
peptides........................................................................................... 252
Fig. 5.18 Circular dichroism spectra of 250 pM 131-40 at pH 7.2
with 0.5 mM Al(lll) and EDTA.......................................................... 263
Fig. 5.19 Comparison of the mean residue ellipticity at 210 and 
224 nm on addition of Al(lll) to 250 pM solution of 131-40. 
.........................................................................................................265
Fig. 5.20 Fractional change in mean residue ellipticity at 210 and 
215 nmfor Al(lll) titration of CD of the CD spectra of 131 - 
40....................................................................................................  266
Fig. 5.21 Hill plot of CD data near midpoint of pseudo-sigmoidal 
transition of the fractional change in mean residue 
ellipticity titration of (31-40 with A l(lll)............................................267
Fig. 5.22 CD spectra for [D-Asp7]l31-40, [D-Asp723]I31-40 and [D- 
Asp1,7'23](31-40 on addition of 0.5 mM Al(lll) after 4 hours. 
 268
Fig. 5.23 Circular dichroism spectra of (36-25 solution in the
presence of Al( 111)............................................................................272
Fig. 5.24 Fractional change in mean residue ellipticity at 215 nm
for Al(lll) titration of CD spectra of (36-25.................................... 273
Fig. 5.25 Circular dichroism spectra for [D-Asp] analogs of (36-25
in presence of A l(lll)........................................................................274
Fig. 5.26 Fractional change in mean residue ellipticity at 210 nm
as a function of Fe(lll) titration of CD spectra of (31-40............. 275
Fig. 5.27 Fractional change in mean residue ellipticity at 210 nm
of Fe(lll) titration of CD spectra (36-25 ..................................... 276
xvii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Tables
Table 2.1 Summary of Fmoc-Amino Acids' Protecting and Blocking
Groups During S P P S .......................................................................39
Table 2.2 AI3P Analogs Synthesized for Chromatographic and
Spectroscopic S tud ies.....................................................................52
Table 2.3 Comparison of Methods of Deprotection and Cleavage
for all Synthetic Analogs ................................................................ 60
Table 2.4 Amino Acid Analyses of Purified AI3P Analogs ........................... 66
Table 3.1 Rate Constants for Observed Band Broadening for
131-40 on Octadecyl Surface ........................................................ 114
Table 3.2 Sequence and Amino Acid Analysis of "Impure" (31-40
Synthesis.........................................................................................125
Table 3.3 Sequence and Amino acid Analyses of (31-40
Incubations with (38-40 and (326-40 ...........................................  128
Table 4.1 Secondary Structure Content of (31-40 as a Function of
T im e ................................................................................................. 166
Table 4.2. Kinetic Parameters of Variation in Ellipticity of (31 -40 at
pH 7.5 .............................................................................................169
xviii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 4.3 Fractional Changes in Secondary Structure Composition 
of 131-40 Calculated from Kinetic Difference CD Spectra 
for the Three Phases of Variation in E llip ticity............................ 176
Table 4.4 Relaxation Times and Amplitudes of (31-40 as a
Function of Concentration and T im e ........................................... 178
Table 4.5 Relaxation Times and Amplitudes of the Two Phases of
Variation of Ellipticity for 0.4 mM (36-25 ..................................... 183
Table 5.1 Quantitative Amino Acid Analysis on Microhetero-
geneous Products of AI(lll)-lncubation with (31-40................... 211
Table 5.2 Summary of Sequence Analyses of Chromatographically
pure Al(lll)-lncubated (31-40 Fractions......................................... 212
Table 5.3 Summary of Sequence Analyses for Al(lll) Incubations
with 131-28, 136-25 and (38-40 ......................................................  226
Table 5.4 Quantitative Amino Acid Analyses on Chromatograph- 
ically-pure Al(lll) Incubated Fractions of 138-40, 131-28 
and 136-25 .................................................................................... 227
Table 5.5 27AI NMR Chemical Shifts and Linewidths for Ligands at
23.30 Mhz ......................................................................................241
Table 5.6 Secondary Structure Content of 131-40 in Presence of
Al(lll) and EDTA............................................................................. 264
xix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Abbreviations
AD Alzheimer's disease
APP Alzheimer precursor protein
AIJP Alzheimer IJ-protein
CD circular dichroism spectroscopy
CNBr cyanogen bromide
CV cerebrovascular
DCC dicyclohexylcarbodiimide
DCM dichloromethane
Dhbt 2-hydroxy-4-oxodihydrobenzotriazole
DITC diisothiocyanate
DMF dimethylformamide
EDT 1,2-ethanedithiol
EMS ethylmethylsulfide
Fmoc 9-fluorenylmethoxycarbonyl
HCHWA-D hereditary cerebral hemorrhage with amyloidosis-Dutch
HFIP hexafluoroisopropanol
HOBt 1-hydroxybenzotriazole
HPLC high performance liquid chromatography
Mbh 4,4'-dimethoxybenzhydrl
Mtr 4-methoxy-2,3,6-trimethylbenzenesulfonyl
NMM N-methylmorpholine
NMR nuclear magnetic resonance spectroscopy
Opfp pentafluorophenyl
Pepsyn KA polyamide-kieselguhr
PIP piperidine
PITC phenylisothiocyanate
PS-PEG polystyrene-polyethylene glycol
xx
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
PVDF polyvinylidene difluoride
RP-HPLC reversed-phase high performance liquid chromatography
SEC size exclusion chromatography
SP senile plaque
SPPS solid-phase peptide synthesis
tboc tert-butyloxycarbonyl, tert-benzyloxycarbonyl
fBu tert-butyl
TFA trifluoroacetic acid
TFE trifluoroethanol
TLC thin layer chromatography
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Acknowledgements
It is often a daunting chore to make the acknowledgments and summary 
astute, bright and candid, without being deceitful, monotonous, or zesty. Since, 
like all other dissertations, these are often the most read sections, I will endeavor 
to keep these as interesting, elevating and stimulating as the rest of this work. 
Many, from the past and present, have contributed significantly toward 
preserving the tottering sanity which is mandatory in accomplishing such lofty 
ventures during one’s lifetime, and it would be invidious not to name them here.
At the outset, I will always be thankful to Dr. Duarte deFreitas at Loyola 
University for developing my interest in protein biochemistry and helping me get 
to UAF, and to Prof. Larry Duffy for taking me under his wing. In his inimitable 
style, Dr. Duffy always kept me moving. During the unanticipated setbacks, if it
xxii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
was not for his "It's a learning experience," graduate life would indeed have been 
agonizing. His immutable freedom to all students in the laboratory fuels the fire 
which is necessary to develop as conscientious workers. And yes, he also 
taught me that the results are not wrong, only the interpretations are. For all that 
he has done for me at UAF and beyond, I thank him. Also, I sincerely appreciate 
the timely and gentle goading from my graduate advisory committee which 
resulted in focussing my efforts.
I commend the Department of Chemistry, the then Biochemistry and 
Molecular Biology program, James R. Crook Fellowship of the UA Foundation 
and the Alzheimer’s Disease and Related Disorders Association for providing 
continued financial support throughout my gradual term at UAF, and the 
Graduate School for providing supplemental travel monies for all my annual 
southerly migrations to present the ongoing work in our laboratory. Many thanks 
to Drs. Sathy Naidu and Gerry Plumley from the IMS for giving me extracurricular 
opportunities during a couple of long summers. I thank Tracy Garrison for 
initiating the CD work in our laboratory. The CD work could not have been 
complete without the prompt arrangements made by Dr. John Sutherland of 
Brookhaven National Laboratory, and the excellent technical assistance from Dr. 
Krzysztof Polewski during the long hours spent at Port U9B of the NSLS.
Sheila Chapin, Marlys Schneider, and St. Laura Morisky nurtured and 
humored me all along, Beth Laursen let me keep my desk, and Norma Mosso let 
me be - for this I will always be thankful to them. Linnea Delatour and Joan
xxiii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Roderick were always there when I needed their company and I cherish them. 
Andree Porchet is to be especially remembered for the priority given to all my 
amino acid analyses, for baking many nutritious cakes, and for being so much 
help in the laboratory. Others who helped me make mundane official matters 
enjoyable were Jean James, Sally Ray and Nancy Connolly from the IAB. I also 
thank Dwight Ittner and Carol Haas for their prompt help with interlibrary loans, 
and Richard Veazey of IMPACT for his timely intervention in the preparation of 
the presentation slides. I now remain indebted to Dr. Katharyn Spiegel and Char 
Raby of Parke Davis' DomLab for keeping me awake during the hours which 
were spent polishing this document.
I express special appreciation to my laboratory colleagues, Xiaohong 
Zhao and Sherri Trask, for providing me with inspiration to finish sooner, and 
See-Tam Woon for making me laugh. I also appreciate the efforts of the City of 
Fairbanks and the Alaska State Troopers for tolerating me on the roadways and 
letting me live to enjoy them. All my ABR soccer teammates can now take a 
breather in that they will not have me outrun them; o yes, I am definitely slower 
after the mastoid bone fragmentation. Carol and Mason, thank you for providing 
me with all the music during the conception of the first draft of this dissertation, 
but I must mention that, I was driving down the road feeling bad, that fateful day.
I thank Jack Townsend for being a true Maverick during the Two-Way Fun Tests, 
and Allen Doyle for sparing me the painful exertions of training for running races. 
Chuck “Horse" Morgan, Paul and Maureen Canarsky and Bhaskar Neogi kept
xxiv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
all the fun and frolic and frosties coming, both on and off the badminton courts; 
thank you comrades. Mars Chambers and Neil Barten will be remembered for 
bringing in a refreshing change in our basement headquarters along with Steve 
Lewis, Mike Petrula and Eva Saulitis. It's a pity Neil, that I will not be waking you 
up in the wee hours of the long winter nights.
Many others who have been friends, philosophers, or guides include - 
Tracer Martinson, who kept laboratory life endurable by her friendly banter in the 
hallowed hallways of AHRB, R. Michael McKay for his keen intellect in adding 
two and two, and the youthful Aynsley McKay for proof reading a majority of this 
manuscript. John Loquvam taught me how to vanquish those sitting ducks on 
a 12% grade and the acumen involved in silently slipping past unsuspecting 
bicyclists. To Steve Butler and Gina Interrante, I say, Listen up! The Windy City 
is just too flat for me. With Brent Golden, I agree Montani sempre liberi. The 
collective brain power of the highly erudite group of Mosa Mohammed, Alex Lai, 
Soren Alimchandani and the Satyals will be remembered for the numerous, 
stimulating and sometimes vapid conversations. The Gillis' with their 
sweethearts Anders and Christina, and the Wyllie Echeverrias with Vickie, 
Beckie and Tessie, always provided me the ideal family atmosphere which is 
necessary at these latitudes. Genezaret Barron spent innumerable cold nights 
with me to shoot the Aurora Borealis, using monochrome films; Paco, no one will 
snuff you away from my memory. The endearing kinships arising from these 
rendezvous have survived beyond the compilation of this work.
xxv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Much of the impetus to finish this work came from my parents, Mummie 
and Pappa. He equipped us with toy construction sets, while building 
macrostructures himself, showed me the importance of the structure of beams, 
girders and columns in their function, and let me find the question of all 
questions without telling me in as many words. To Mummie, thanks for letting me 
know that to understand the physical world outside, one has to go deep inside 
oneself first, and that, sometimes, letting things happen has its own charm. To 
Jagdip, my giant little brother, I can only wish that I can be as strong as you are, 
both, emotionally and physically. To, Laurie Wonnell, thanks for being a 
confidante and a pal in the strangest of places; to Anna Yeakley, I say, it was 
nice of you to let me see the path leading to the other end of this Universe; you 
consolidate my faith in human society. Deborah Koons stood by me with tissue 
restorers while I was slaying the demons and helped me stand during the "tripod 
daze," and Christa Morrow helped me get strong shoulders for the same; thank 
you both for letting me fulfil the prerequisites to shrug this world.
And finally, thank you Amy Lloyd, for keeping the laboratory filled with 
all the excitement that I could handle.
xxv i
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 1
Introduction
The deposition of fibrillar proteinaceous matter in brains and other 
tissues in the body is a characteristic of many amyloidogenic diseases such as 
multiple myeloma (Glenner et al., 1970), scrapie (Prusiner et al., 1983), Down's 
syndrome (Masters et al., 1985), type II diabetes (Nishi et al., 1990), 
leukoaraiosis (Tabaton et al., 1991) and Alzheimer's disease (Katzman and 
Saitoh, 1991). The process of amyloid deposition is yet unclear, but it is 
believed that amyloid deposits lead to dysfunction and death for the tissue or 
organ. In Alzheimer's disease, the progressive neurodegeneration is correlated 
with the accumulation of senile plaques (SPs), the occurrence of cerebrovascular 
(CV) deposits, and neurofibrillary tangle (NFT) formation in the brain.
1
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Irrespective of the origin, amyloid deposits are stained with Congo red giving a 
characteristic green birefringence under polarized light, and exhibit an X-ray 
diffraction pattern typical of 13-pleated sheets. The CV and SP deposits have 
been found to be made up primarily of the Alzheimer 13-protein, AGP, a 39-43 
amino acid protein having frayed amino and carboxyl termini (Masters et al., 
1985; Roher et al., 1993). The formation of amyloid deposits is one of the foci 
of this study.
Certain metals, like aluminum, iron and zinc have been proposed as risk 
factors in many neurodegenerative ailments (Frederickson, 1989; Connor et al.,
1992), and may therefore have a neurotoxic effect. The involvement of metal 
ions such as aluminum was discovered in various pathological disorders 
including Parkinsonism with dementia (Hirano et al., 1961) and AD (Crapper et 
al., 1973). The overall aluminum levels in undiseased human brain have been 
found to increase with age (Katzman et al., 1978), and in AD brains, higher 
levels of many elements including aluminum are found ( Thomson et al., 1988). 
The aluminum salts in AD brains were found to be closely associated with the 
NFTs (Perl and Brody, 1980; Candy et al., 1986; 1992;), albeit its presence in 
SPs is still controversial (Landsberg et al., 1992). The association of aluminum 
with AGP, and its significance in amyloid deposition is another theme of this 
thesis. A brief review of the studies in the field of amyloid research is now given. 
This will be followed by a discussion of the factors involved in the structural 
stability of the AGP, and finally, the goals of this study.
2
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1.1. The Generation of Amyloid
The term, amyloid, was coined in the mid 19th century by Rudolph 
Virchow to describe the stainable carbohydrate deposits in the liver. Some years 
later, Friedreich and Kekule found these deposits to be made of protein, not 
starch (Hind, 1986). The nomenclature, however, prevailed, and is currently 
used to identify all forms of fibrillar and relatively insoluble protein deposits. 
Glenner et al. (1970) were successful in solubilizing and purifying amyloid 
deposits from people having systemic amyloidosis, an inherited condition which 
is characterized by a widespread deposition of amyloid throughout the body. A 
subsequent analysis of these deposits revealed them to be fragments of 
immunoglobulin light chain (Glenner et al., 1970). Other amyloid deposits which 
are tissue or organ specific are found in localized amyloidosis, and can arise 
from genetic or non-genetic factors (Glenner, 1980). Like most age-related 
diseases, the slow manifestation of symptoms in amyloidosis is analogous to a 
gradual deposition of amyloid.
Although it has not been satisfactorily proven in the pathogenesis of AD, 
the amyloid can be generated by two major possible routes (Fig. 1.1). As 
proposed by the enzymatic theory, cleavage of a precursor protein due to 
modifications by enzyme, and/or cleavage by modified enzyme takes place, 
releasing peptides which aggregate to give the amyloid deposits. Alternately, 
it can be theorized that conformational changes occur in the released peptide 
fragments imparting resistance to further proteolysis and a subsequent
3
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Fig. 1.1 Possible mechanisms for the generation of amyloid.
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aggregation. In fact, a conformational change is associated with cerebral 
amyloidosis in scrapie, a prion-related disease (Prusiner, 1991). The final event 
during amyloidogenesis in all instances is, however, dysfunction and 
concomitant death for the tissues and organs involved. When localized sites in 
the brain have a predilection for amyloid deposition, the result is a progressive 
loss of cognitive functions due to the inevitable death of associated neurons.
5
1.1.1. Identification of Amyloid
The difficulties in purifying the insoluble amyloid deposits led to 
elucidation of their morphology long before characterization of the protein. Divry 
(1952) employed Congo red to specifically stain the amyloid deposits and 
identify them under polarized light. In 1959, Cohen and Calkins used electron 
microscopy and observed that the amyloid deposits from different origins 
possessed identical fibrillar morphology. Cooper (1974) observed that the 
amyloid deposits stained by the dye Congo red exhibited a distinctive 
birefringence pattern, red under non-polarized light and green under polarized 
light.
Glenner (1980) used X-ray diffraction and found that amyloid deposits 
exhibited reflections characteristic of repeating (3-sheet motifs. A similar 
morphology is found in Bombyx mori silk, which was schematically described by
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Marsh et al. (1955) as a stacked cross-13 assembly even before the advent of 
high resolution structural techniques. The direction of the sheets is 
perpendicular to, i.e., across, the direction of the fibril formed (Fig. 1.2) which 
gives rise to macroscopic fibrillar structures. Amyloid deposits have also been 
identified by certain tinctorial properties of fluorophores like thioflavine S and 
thioflavine T (Vassar and Culling, 1959). Although the mode of interaction is not 
fully understood, these stains have been used as suitable probes for all 
amyloids, including AfJP. The observed birefringence could be due to a 
structured binding of the dye molecule to the repeating cross-fJ motif of amyloid 
proteins. The binding could arise due to the ionic interactions between the 
negatively charged sulfate groups of Congo red and the positively charged 
amino acids, histidine, arginine and lysine (Klunk et al., 1989) present in AfiP. 
Caging of the dye between the stacked cross-R sheets could also take place, as 
has been suggested by Cooper (1974), and Glenner (1980).
6
1.2. The Alzheimer’s fl-Protein
The most characteristic histopathological feature of Alzheimer's disease 
is the localized amyloid deposits in the brain as senile plaques, as well as 
neurofibrillary tangles. Amyloid deposits are also seen in brains of aged
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primates - monkeys, dogs, and polar bears (Selkoe, 1989). The partial amino 
acid sequence of leptomeningeal amyloid in AD was first reported by Glenner 
and Wong (1984a) which corresponded to a 4.2 kDa protein, the Alzheimer 
S-Protein, ASP. The amyloid deposits found in the aged and AD brain are found 
primarily in the entorhinal cortex and hippocampal regions (Whitehouse et al., 
1982; Pearson et al., 1985). The ASP deposits in senile plaques are associated 
with the walls of blood vessels (neuritic plaques), and amyloid deposition also 
takes place in the cerebrovascular region (Wisniewski and Terry, 1973). The 
primary structure of AGP purified from neuritic plaques and vascular amyloid 
indicate peptides varying between 42-43 and 39-40 amino acids respectively 
(Masters et al., 1985; Selkoe et al., 1986; Prelli et al., 1988; Miller et al., 1993; 
Roher et al., 1993).
There has been extensive unresolved discussions on whether the 
formation of senile plaques or neurofibrillary tangles is the primary change in AD 
(Wisniewski et al., 1994). There are reasons to believe that amyloid deposition 
precedes the neuropathological phenomena (Giaccone et al., 1989; Mann, 1989; 
Motte et al., 1989). Supporting this belief was the discovery of a 40 residue 
soluble ASP variant, S1-40, which was produced constitutively by normal cells 
(Seubert et al., 1992; Shoji et al., 1992). The longer variant of ASP, S1-42, has 
also been identified in human cerebrospinal fluid (Vigo-Pelfrey et al., 1993). 
Moreover, the ASP first deposited in pre-amyloid deposits (Wisniewski et al., 
1994) is not stainable with either Congo red or thioflavine S (Tagliavani et al.,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1988) which indicates that the morphology of ARP varies with the deposits. 
Given the possibilities that soluble variants of ARP circulate freely in their 
biological environment, it appears that under appropriate conditions, ARP would 
eventually lead to amyloid formation.
In Alzheimer's disease, the mechanisms of amyloid formation have been 
at the forefront of most current research. The identification of soluble forms of 
ARP has made it necessary to know the pathway(s) by which they are generated. 
Synthetic peptides homologous to ARP have been shown to form amyloid fibrils 
in vitro (Castano et al., 1986; Kirschner et al., 1987). It is clear that these 
peptides do not spontaneously form aggregates but only under conditions which 
are conducive to form fibrils. The aggregation of these peptides was 
demonstrated to be related to their concentration, pH of the solutions, the 
presence of salt, and metal ion concentrations (Castano et al., 1986; Kirschner 
et al., 1987; Barrow etal., 1992; Burdick et al., 1992; Hilbich et al., 1992). Once 
formed, the well-defined morphology of these aggregates can exert its toxic 
influence in their vicinity.
The amyloid deposits contain components of a complementary cascade 
which could usher the events leading to annihilation of the neuronal milieu in 
elderly or AD brains. The best hypothesis about the origin of neuritic plaques 
contends that their origin is free from any neuritic involvement (Yamaguchi et al., 
1988; Armstrong et al., 1991). In fact, many researchers have found that ARP 
exerts neurotoxic effects based on its aggregated state (Whitson et al., 1989;
9
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Yankner et al., 1990; Pike et al., 1993). The opposing view is that selective 
amyloid deposition does not co-exist with neurofibrillary abnormalities (Davies, 
1994). Altered neurites may initiate the aggregation of monomeric AGP to form 
amyloid (Price, 1986). There are instances when AGP enhances the survival of 
neurons (Whitson et al., 1989, 1990). Thus, the amyloid deposits might be a 
tombstone heralding some secondary event(s) in an aging or AD brain. 
Regardless, AGP is intimately involved with neuronal degeneration. The 
extensive characterization of the primary structure of AGP variants has allowed 
researchers to isolate and identify the cDNA for the parent protein of AGP.
10
1.2.1. The Alzheimer Precursor Protein
The proteins found in the amyloid deposits of AD, like all other 
amyloidogenic proteins, are formed by degradation of a much larger precursor 
protein (Glenner, 1988; Selkoe, 1989; Crowther, 1991). Kang et al. (1987) have 
shown that the AGP is a by-product of processing a large integral membrane 
glycoprotein, the Alzheimer precursor protein, APP. The human APP exists as 
three major isoforms ranging from 695 to 770 amino acids (Fig. 1.3) which are 
expressed throughout the body (Palmert et al., 1989), but whose biological 
function is still unclear. APP isoforms, arising due to alternatively spliced 
pre-mRNA (Kang, 1987; Lemaire, 1989), possess 56 and 75 amino acid
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Fig. 1.3 The schematic of the full-length Alzheimer Precursor Protein, APP, isoforms 
APP695, APP751 and APP770. The longer APPs include the Kunitz protease inhibitor 
(KPI) region and a 19 amino acid insert near the amino terminus in the extracellular 
domain. The lengths of the respective regions are not to scale.
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Kunitz-protease inhibitors (KPI) inserts to form, respectively, APP751 and APP770.
The processing of APP is now extensively characterized and recent 
metabolic data suggest that soluble forms of ARP are released from various cells 
and tissues (Gandy et al., 1994). One processing pathway results in the 
cleavage of APP between Gln611-I_ys612 or Lys612-L e u 61^  which is in the ARP 
region (Palmert et al., 1989; Esch et al., 1990; Seubert et al., 1993). When this 
occurs, a large soluble extracellular protein, protease nexin II, is released; since 
there is no intact ARP sequence in the released protein, there is no amyloid 
deposition by this mode of processing (Hardy and Higgins, 1992). However, 
cleavage by a "secretase," one of the several enzymes responsible for the 
processing of the APPs (Sisodia et al., 1990; Pasternack et a I., 1992), generates 
amyloidogenic peptides. The amino acid sequence of the ARP region of APP 
showing the proteolytic sites is given in Fig. 1.4.
Other evidence for cleavage of APPs is consistent with action occurring 
within the lysosomal/endosomal system (Golde et al., 1992; Haass et al., 1992). 
The lysosomal processing of APP leads to potentially amyloidogenic fragments, 
which could be further metabolized to produce ARP variants (Shoji et al., 1992). 
There may be other factor- which are equally important in forming amyloid 
deposits from the soluble ARP variants; these contributions could arise from 
processing of soluble ARP into aggregated forms (Knauer et al., 1992), and/or 
the association of ARP with other molecules (Wisniewski and Frangione, 1992).
12
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Fig. 1.4 Primary sequence of human Alzheimer G-protein, AGP, indicating the proteolytic sites. The non-amyloidogenic 
sites of the AGP region of APP (-] [-) which generate large soluble by-products are indicated above the 
sequence by *i. The cleavage sites that form the neuritic plaque amyloid peptides are given above the 
sequence by i, and those forming the cerebrovascular amyloid peptides are shown below the sequence by t*. 
The CNBr cleavage site in AGP is indicated by I.
1.3. Intrinsic Factors for AIJP Deposition
There have been several studies on the sequence similarities between 
the senile plaque core protein and the cerebrovascular amyloid (Glenner and 
Wong, 1984a; Masters et al., 1985; Selkoe, 1986; Selkoe et al., 1987). The 
heterogeneity in the amino and carboxyl termini of the isolated AGP variants 
would indicate differences in degradative pathways of the APP, or multiple 
proteolytic attacks on the amyloid protein (Miller et al., 1993). However, results 
from electron microscopy of purified brain amyloid (Glenner, 1980) mutually 
agree with synthetic peptides homologous to the AGP sequence (Kirschner et al.,
1987). The amyloid fibrils are observed to be rigid unbranched structures which 
self-associate and form twisted helices with a periodicity akin to the cross-G 
fibrils of Bombyx mori silk protein. The morphology of the CV and SP amyloid 
deposits and the fibrils formed by synthetic peptides indicate that there must be 
considerable inherent contribution from the peptide molecule. These intrinsic 
factors arise due to the amino acids constituting the protein(s), their positions 
along the peptide backbone, and the side chain contributions.
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1.3.1. Putative Salt-bridges in AGP
Kirschner et al. (1987) have proposed a salt-bridge between charged 
residues His13 and Asp23 as a mode for intersheet stabilization in synthetic G1 -28
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(Fig. 1.5), which exhibits fibrillar morphology similar to AGP. The formation of 
ion-pairs resulting in increased G-pleated sheet content has also been suggested 
on the basis of pH studies on synthetic AGP fragments G1-28, G1-39 and G1-43 
(Barrow and Zagorski, 1991; Fraser et al., 1991; Burdick et al., 1992). These 
observations are in agreement with the morphology of native SP amyloid isolated 
from post-mortem brain tissue (Masters et al., 1985). The pH dependence of 
AGP and enhanced G-pleated sheet structure in solution would suggest a strong 
contribution from the amino terminal region, which contains all the ionizable 
residues, to form stable oriented fibrils.
Fraser and colleagues (1991b, 1992; Inouye et al., 1993) maintain the 
importance of electrostatic interactions between His and Asp/Glu residues as the 
primary driving force for the fibril formation of G1-40 and its derived analogs. 
Their reversible fibril assembly/disassembly was pH-dependent which was 
consistent with observations of Masters et al. (1985) that oligomers of AGP 
occurred only when the histidine residues were ionized.
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1.3.2. Mutations in AGP of Different Origins
When compared to human AGP, there are three amino acid substitutions 
in the rodent AGP sequence, Arg5-Gly, Tyr10-Phe and His13-A rg which are 
present in the extracellular amino-terminal region. The human AGP readily forms
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Fig. 1.5 The hypothetical aggregation model for IS1-40 based on putative intersheet 
electrostatic interaction between His13-Asp23. The antiparallel fc-strands are 
shown with a meridian spacing of 4.7 A. The lysine residues, Lys16 
(darkened circles), in the sheets face outside. Only the first 24 residues have 
been indicated here for clarity.
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a cross-R structure, revealed by the X-ray diffraction study (Kirschner et al., 
1987), but the rodent ARP forms R-pleated sheets only under certain conditions 
(Otvos et al., 1993). The differences in primary sequence for the rodent ARP 
could account for its inability to form fibrillar deposits (Fraser et al., 1992; Otvos 
et al., 1993). On the other hand, the synthetic peptide corresponding to the 
Dutch variant of familial AD, hereditary cerebral hemorrhage with amyloidosis, 
Dutch type (HCHWA-D) with a single Gln22-Glu change greatly accelerates fibril 
formation (Wisniewski et al., 1991; Fraser et al., 1992; Fabian et al., 1993), 
indicating its greater propensity to form R-pleated sheets. It is intriguing to note 
that the fibrils formed by the Dutch mutant have the potential to act as templates 
speeding fibril formation by non-mutant peptides (Frangione et al., 1993).
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1.3.3. Hydrophobicity and Solubility
The two major fragments of the human ARP consist of R1-39 in the 
cerebrovascular amyloid (Glenner and Wong, 1984a) and R1-42 in the 
extracellular senile plaque deposits (Masters et al., 1985). Hilbich et al. (1992) 
have observed that substitutions of hydrophobic amino acids at the carboxyl 
terminus reduces the amyloidogenicity of peptides homologous to ARP. 
Synthetic peptide homologs of ARP with very different solubilities were also 
observed by Burdick et al. (1992). The hydropathic analyses of the primary
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sequence of ARP, based on Kyte-Doolittle and Fauchere-Pliska scales for 
hydrophilicity, are given in Fig. 1.6 (panel A). There are two regions with 
discrete hydrophobicity, the carboxyl end having maximum hydrophobicity, while 
the amino terminus is distinctly more hydrophilic. The hydrophobic carboxyl 
terminal is also the end terminus which has higher propensity for R-sheet 
formation according to Chou-Fasman analysis (panel B).
The intrinsic insolubility of ARP, arising due to the amino acid content 
and sequence of the peptide, was investigated by Halverson and coworkers 
(1990). By using the amide I band absorption, they found that the strong 
intermolecular interactions in the highly hydrophobic region comprising residues 
34-42 may be responsible for the inherent insolubility of this fragment. Their 
spectroscopic data also indicated that R26-33 and R34-42 fragments possessed 
ordered R-sheet structure in the solid state. For the R34-42 peptide, which 
contains at least 45% branched residues, the antiparallel R-sheet character in 
the solid state, and the unusual resistance to solvolysis, were only overcome by 
strong amide-chelating solvents like LiBr/THF (Halverson, 1992). The carboxyl 
terminal domain was therefore proposed as a major determinant of the 
aggregation of the ARP which could nucleate R-pleated sheets in amyloid fibrils. 
The reduction in solubility can be attributed to the increase in hydrophobicity for 
the larger fragments. There are reports that the Leu17-V a l21 region provides the 
hydrophobic cluster for packing of the synthetic amyloid fibrils (Fraser et al., 
1992; Inouye et al., 1993). The van der Waals interaction between amino acid
18
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side chains become increasingly important during stacking of the R-pleated 
sheets, and with a concurrent solvent-exclusion can pack the sheets tightly which 
would result in stable fibrils.
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1.3.4. Membrane Anchoring Site
There is mounting evidence that intact ARP variants are membrane- 
associated in fractions isolated from the cerebral cortex, cerebral microvessels, 
and leptomeningeal vessels (Wisniewski and Terry, 1973; Matsumoto and 
Fujiwara, 1991; Haass et al., 1992), platelets, and in bacilovirus-infected insect 
cell lines (Gardella et al., 1992; Ghiso et al., 1992; Gandy et al., 1992; 
Ramabhadran et al., 1993). The ARP sequence possesses a cell-adhesion site 
(Chen and Yankner, 1991). The Hopp-Woods designation, a measure of 
hydrophilicity (Fig. 1.6, panel A), locates a potential cell-adhesion site near the 
amino terminus of ARP. Ghiso et al. (1992) demonstrated that the -R H D S - 
sequence of the 109 amino acid carboxyl terminus (amino acids 5 to 8 in the ARP 
nomenclature) of APP, which includes the ARP, promotes cell-substratum 
adhesion. This larger fragment which contains the putative transmembrane and 
cytosolic regions of the APP, spontaneously forms amyloid fibrils. The 
cell-attachment region could anchor the ARP domain thereby inducing the 
proteolysis of APP, eventually leading to fibrillar aggregates.
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1.3.5. Secondary Structure of AIJP Variants
The presence of soluble forms of ARP variants emphasizes the dual 
nature possessed by the amino acid sequence in these proteins. It has been 
theorized earlier that inhibition to proteolysis of proteins liberated from the 
processing of APP can take place due to a change in conformation. In fact, a 
conformational change in the amyloid forming scrapie protein, PrPSc, is known 
to be responsible for its aggregation (Prusiner, 1991). In spite of being a 
debatable issue, the conformational state of ARP might be a key determinant in 
neurotoxicity (Kosik and Coleman, 1992). However, due to the existence of ARP 
in various conformational states which are modulated by its environment, one 
could speculate on the inconsistency between neurotoxicity reports from different 
laboratories. Based on the Chou-Fasman analysis (Chou and Fasman, 1977; 
1978) of its primary sequence (Fig. 1.6, panel B), ARP has inherent propensities 
of forming a-helical and R-pleated sheet structures.
There has been a proliferation of spectroscopic investigations on the 
secondary and tertiary structures of synthetic peptides homologous to the native 
ARP sequence. Using electron microscopy and X-ray diffraction, Kirschner and 
colleagues (1987) found that aggregates formed by the amino terminal domain 
comprising residues R1-28 resembled the in vivo amyloid of senile plaque cores. 
Solid state Fourier transform infrared (FTIR) spectroscopic studies on the 
hydrophobic carboxyl region, comprising R34-42, showed that it is made entirely 
of antiparallel R-pleated sheets (Halverson et al., 1990; Halverson, 1992).
21
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The circular dichroism (CD) spectroscopy done by several groups has 
shown that the amino terminus of A(3P, 131 -28, forms a-helical structure which 
can be modulated by the solution environment (Hollosi et al., 1989; Barrow and 
Zagorski, 1992; Burdick et al., 1992). The CD findings on the longer synthetic 
variant, 131-42, between pH 4 and 7 revealed that a secondary structure 
transition was accelerated at pH 5.5, suggesting that the Val40-A la42 segment 
was critical for the (3-sheet stability in solution (Barrow et al., 1992). The 
HCHWA-D sequence having a point mutation, Glu22 -* Gin, has the highest 
predicted (3-sheet content of any amyloid sequence (Fabian et al., 1993). Hollosi 
et al. (1989) used the smaller fragments, (31-12 and (311-25, and showed that 
these peptides, respectively, exhibited a random coil and antiparallel (3-pleated 
sheet structures in aqueous solutions. Employing high resolution nuclear 
magnetic resonance (NMR) spectroscopy, a short a-helical stretch between Ala2- 
His6 and a longer a-helical segment between Tyr10/Glu11-Ser26 was identified 
(Barrow and Zagorski, 1991; Sorimachi and Craik, 1994). In the rodent A(3P, 
having Arg5 -> Gly, Tyr10 _* Phe and His13 -> Arg substitutions, Otvos et al. (1993) 
found that a double conformational transition region located between residues 
9-19 in the extracellular domain. A commercial preparation of synthetic (31-40 
has been reported to form calcium-ion channels when incorporated into 
phosphatidyl-serine liposomes (Arispe et al., 1993).
Solid state dispersive infrared spectroscopy and CD were used to 
demonstrate the requirements for in vitro filament formation in synthetic amyloid
22
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peptides (Hilbich et al., 1991). These workers found that all the information 
leading to aggregation is stored in the 13-sheet forming sequence of the 12-43 
segment. Their results showed that the 10-42 fragment formed the core 13-sheet 
portion of filaments during aggregation; however, they also believe that residues 
29-42 primarily forms an oc-helix. With the aid of isotope-induced shifts in the 
amide I band, Halverson and coworkers (1991) found that the valine residues at 
positions 36, 39 and 40 are in the fl-pleated sheet region of the 1334-42 
aggregate, whereas Leu34, lie41, and the Gly37-G ly38 sequence were not part of 
an idealized cross-13 sheet due to a cis-amide linkage.
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1.3.6. Post-translational Modifications in ABP
The occurrence of D-amino acids in proteins as a post-translational 
modification is an important stereochemical event. Bada (1985) pointed out that 
in some cases, D-enantiomers arise spontaneously from racemization reactions 
related to the aging phenomenon. Altered forms of aspartic acid, viz., L-iso-Asp 
and D-Asp, were first detected in the protein partially purified and isolated from 
SPs (Shapira et al., 1988). The effects of racemization of Asp1, Asp7 and Ser8 
in ABP from the brain parenchyma may be to impart stability and proteolytic 
resistance in neuritic plaques (Roher et al., 1993). These isomerizations can 
cause structural alterations in the polypeptide backbone leading to functional
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changes in the AGP. In fact, the D-Asp levels in the brain proteins from rats are 
enhanced due to a high aluminum diet (Anderson et al., 1990).
Other modes of modifications in ARP involve oxidation of methionine 
residue at position 35 (Prelli et al., 1988), which inhibits cleavage by cyanogen 
bromide, or certain proteases. Deamidation and phosphorylation which occur 
in many proteins with time, could also influence fibril formation in ARP. Such 
modifications can have deleterious consequences on structure-function 
relationships of the proteins.
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1.4. Extrinsic Factors
The molecular organization and morphology of macromolecular 
assemblies seen in ARP deposits are also governed by the environment. Some 
of the extrinsic factors which modulate the peptide conformation include pH, 
temperature, metal ions and presence of other peptides and proteases. The 
association of aluminum with brain amyloid has gained much publicity with a 
specific focus on its neurotoxic role in Alzheimer disease. The compositions of 
CV and SP core amyloid deposits show considerable heterogeneity in both the 
amino and carboxyl termini lending credence to the hypothesis of multiple 
proteolysis (Glenner and Wong, 1984a; Masters et al., 1985). The role of these 
fragments in aggregation or stability of the deposit has not been studied.
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1.4.1. The Role of Aluminum
Metals are known to be good chelators of Asp-, His-, Glu- and Cys- 
amino acids. Metal ions also form complexes with the polypeptide backbone, in 
part due to the stabilization of the intermediate carbanion formed by the loss of 
a-H; and this interaction increases the racemization rate by several orders of 
magnitude (Buckingham et al., 1967). Elevated levels of D-asp in the brain 
proteins of rats have been observed when solutions of AICI3 were fed orally over 
a period often weeks (Anderson et al., 1990).
There are elevated levels of aluminum and other metals in the brain 
tissues of AD patients (McDermott et al., 1978, 1979; Markesbury et al., 1981; 
Thompson et al., 1988). High levels of aluminum have been found in the 
autopsied Alzheimer brain NFTs (Perl and Brody, 1980) and SPs (Candy et al., 
1986; Crapper et al., 1973). In the case of SPs, high levels of aluminosilicate 
were seen by some workers (Candy et al., 1986), while this observation is 
strongly contested by others (Landsberg et al., 1992). The fact that A l3+ has a 
high affinity for PO43" was proposed in the appearance of NFTs which include 
phosphorylated proteins (Perl, 1985).
Arispe et al. (1993) have found that A l3+ blocks calcium-ion channels 
which are formed by (3.1 -40. The amino terminus of AI3.P consists of aspartate, 
glutamate, and histidine residues, which are known to complex trivalent cations 
(Chalet et al., 1984). Aluminum ions have a potential to form interchain and 
intrachain peptide complexes and could increase the structural stability of the
25
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peptides by forming macromolecules using water-metal bridges (Hollosi et al., 
1994). It can be recalled that the intersheet distance of 4.7 A in 131-40 and 
derived analogs (Fig. 1.5) could be stabilized by accommodating such bridges. 
More recently, several workers have demonstrated that A l3+ interacts with 131-40 
in solution (Exley et al., 1993), while other reports include aggregation caused 
by A l3+, Fe3+ and Z n2+ (Mantyh et al., 1993; Kawahara et al., 1994).
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1.5.2. The Presence of Other Peptides and Proteins
The proteolytic cleavages occurring in APP takes place within the 
putative transmembrane sequence of AI3P which lead to the formation of amyloid 
deposits. While only 25-30% of the mass has been characterized, the protein 
content of amyloid deposits outnumber all other CV and SP proteins by a mole 
ratio of 40:1 (Miller et al., 1993). The amyloid deposits include peptides having 
frayed amino and carboxyl termini of AI3P (Roher et al., 1993). The AI3P has 
also been shown to be overexpressed in some, but not all, AD brains (Seubert 
et al., 1992; Cai et al., 1993). Other exogenous molecules which are good 
candidates for fibrillogenesis, and are ultrastructurally related with the amyloid 
fibrils include lipids, amyloid P component (Hind, 1986), and glycosaminoglycans 
(Snow et al., 1988). It is therefore important to understand the role of these 
peptides and proteins in the aggregation of AI3P.
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The fibril formation in synthetic peptides homologous to G1-40 is 
inhibited when incubated with human cerebrospinal fluid (Wisniewski et al.,
1993). Apolipoprotein isoforms E and J have been shown to bind to soluble AGP 
(Strittmater et al., 1993). The penchant for fibril formation is greatly enhanced 
in soluble synthetic AGP derived analogs by the presence of apo E3 and E4 
(Sanan et al., 1994). Since amyloid generation takes place over years, any 
increase in the nucleating agents would also result in considerable acceleration 
of the aggregation rate (Hofrichter et al., 1974). In fact, supersaturated solutions 
of AGP variants, G1-39 and G1-40 are stable for days, whereas an equimolar 
solution of G1-42 leads to precipitation of the peptide (Jarrett et al., 1993). This 
indicates that nucleation-dependent mechanisms might be important in the 
aggregation of soluble AGP (Jarrett and Lansbury, 1993). Moreover, the derived 
analogs, G26-39 and G26-40, precipitate from solution upon the addition of more 
hydrophobic fragments, G26-42 and G26-43 (Jarrett et al., 1993).
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1.5. Objectives
The collation of preliminary and published data gives rise to an 
emerging scene which includes parts played by the increased production of 
soluble AGP and AGP variants and their precursors, mutation and racemization,
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and external factors like pH, metal ions and solution environment. However, 
there are some important links missing from the picture. The foremost is the 
conversion of soluble ARP, which in its native physiological form has a mixture 
of secondary structures, to the predominantly stacked R-pleated sheet structure 
of the insoluble amyloid deposits. In the aged and diseased stage, this 
conformational change could be triggered by a host of endogenous and 
exogenous factors as described above.
This thesis sought to discover and identify the importance of the 
structural domains of ARP responsible for the intractable nature of the amyloid 
deposits. Since many amyloidogenic proteins having little or no sequence 
homology, but very similar morphology, it was hoped that tracing the pathway(s) 
followed by ARP might also provide better direction for understanding 
amyloidosis in other cellular dysfunctions. The role of secondary structure in the 
aggregation of ARP was studied by using synthetic R1-40 and derived analogs. 
Also, the role of aluminum in the conformational stability of the polypeptide 
backbone was investigated.
Chapter 2 describes the syntheses and purification of R1 -40 and derived 
analogs which were used for evaluating secondary structural characteristics. 
These analogs were investigated to provide clues for secondary structural 
changes by studying their chromatographic behavior. The reversed-phase high- 
performance liquid chromatography (RP-HPLC) studies are highlighted in 
chapter 3. The kinetics of secondary structure change in aqueous solutions of
28
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(31-40 and derived analogs were performed using circular dichroic (CD) 
spectroscopy and are elucidated in chapter 4. The association of aluminum with 
131-40 and (36-25 was studied using 27AI nuclear magnetic resonance (NMR) 
spectroscopy. The characterization of AI(lll)-complexed peptide species, and 
chromatographically-pure AI(lll)-bound 131-40 and (36-25 peptides based on their 
unique 27AI NMR resonances is covered in chapter 5.
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Chapter 2
Materials and Methods
Introduction
In order to understand the function of ASP, it is important to work with 
a protein which is amenable to structural investigations. To elucidate the 
process of aggregation in ASP, it is also necessary to study the protein as its 
structural domains, preferably in solution. To obtain an array of overlapping 
peptides in a soluble form, the investigations in this work utilized peptides 
containing D-amino acids, and substitutions of amino acids which are not present 
in the native ASP sequence. The natural sources of ASP variants, viz., the 
cerebrospinal fluid (Seubert et al., 1992), and the post-mortem AD brains 
(Glenner and Wong, 1984) yield only minuscule amounts of ASP, for instance,
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only 100 pg of AI3P per neuritic plaque core can be isolated (Miller et al., 1993). 
The manipulation of biological systems by genetic engineering to produce AI3P 
has been limited in the face of its structural novelty; however partial success has 
been achieved with bacterial cell lines to generate a larger cytosolic fragment of 
APP to yield 325 pg/mL of protein (Gardella et al., 1992; Ghiso et al., 1992). 
Chemical synthesis, on the other hand, has proved to be a valuable approach 
to manufacture a large number of A(3P variants in substantial quantities (Hendrix 
and Lansbury, 1992). A stepwise coupling of amino acids on a non- 
compressible support, usually a resin, offers a viable chemical approach for 
obtaining large amounts of peptides which are easily purified with a minimum of 
difficulty (Merrifield, 1963). The total synthesis of 131-40 and derived analogs 
using a stepwise solid-phase peptide synthesis (SPPS) approach utilized here 
have provided a practical tool to simultaneously manufacture peptide analogs in 
substantial amounts for the study of their structure-function relationships.
Any pretension to the ease of chemical synthesis of AI3P and derived 
analogs and the subsequent purification of the product is vehemently denied. 
The chemistry cannot be taken for granted, because experience has shown that 
subtle synthetic problems lurk even in the simplest of amino acid sequence 
(Kent, 1988). These problems are exacerbated by the difficult amino acid 
sequence of AI3P at the carboxyl terminus; some of which have been overcome 
by using exotic fragment-condensation to generate AI3P sequence analogs 
(Hendrix and Lansbury, 1992; Halverson, 1992). Most synthetic difficulties in
31
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AGP also involve large resin loadings - the propensity to form aggregates during 
synthesis has been repeatedly stressed by peptide chemists (Kent, 1988). The 
aggregation is intensified by the carboxyl terminal of AGP which forms 
antiparallel G-pleated sheets during synthesis (Halverson, 1992), and therefore 
requires extensive measures to keep the growing peptide chain solvated during 
the assembly of amino acids. The stepwise synthesis of 131-42 has also 
suggested difficulties during purification due to its insolubility (Burdick et al., 
1992) as compared to 131-40.
Keeping these factors in mind, SPPS was employed in this study to 
generate fragments of AGP, viz., G1-40 and derived analogs. Low resin loadings, 
and multiple couplings in conjunction with solvating agents were used during the 
stepwise assembly of the peptides; this approach eliminated the purported 
aggregation during stepwise assembly. Also, elimination of the two G-branched 
amino acids in the generally difficult -VG G W (/A )- sequence of G1-42 alleviated 
the aggravation of inefficient couplings during assembly of G1 -40. Forbearance 
coupled with low resin-loading usually terminated in yields satisfactory for the 
structural investigations of pure G1-40 and derived analogs; however, the 
assembly of forty amino acids starting with an initial hydrophobic sequence, and 
the coupling of the His-Arg and Arg-Arg sequence in the derived analogs 
warranted considerations unique to G1-40. A brief overview of the protocols 
employed in the stepwise synthesis of peptides, and their actual use in the 
synthesis of AGP and derived analogs is therefore in order.
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2.1. Problems and Strategies in Solid Phase Peptide Synthesis
of B1-40
The introduction of solid phase method for chemical syntheses of 
peptides by Bruce Merrifield (1963) has greatly improved the ability to generate 
large quantities of peptides; an improvement over solution methods where the 
primary obstacle was the poor solubility of protected intermediates (Wieland, 
1978). Also, unnatural and/or unusual amino acids can be easily incorporated 
in the growing peptide chain, which is useful for structure-function studies in 
proteins and peptides. The severity of reaction conditions during solid-phase 
peptide synthesis, v/z., large excesses of reagents, extended reaction times, and 
elevated temperatures mandates side chain protection in the amino acids 
(Atherton and Sheppard, 1987). The Merrifield technique employs tert- 
butyloxycarbonyl (tboc) protection for the a-amino group, and the amino acids 
are assembled sequentially from the carboxyl to the amino terminus on a non- 
collapsible solid support, usually a clay or resin. The lability of the resin-peptide 
bond depends on the chemical nature of the linking group of the support to the 
first amino acid. However, the use of repetitive acidolysis causes cleavage of 
the peptide from the resin during assembly (Fankhauser et al., 1973), and partial 
acetylation (Kent et al., 1979) leading to undesired side products. Also, the 
removal of tboc protective group requires use of the very corrosive hydrofluoric 
acid, mandating special handling and equipment. Moreover, some of the 
side-chain protecting groups are not completely removed by strong acids.
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The orthogonal approach of side-chain protection and coupling by the 
use of 9-fluorenylmethoxycarbonyl (fmoc) amino acids provides a safer and more 
efficient alternative to the Merrifield chemistry of peptide synthesis. The 
protected side chains are easily cleaved by a relatively safe, trifluoroacetic acid 
(TFA), to which appropriate scavengers are added. The orthogonal strategy of 
fmoc-chemistry involves a simultaneous protection of the growing peptide chain 
at the amino end by the fmoc-group and the use of protected amino acid esters 
(Udenfriend and Meienhofer, 1979-1985). During cleavage from the resin, a 
concurrent deprotection of the amino acids gives the crude peptide which is 
subsequently purified by preparative and analytical chromatography.
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2.1.1. Solvation of Solid-Phase
The most important and fundamental consideration during SPPS is the 
macroscopic insolubility of the solid support (Sarin et al., 1980), and the 
solvation of the resin-peptide (Kent, 1985). The ability of a resin to swell is 
directly related to the net increase in free energy from solvation of the linear 
peptide chain. However, with a sequence of nonpolar amino acids and side 
chain protecting groups the peptide is prevented from dilution by solvent, 
eventually leading to decrease in the free energy of peptide within the resin 
matrix and shrinking of the resin (Sarin et al., 1980). The resultant collapse of
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the peptide-resin leads to truncated sequences; this problem of keeping the 
peptide-resin solvated during assembly is exacerbated in peptides forming 
ft-pleated sheets (Kent, 1985), like AGP. Use of polar solvents, like 
dimethylformamide (DMF) helps in alleviating this condition by simultaneously 
solvating the nonpolar groups and also swelling the resin (Sarin et al., 1980; 
Atherton and Sheppard, 1985). The use of higher substitutions which lead to 
higher overall peptide yields results in peptide-resins whose solvation has 
changed substantially during the course of synthesis (Sarin et al., 1980). For the 
purpose of syntheses of R.1-40 and derived analogs it was therefore simpler to 
use loadings which gave less than 1 g peptide per gram of resin.
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2.1.2. Side-Chain Protection in Fmoc-Amino Acids
Most of the amino acids of the AGP contain functional side chains, e.g., 
acidic carboxyl groups (aspartic, glutamic acids); basic residues (lysine, 
histidine, arginine); and hydroxyamino acids (serine, tyrosine). The various 
side-chain protecting groups for these amino acids are summarized in Table 2.1, 
and their use during coupling of these amino acids is highlighted below:
(a) Aspartic and Glutamic acids: The side chains of aspartate and glutamate 
residues are in excellent position to form the respective succinimide and 
pyrrolidone carbonyl derivatives (Fig. 2.1). These reactions can be avoided by
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using sterically hindered esters which minimize the ring-forming interactions, 
f-butyl (fBu) esters of aspartic and glutamic acids were used for the ease during 
acidic cleavage,.
(b) Histidine: The imidazole (im) of histidine gets partially acylated during 
coupling reactions and the acyl-im can promote acyl transfer side reactions. 
Imidazole ring is in itself a powerful catalyst of chiral a-carbons and facilitates 
self racemization of the carboxyl-activated histidine. Alkyl derivatives can be 
located on the n- or the x-nitrogen atom of the im, and the acid-labile f-benzyl- 
oxycarbonyl (fBoc) compound (Fig. 2.2) is considered appropriate for fmoc- 
histidine. The im-boc derivative exhibits substantial stability toward deprotection 
and acylation steps during the peptide chain growth (Atherton et al., 1987).
(c) Arginine: The exceptionally high basicity of the guanidine group of 
arginine mandates special attention during stepwise synthesis. The side-chain 
monoacyl derivatives (benzyloxycarbonyl, butyloxycarbonyl) when assigned to 
the co-nitrogen offer limited protection and are susceptible for lactam formation 
(see Fig. 2.3). Diacyl derivatives could be better in preventing unwanted 
secondary peptide chain growth (Atherton and Sheppard, 1987). The 4- 
methoxy-2,3,6-trimethylbenzenesulfonyl derivative (Mtr) however has been found 
to be a useful protective group for guanidine, and also acid-labile (Atherton et 
al., 1983). However, complications arise during deprotection when His-Arg and 
Arg-His sequence is encountered due to partial conversion of arginine to 
ornithine. The deprotection of Arg(Mtr) is dealt separately in a later section.
36
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(d) Lysine: The protection offered by benzyloxycarbonyl group to the lysine 
side chain is considered adequate. The pentafluorophenyl (OPfp) ester of 
boc-Lys couples reliably and the boc functionality is acid-labile, requiring no 
special techniques (Atherton et al., 1981).
(e) Tyrosine: The f-butyl group protects the phenolic side chain of tyrosine 
rather well and is easily liberated during treatment with trifluoroacetic acid 
solutions (Stewart and Young, 1984).
(f) Methionine: Unprotected methionines oxidize to methionine sulfoxide 
when cleaving with trifluoroacetic acid (Stewart and Young, 1984). While this is 
reversed by the use of A/-methylmercaptoacetamide (Houghton and Li, 1979), 
avoiding oxidation by using ethylmethylsulphide (EMS) during cleavage of 
peptide from the resin support is equally satisfactory.
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2.1.3. Activation of Fmoc-Amino Acid Esters
Merrifield chemistry uses f-boc amino acids which are activated and 
coupled as preformed symmetrical anhydrides in methylene chloride (Kent, 
1988). Unfortunately, the fmoc-amino acids are not so readily soluble in 
methylene chloride and are sterically hindered to form anhydrides. This minor 
inconvenience is overcome by using activated esters of the respective 
fmoc-amino acids. Efficient couplings have been shown for pentafluorophenyl
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(OPfp) esters (Kisfaludy and Schon, 1983) in the presence of 1-hydroxy- 
benzotriazole (HOBt) as catalyst (Atherton et al, 1988). While the OPfp esters 
are suitable for most of the amino acids, the analogous 2-hydroxy-4- 
oxodihydrobenzotriazole (Dhbt) esters prove necessary for serine and threonine 
since their OPfp esters are relatively insoluble in DMF. The generic OPfp and 
Dhbt esters of the fmoc amino acids are shown in Fig. 2.4. However, caution has 
to be exercised when using Dhbt ester of fmoc-serine since under appropriate 
reaction conditions, undesirable azidobenzoate is formed (Fig. 2.4) which leads 
to truncation of the peptide chain (Atherton et al., 1988).
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2.2. General Procedures for Synthesis and Purification of 111 -40 
and Derived Analogs
At the time this thesis was begun, there was a necessity to come up with 
a satisfactory stepwise SPPS protocol for 131-40, as large quantities of this 
peptide and its constituent fragments were desirable using the minimum steps. 
Since the stability of the synthetic peptide(s) was also evaluated over time, large 
amounts of peptides readily obtained by the stepwise protocol were needed. 
Initially, the stepwise syntheses of 131 -28, 131 -40 and 136-25 were performed on 
a Milligen/BioSearch semi-manual peptide synthesizer.
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Table 2.1
Summary o f Fmoc-Amino Acids' Protecting and Blocking Groups During SPPS
Amino Acid Protecting Group1
Asp, Glu OtBu
Asn, Gin Mbh, Trt
Ser, Tyr fBu, ODhbt
His Fmoc, Trt
Lys Boc
Arg Mtr, Pmc
1 Abbreviations:
Fmoc 9-fluorenylmethoxycarbonyl-
OtBu, fBu terf-butyl-
Mbh 4,4-dimethoxybenzhydryl-
T  rt trityl-
ODhbt 3,4-dihydro-4-oxo-benzotriazin-3-yl-
Boc f-butoxycarbonyl-
Mtr 4-methoxy-2,3,5-trimethylbenzenesulfonyl-
Pmc 2,2,5,5,7-pentamethylchroman-6-sulfonyl-
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Fig. 2.1 Side-chain esters in aspartate and glutamate residues form cyclized derivatives. 
Sterically hindered esters, R = f-butyl or cyclohexyl, minimize these interactions.
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Fig. 2 .2  Self-racemization in histidyl residues - differentiation of k-  and r-derivatized histidine 
residues. The intrinsic activity of the two side-chain nitrogens is similar, and both 
mechanisms can be made inoperable by placing electron-withdrawing groups (P 
= Trt, or Fmoc). The a-am ino protecting group, P", is Fmoc.
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Monoacyl arginine derivative Lactam derivative
Fig. 2.3 Cyclization in the arginyl guanidine group; lactam formation from activated carboxyl. The  
ring formation is accelerated by a base.
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Fig. 2 .4  Pentafluorophenyl (OPfp) and 3,4-dihydro-4-oxobenzotriazin-3-yl (ODhbt) esters of 
fmoc-amino acids. Formation of azidobenzoate takes place on activation of the triazine 
of ODhbt by carbodiimide, which is in turn attacked at the ring carbonyl of the second 
molecule. Formation of the azidobenzoate species leads to chain termination when 
Fmoc-Ser-ODhbt is used during SPPS.
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For the assembly of (31-40 and its fragments, 100% dry 
dimethylformamide (DMF) provided a good solvation and coupling medium for 
the polyamide-kieselguhr resin-peptide. Additionally, the use of 10% anhydrous 
trifluoroethanol (TFE) or hexafluoroisopropanol (HFIP) in dry DMF during 
multiple couplings was found to be extremely efficient for the stepwise assembly 
of the 40 to 29 segments of 131-40 and 138-40. Also, the resins used had low 
subsitutions, 0.07-0.1 mEq which resulted in lower overall yields of peptides but 
did not result in truncated sequences or secondary peptides. By using higher 
syntheses temperatures, coupling efficiency was greatly improved. Typical 
temperatures between 40° and 42°C were obtained and this was deemed 
effective in increasing the coupling of the activated fmoc-amino acid esters.
2.2.1. Stepwise Synthesis of Protected Peptides
The (31-40 and derived analogs were assembled either by (i) peptide 
elongation on Pepsyn KA-Axx-Fmoc resins, or (ii) preparing the Pepsyn KA resin 
with the starting amino acid, i.e., Fmoc-Axx, where Axx represents the amino 
acid. Before assembling the peptides, quantitative amino acid analysis was 
performed to determine the level of resin substitution. Typically, <0.1 mmol/g 
(0.07-0.09 mmol/g) resin equivalent was used. This alleviated the purported 
aggregation on the resin for the larger fragments. (31 -40 has a very hydrophobic
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carboxyl end, viz., residues 29-40 (Fig. 1.5) for which the standard coupling 
schemes cannot be satisfactorily applied. The special coupling techniques used 
for the 40 to 29 segment included (a) triple couplings, (b) increased 
temperatures, and (c) either 10% TFE or HFIP solution in DMF. During coupling 
of the protected fmoc-amino acid, the OPfp esters were activated to anhydrides 
in DMF using HOBt. The cleavage of the fmoc group during the coupling step 
was performed by the use of a relatively mild base, 20% piperidine (PIP), while 
the resin-peptide linkages were cleaved by TFA having appropriate scavengers.
The general methodology for stepwise Fmoc-SPPS is schematically 
shown in Fig. 2.5. The starting resin (1.0 g) was allowed to swell at room 
temperature for 15 min in dry DMF. The finer resin particles were decanted 
before the swollen resin was loaded in 10 cm glass columns available from 
Millipore, Marlborough, MA. The first synthetic cycle involved washing the resin 
with 100% dichloromethane (DCM) for 10 min. The fmoc-amino acid attached 
to the resin was deprotected using PIP. The next fmoc-amino acid was coupled 
as its activated ester and the deprotection-coupling cycles repeated for the 
desired peptide sequence. The progress of the coupling steps was qualitatively 
monitored by the absorbance of the deprotected fmoc group at 365 nm after 
each coupling cycle.
The activation and coupling criteria for the amino acids used for the 
semi-manual syntheses of IS1-40 and derived analogs were as follows:
45
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(i) Fmoc-Val, Fmoc-lle, Fmoc-Leu and Fmoc-Tyr(tBu): Dissolve a 4-fold 
excess of the amino acid in 10 ml_ of dry DMF, activate using equimolar
1-hydroxybenzotriazole (HOBt), vortex, let stand for 15-30 min, inject through a 
0.5 pM filter into loop, couple for 120 min, 10% TFE or HFIP in DMF used as 
solvating agent, temperature of solvents maintained between 40° and 45°C;
(ii) Fmoc-Gly and Fmoc-Ala: Same as in (i), except that coupling times were 
reduced to 60 min after Gly25, 10% TFE or HFIP in DMF, temperature of solvents 
maintained between 40° and 45°C;
(iii) Fmoc-His(Fmoc), Fmoc-Lys(tBoc), Fmoc-Asp(tBu), Fmoc-Glu(tBu), 
Fmoc-Asn and Fmoc-GIn: Same as in (i), however coupling was performed for 
90 min at room temperature;
(iv) Fmoc-Arg(Mtr): Same as in (i), except for the monosubstituted Arg13 and 
Arg14 analogs where coupling was extended for 180 min and assembly was done 
at room temperature;
(v) Fmoc-Ser(ODhbt): Fmoc-Ser(ODhbt) was chromatographed for purity 
before coupling; same as in (i), however the activated ester solution was kept 
cold at 5°C. The occurrence of substantial syntheses-impurities terminating at 
Ser8 and Ser26 was randomly observed. These failed sequences were later 
traced to certain Fmoc-Ser(ODhbt) batches used during syntheses. 
Chromatographically-pure Fmoc-Ser(ODhbt) esters were used to avoid this 
minor inconvenience in the subsequent preparations of 111-40 and derived 
analogs;
4 6
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(vi) Fmoc-D-Asp(tBu): Same as in (i), except the coupling times were 
150 min for the tri-D-substituted analog of (31-40.
Analogous methodology was used for obtaining the derived analogs 
f31-28, (3.6-25, (322-35, (315-28 and the 'synthesis-impurities' (38-40 and (326-40. 
In the case of (31-40, D-Asp was substituted at positions 1, 7 and 23 to give the 
respective [D-Asp17'23](31-40, [D-Asp723]l31-40, [D-Asp1'23]l31-40, [D-Asp17](31-40 
and the mono-substituted D-analogs of (31 -40. (36-25 was also synthesized with 
D-Asp substitutions at 7 and 23. The complete array of peptides synthesized for 
this study is given in Table 2.2.
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2.2.2. Cleavage and Deprotection Methods
Certain amino acids are susceptible to interfering reactions during 
cleavage of the side-chain protecting groups using TFA. Of particular concern 
was the Mtr group protecting Arg residues. Moreover, the low-resin loading 
employed required optimization of the yield of pure peptides. This was done by 
systematically employing a battery of cleavage mixtures containing scavengers, 
viz., phenol, thioanisole, 1,2-ethanedithiol (EDT), EMS, in order to standardize 
the most effective protocol for each peptide analog. The general scheme used 
was a variation from published procedures and is represented in Fig. 2.6. The 
following cleaving cocktails containing the scavenging agents were used:
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(i) Reagent Z: 90% TFA, 5% phenol, 5% H20,
(ii) Reagent E: 70% TFA, 25% EDT, 5% H20,
(iii) Reagent R: 87% TFA, 6.5% thioanisole, 4% EDT, 2.5% anisole,
(iv) Reagent K: 83.5% TFA, 5% phenol, 5% thioanisole, 4% EDT, 2.5%
anisole. With Met containing peptides, 1 part EMS was added to 99 parts of 
cleaving mixture. All reagents were freshly prepared on a v/v basis, sonicated 
for 10 sec and kept under nitrogen in the dark during use. The comparison of 
the cleavage and deprotection protocol for 131-40 and 136-25 is given in 
Table 2.3.
The resin-bound peptide was dried in vacuo to remove all traces of DMF 
or DCM. Cleaving reagent was then added; the proportion was usually 5 ml_ for 
each 100 mg and an additional 1 mL for each 10 mg of resin-peptide. An 
atmosphere of nitrogen or helium was always maintained in the reaction flask. 
The reaction flask was covered with aluminum foil to shield the mixture from light. 
All cleavage reactions were carried at room temperature.
Aliquots (100 pL) were drawn every hour in polypropylene tubes after 
2 h, filtered and were vacuum centrifuged. This resultant crude product was 
treated with 500 pL cold diethyl ether at 4°C three times to remove all traces of 
residual organics. The presence of the expected peptide was established by 
Vis/UV spectroscopy and on the basis of extinction coefficients of Tyr, 
e275 = 1400 M'1cm'1 and e258 = 195 M'1cm'1 for all peptides. Additionally, thin 
layer chromatography (TLC) was performed to verify the extracted components.
4 8
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Silica gel 60 (2.5 X 7 cm plates) was used and the developing solvent was 
CHCI3:MeOH:HAc::80:15:5. Visual identification was done after placing the TLC 
plate in another chamber containing 4N HBr in glacial HAc for 15 min, spraying 
with ninhydrin, and heating.
The bulk of the reaction mixture was ready for further treatment when no 
differences between the consecutive aliquots were observed. After filtering and 
washing the bulk resin with two aliquots of 2 mL of cleaving reagent, the filtrate 
was concentrated on a rotary evaporator. The crude product was washed with 
cold diethyl ether to remove all traces of cleaving reagent and blocking groups. 
The bulk product was dissolved in 2% HAc and these peptide solutions were 
filtered through Millipore Millex 0.5 pM filters, followed by desalting on Biogel P-6 
columns. Additional desalting was done on 0.5 cm disposable C18 columns by 
applying 0.2 mg/mL solutions. Peptides were usually recovered (90-97%) by 
running 40% to 50% MeCN containing 0.2% TFA. The eluting peptide fractions 
were lyophilized using a Labconco freeze dry Lyph Lock 4.5 system, and the 
amorphous residues were stored under helium or nitrogen at -70° C.
Custom peptide syntheses of (3.22-35 and the 20-mer cytoplasmic 
carboxyl terminal (GC-pep) of the full length APP695 was done by Cambridge 
Research Biochemicals, MA, USA. For long term storage, the peptide-resins 
were stored after drying to constant weight at -70°C in polystyrene tubes or glass 
vials under an inert atmosphere. These were taken up for cleavage and
4 9
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Fig. 2.5 General scheme for the total synthesis of IS1-40 and derived analogs by SPPS. The
side-chain protected amino acids are denoted b y  defined in Table 2.1. The starting
resin for G1-40 synthesis was either (i) Pepsyn-KA-Val-Fmoc (purchased pre-linked, or 
prepared by coupling the Fmoc-AA to resin), or (ii) PS-PEG-Val-Fmoc.
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Fig. 2.6 Cleavage, deprotection and isolation schemes for the AGP fragments.
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ARP Analogs Synthesized for Chromatographic and Spectroscopic Studies
Table 2.2a
Number Peptide Primary sequence
1 81-40 D l-A -E-F-R-H-D7-S-G -Y-E-V-tf13-H 14-Q-K-L-V-F-F-A-E-D23-V-G-S-N-K-G-A-l-l-G-L-M -V-G-G-V-V
2 [Arg13]G1-40 D -A-E-F-R-H-D-S-G -Y-E-V-R13-H-Q-K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-l-l-G-L-M-V-G-G-V-V
3 [Arg’4]IS1-40 D -A-E-F-R-H-D-S-G -Y-E-V-H-R14-Q-K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-l-l-G-L-M-V-G-G-V-V
3A [Arg'314](J1-40 D-A-E-F-R-H-D-S-G -Y-E-V-R13-R 14-Q-K-L-V-F-F-A'E-D-V-G-S-N-K-G-A-I-I-G-L-M -V-G-G-V-V
4 [Arg13,D-Asp23]tJ1-40 D-A-E-F-R-H-D-S-G -Y-E-V-R '3-H-Q-K-L-V-F-F-A-E-D-D23-V-G-S-N-K-G-A-i-l-G-L-M -V-G-G-V-V
5 [Arg14,D-Asp23]IJ1-40 D -A-E-F-R-H-D-S-G -Y-E-V-H-R14-Q-K-L-V-F-F-A-E-d-D 23-V-G-S-N-K-G-A-I-I-G-L-M -V-G-G-V-V
6 [D-Asp’]81-40 d-D ’-A-E-F-R-H-D-S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-I-I-G-L-M -V-G-G-V-V
7 [D-Asp7 23] 81-40 D-A-E-F-R-H-d-D 7-S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-d-D 23-V-G-S-N-K-G-A-I-I-G-L-M -V-G-G-V-V
8 [D-Asp,723]81-40 d-D 1-A -E-F-R-H-d-D 7-S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-d-D 23-V-G-S-N-K-G-A-I-I-G-L-M -V-G-G-V-V
a continued on next page
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Table 2.2 (contd.)
Number Peptide Primary sequence
9 81-28 D -A-E-F-R-H-D-S-G -Y-E-V-H13-H 14-Q-K-L-V-F-F-A-E-D-V-G-S-N-K
10 [Arg13](51 -28 D-A-E-F-R-H-D-S-G -Y-E-V-R13-H-Q-K-L-V-F-F-A-E-D-V-G-S-N-K
11 [Arg14](51 -28 D-A-E-F-R-H-D-S-G -Y-E-V-H-R ’4-Q-K-L-V-F-F-A-E-D-V-G-S-N-K
12 [Arg1314]81-28 D-A-E-F-R-H-D-S-G -Y-E-V-R13-R 14-Q-K-L-V-F-F-A-E-D-V-G-S-N-K
13 86-25 H-D7-S-G -Y-E-V-H 13-H ’4-Q-K-L-V-F-F-A-E-D23-V-G
14 [Arg13]86-25 H-D-S-G -Y-E-V-R ,3-H-Q-K-L-V-F-F-A-E-D-V-G
15 [Arg’4]86-25 H-D-S-G -Y-E-V-H-R ’4-Q-K-L-V-F-F-A-E-D-V-G
16 [Arg1314]86-25 H-D-S-G -Y-E-V-R13-R 14-Q-K-L-V-F-F-A-E-D-V-G
17 [Argl314,d-Asp23l86-25 H-D-S-G -Y-E-V-R ,3-R 14-Q-K-L-V-F-F-A-E-d-D23-V-G
18 [d-Asp23]86-25 H-D-S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-d-D 23-V-G
19 [d-Asp7 23]86-25 H -d-D7-S-G -Y-E-V-H-H-Q-K-L-V-F-F-A-E-d-D23-V-G
20 8 8 4 0 S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-l-l-G -L-M-V-G-G-V-V
21 8 2 6 4 0 S-N-K-G-A-l-l-G-L-M-V-G-G-V-V
The peptides are designated by the numbers given in bold; these numbers are referred in the succeeding tables and figures.
The bold face peptide labels indicate the native sequence analogs of (51-40 for which the primary sequence is indicated by the single letter code 
of amino acids; the italics indicate the amino acid substitutions in the derived analogs.
The amino acids given in bold in the derived analogs indicate the substitutions.
Ul
CO
purification as and when needed. Impure fractions arising due to inappropriate 
storage of purified peptides were eliminated due to their better stability at -70°C, 
and especially if the peptide was left on the solid phase.
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2.2.3. Evaluation of the Stepwise Solid-Phase Syntheses
Purification using reverse-phase chromatography
All deprotected peptides were chromatographed on reversed-phase 
(RP) columns before characterization by Edman degradation and quantitative 
amino acid analyses. Two high-performance liquid chromatography (HPLC) 
systems were employed for purification: (i) an initial semi-preparative system, 
and (ii) analytical system. A SpectraPhysics Model 570 pump, and an Extended 
Range 8100XR Liquid Chromatograph replete with a thermostated column 
chamber were used and semi-preparative chromatography was performed on two 
semi-preparative C18 columns: a Vydac 10 X 300 mm, 50-100 pM, 300 A, and an 
Altex 8 X 150 mm C18. The following gradients were employed for purifying the 
crude peptides: (a) a linear AB gradient from 0-100% B in 30 min at a flow rate 
of 10 mL/min; Solvent A: 0.1% TFA in 15% MeCN; Solvent B: 0.1% TFA in 75% 
MeCN, or (b) isocratically with 40% MeCN containing 0.1% TFA at elevated 
column temperatures appropriate to the peptide. All solvents were degassed by 
sonication for 30-40 min or sparged with helium during chromatography.
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Peptides (8-10 mg) were introduced as aqueous solutions (2 ml_) for each 
semi-preparative run and the eluting peptide fractions were recovered, pooled, 
and lyophilized to yield fluffy amorphous powders. These fluffy products were 
dissolved in 2-10% acetic acid (HAc), the solutions were vigourously vortexed, 
filtered using Millipore Millex 0.22 /^M filters and the filtrate was subjected to 
analytical chromatography.
Analytical reversed-phase high performance liquid chromatography (RP- 
HPLC) was performed using dual Waters Model 510 pumps operated via a 
Baseline 810 chromatographic workstation. A Waters U6K injector with a 200 
lA. loop, and two Waters 441 detectors operating at 214 and 254 nm completed 
the dedicated peptide purification setup. The following columns were employed 
for analytical purifications: Vydac 4.6 X 150 mm, 5 p, 300 A C18, 4.6 X 300 mm, 
5 p, 300 A C4 and C8, and Beckman Ultrasphere ODS 5 p, 300 A C18. The flow 
rate for all analytical chromatography was 1.0 mL/min using linear AB gradients 
at room temperature. Mixtures of solvents A (0.1 % TFA in 0-20% MeCN), and 
B (0.1% TFA in 60-100% MeCN) were composed as per the peptide 
chromatographed. Linear gradients were used for the more hydrophilic peptides, 
whereas 1326-40 was purified isocratically. For each analytical separation, 
typical loadings contained between 0.1-0.3 mg peptide as aqueous solutions 
containing 10 pL MeCN. The appropriate fractions were pooled, lyophilized 
immediately and the pure peptide verified for sequence and amino acid 
analyses.
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The summary of yields for the 131-40 and 136-25 analogs is given in 
Table 2.3. The yields of pure peptides, as determined by quantitiative amino 
acid analyses, varied between 50-80% (based on the resin) from all the 
syntheses. The analytical RP-HPLC profiles for 131-40 using the cleaving 
protocols given in Table 2.3 are depicted in Fig. 2.7. The 'apparent' increase in 
the amount of impurities with inappropriate cleavage was determined to be due 
to the higher extinction coefficients of the organic protecting groups, and are 
therefore not a true representation of synthesis or deprotection efficiency. The 
increase in the pure peptide content indicates the actual efficiency of each 
cleavage/scavenger mixture as seen from the summary in Table 2.3. The 
generation of microheterogeneity from a typical truncated sequence during 
synthesis off31-40 is illustrated in Fig. 2.8. A more detailed evaluation of these 
synthesis-fragments is undertaken in chapter 3.
A clear picture of improper deprotection and interfering side reactions 
during cleavage of 136-25 and the [Arg13]l36-25 derived analog is illustrated by the 
RP-HPLC profiles given in Fig. 2.9. The Mtr group released during deprotection 
of Arg had reacted with thioanisole giving a seemingly large impure fraction. The 
actual content of the incompletely deprotected [Arg13]l36-25 was 6 mole% based 
on quantitative amino acid analysis. These results are summarized in Table 2.3.
Further characterization of the peptides in solutions was done by size 
exclusion chromatography (SEC). A Millipore FPLC with a Waters 425 tunable 
UV Detector operating at 214 nm was used to perform SEC on Protein Pak
56
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Fig. 2.7 Analytical RP-HPLC elution profiles of crude 131-40 as a time-dependent function of 
cleaving mixtures, (a) Reagent Z, (b) Reagent E, (c) Reagent R, and (d) Reagent K. 
The chromatography was performed on a 4.6 X 300 mm Beckman Ultrasphere C 18 
column operated at ambient temperatures. A linear gradient from 0-100%B in 60 min 
was used at a flow rate of 1.0 mL/min using solvent A as 0.1%  TFA and solvent B as 
0.1% TFA in 80% MeCN. The column was equilibrated in solvent A for 10 minutes prior 
to start of the gradient.
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Fig. 2.8 Analytical RP-HPLC profile of a representative impure synthesis of 131-40 showing the 
elution of (326-40 and 138-40 synthesis-fragments. Chromatographic conditions as given 
in Fig. 2.7. The identity of the fractions indicated by arrows were determined by 
quantitative amino acid analysis and Edman sequencing.
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Fig. 2.9 Analytical RP-HPLC elution profiles for crude (16-25, [Arg’3](J6-25, and [Arg(Mtr)]G6-25.
Chromatographic conditions as given in Fig. 2.7. The peak eluting just before 30 min is 
the incompletely deprotected [Arg(Mtr)]S6-25 seen in panels (A)-(C), while the broad 
hydrophobic component in (C) is Mtr/thioanisole. The pure [Arg13]l36-25 derived analog 
elutes near 25 min, as seen in (D).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
60
Table 2.3
Comparison of Methods of Deprotection and Cleavage for all Synthetic
Analogs
Method
(51-40
m g’ (% )2
[Arg13]
(51-40
mg1(% )2
[Arg(Mtr)]
(51-40
(% )2
(56-25 
mg1 (% )2
[Arg13]
(56-25
m g1 (% )2
[Arg(Mtr)]
(56-25
(% )2
R eagentR
3 hours 45 (69.2) 40 (61.2) 18.8 34 (85.0) 28 (70.8) 13.3
6 hours 9 (81.0) 46 (70.5) 8.0 34 (86.2) 28 (80.8) 6.0
ReagentK
2 hours 48 (72.5) 43 (65.1) 21.7 35 (84.5) 29 (83.4) 12.3
4 hours 50 (77.7) 44 (68.9) 13.2 37 (92.8) 32 (91.0) 5.1
R eagentE
4 hours 36 (58.7) 20 (31.3) 41.1 37 (91.1) 22 (62.6) 25.6
overnight 40 (61.2) 23 (33.3) 36.2 32 (85.4) 18 (58 .5 ) 20.0
R eagentZ
4 hours 35 (48.8) 15 (23.3) 65.5 36 (90.6) 16 (45 .5 ) 40.4
overnight 38 (51.5) 17 (28 .9 ) 55.3 36 (91.8) 17 (48 .2 ) 38.6
The recovery of crude peptides were based on 200-250 mg of resin-peptide. The resin 
substitutions 0.084 mEq for (51-40, and 0.09 mEq for (56-25.
The percentages were based on calculations from analytical RP-HPLC of the crude 
peptides. The amounts of peptides were based on the extinction coefficients for all the 
indicated peptides at 214 nm, and quantitative amino acid analyses.
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TSK300SW gel 10 X 300 mm and Sephadex-G250 10 X 450mm columns. The 
peptides were chromatographed using 0.1% TFA in 50% acetonitrile (MeCN) 
containing 100 mM KCI at a flow rate of 0.25 mL/min. The molecular weight 
markers used as calibration standards were BSA (64 kDa), myoglobin (16 kDa), 
cytochrome c (12 kDa), aprotinin (6 kDa), ft-chain of insulin (3.5 kDa) and 
bacitracin (1.4 kDa).
Amino acid sequence analyses during synthesis
Progressive verification of the assembled amino acids was done by 
subjecting the resin-peptide to gas-phase sequencing on a Model 6600 
ProSequencer from MilliGen equipped with on-line PTH identification unit. The 
resin-peptide was washed with DMF, dried in vacuo, and a polyvinylidene 
difluoride (PVDF) membrane sandwich was prepared. The resin-peptide-PVDF 
sandwich was sealed on all sides with a spatula to entrap the resin-peptide. Two 
peptide bearing resin beads were sufficient for sequence analysis with an 
equivalent PTH derivative in pmol range (Matsudaira, 1987).
Sequence analyses was only qualitative at this stage and was used to 
verify the assembly of fmoc amino acid esters on the resin. The resin-peptides 
routinely tested were those containing the hydrophobic carboxyl terminal, 
especially, the 29 to 40 segment, and the D-Asp containing peptides. High noise 
levels were usually developed during later cycles for the sandwiched resin 
sequencing and assignments were difficult. Substitution of
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1.5% diidopropylethylene amine (w/w) for the coupling base gave reasonable 
background (Farnsworth et al., 1991). Proper assignment of the two serine 
residues present in the longer peptides was accomplished by lowering the 
cartridge temperature to 45°C (Scott et al., 1988).
Post-synthesis sequence analyses
The sequence of the assembled peptide was verified on 
chromatographically-pure peptides after the RP-HPLC purification. The peptides 
were covalently attached on PVDF membranes impregnated with 
diisothiocyanate (DITC) obtained from Millipore. Attachment buffer was 5% 
N-methylmorpholine (NMM) in 70% methanol containing 0.1% cyclohexylamine. 
The membrane was warmed to 55°C on a heating block for 5-10 min and this 
procedure repeated to load at least 100 pmol peptide on the membrane. 
Membranes prepared in such manner gave good repetitive yields. Only peptides 
with the desired sequence were used for structural analyses.
Cleavage by Trypsin and CNBr
The problems with high background were worsened during the later 
stages of sequencing and poor repetitive yields were obtained beyond the 
fifteenth sequencing cycle. Internal amino acid sequence was performed in such 
cases to avoid ambigious sequence assignments. This technique was used for 
all the D-Asp and the Arg13 and/or Arg14 substituted peptides. These peptides
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were covalently bound on arylamine (AA) membranes to verify each of their 
sequence.
Similar methodology was utilized for the tryptic and cyanogen bromide 
(CNBr) digests of peptides. It was necessary to remove interfering buffers and 
this was performed by analytical chromatography of the digested peptides on a 
Deltapak 3.9 X 150 mm C18 reverse phase column. The eluting peptide fractions 
were directly loaded on Immobilon-AA or DITC membranes for sequence 
determination. Chromatographically-pure peptides were dissolved in 2% acetic 
acid solution and 50 pg aliquots were dried in polystyrene tubes. The resulting 
films were suspended in 50 pL 100 mM citrate buffer (pH 7). After sonication for 
1 min, trypsin digestion was performed for 12 h and 37°C. The reaction was 
terminated by freeze-drying. These tryptic digests were resolved by RP-HPLC, 
using a linear AB gradient consisting of A: 0.1% TFA in 20% MeCN and B: 
0.1% TFA in 80% MeCN developing over 60 min, at a flow rate of 1 mL/min. 
Detection of the eluting components was done at 214 nm. The eluting 
components were subjected to Edman sequencing after lyophilization of pooled 
fractions.
For the CNBr cleavage, the peptides were incubated overnight at room 
temperature in 50 pL formic acid containing 10 pM CNBr (Scott et al., 1988). 
The conversion of methionine to methionine sulfoxide was prohibited by addition 
of mercaptoethanol. This mixture was chromatographed directly on Vydac C4 
reverse phase column under conditions identical to the tryptic digests. The
6 3
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eluting components were subject to sequencing after lyophilization of the pooled 
fractions for their identification.
Amino Acid Analysis
(a) Determination o f resin substitution
Quantitative amino acid analyses were performed on all resins to verify 
the amount of resin substitution. Two resin beads (50 pg) were hydrolysed 
under vacuum with 50 pL of constant boiling 6N HCI and 0.1% phenol for 12 h 
at 105°C. Norleucine was used as an internal standard. At the end of 
hydrolysis, the sample was diluted in 100 pL Li-N sample buffer (Beckman 
Instruments, Palo Alto) and analyzed on a Beckman 6300 Amino Acid Analyzer 
which uses post-column derivatization and ninhydrin reagent. Detection was at 
570 nm for primary amines and 440 nm for secondary amines.
(b) Determining amino acid composition
Qualitative amino acid analyses for all synthetic peptides were initiated 
following analytical chromatography. In the case of peptide fractions, and tryptic 
digests, amino acid analyses on the solid obtained after repeated freeze-thawing 
and degassing of the pooled eluants under vacuum. Hydrolysis was performed 
using constant boiling 6N HCI containing 0.1% phenol in a sealed tube at 110°C 
for 24 h. The hydrolysate was diluted with 200 pL of Li-N sample buffer and 
analyzed at 440 and 570 nm. Norleucine was used as an internal standard and
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in the case of D-Asp containing peptides, the corresponding analyses was 
compared with the unsubstituted peptide as control. There was extensive 
degradation of serine residues for all these peptides.
(c) Quantitative amino acid analyses
The results of quantitative amino acid analyses are summarized in Table
2.4. All values were normalized in the form of ratios with respect to nor-Leu 
which was used as the internal standard.
Additionally, a spectrophotometric analysis method was employed to 
determine the relative concentration of Tyr and Phe in peptide solutions using 
e275 = 1400 M'1cm'1 and e258 = 195 M'1cm'1 respectively (Mihalyi, 1969). The 
presence of a single tyrosine, without any interfering tryptophan (Chrastil, 1986) 
in most of these peptides greatly facilitated the quantitative analyses.
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2.2.4. Peptide Concentration Determination
Besides the quantitative amino acid analyses outline in the earlier 
section, concentrations of peptides were determined by Vis/UV spectroscopy 
using a Hewlett-Packard 8452A Single Channel Photo Diode Array 
Spectrometer. Since elution was monitored at 214 and 254 nm during 
chromatography, extinction coefficients were determined at these wavelengths.
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Table 2.4
Amino Acid Analyses o f Purified ARP Analogsa
Amino
Acid ( 1 ) r ( 2 ) r ( 4 ) r b ( 6 ) r b (7 ) 1*b ( 9 ) r (1 2 ) .* (1 3 ) , - ( 1 7 ) r b (1 9 ) r b ( 2 0 ) , . (2 1 ) , .
D 3.69(4)2 3.72 2.65 2.58 1.88 3.84(4)2 3.77 1.84(2)2 0.97 0.55 1.74(2)2 0.24(0)2
E 3.81(4) 3.69 3.75 3.58 3.75 3.72(4) 3.445 1.79(2) 1.82 1.75 2.91(3) 0.33(0)
S 1.11(2) 1.21 0.88 0.99 1.11 0.85(2) 1.025 0.49(1) 0.65 0.63 1.04(2) 0.35(1)
G 5.88(6) 5.73 5.81 5.55 5.67 1.87(2) 1.83 1.78(2) 1.91 1.83 5.73(6) 3.84(4)
Hc 2.66(3) 1.67 1.73 2.76 2.54 2.57(3) 0.83 2.75(3) 0.83 2.64 1.67(2) 0.35(0)
Rc 1.01(1) 1.88 1.83 0.89 0.91 0.92(1) 2.68 0.07(0) 1.79 0.09 0.14(0) 0.14(0)
A 2.67(3) 2.54 2.73 2.81 2.67 1.87(2) 1.85 0.93(1) 0.94 0.89 1.84(2) 0.94(1)
Y 0.99(1) 0.97 0.91 0.89 0.94 0.97(1) 0.97 0.90(1) 0.89 0.88 0.95(1) 0.05(0)
V 5.84(6) 5.72 5.75 5.55 5.67 2.77(3) 2.78 2.74(3) 2.72 2.84 5.88(6) 2.74(3)
M 0.45(1) 0.54 0.55 0.51 0.53 0.21(0) 0.18 0.33(0) 0.34 0.25 0.44(1) 0.40(1)
1 1.67(2) 1.67 1.65 1.67 1.60 0.05(0) 0.01 0.00(0) 0.01 0.02 1.75(2) 1.81(2)
L 1.74(2) 1.77 1.77 1.72 1.75 0.87(1) 0.88 0.90(1) 0.81 0.83 1.67(2) 0.83(1)
F 2.54(3) 2.45 2.67 2.37 2.38 2.51(3) 2.45 1.54(2) 1.80 1.75 1.76(2) 0.66(1)
K 1.89(2) 1.85 1.78 1.91 1.75 1.75(2) 1.85 0.95(1) 0.95 0.89 1.75(2) 1.11(1)
a signifies the mean of five quantifications within 0.5 standard deviation. 
b gives the values for two determinations for these [D-Asp] analogues.
c denotes that these were His^ Arg substitutions, and the amino acid content for these peptides were calculated accordingly.
'* The numbers correspond to peptides given in Table 2.2.
2 Values in parentheses are the expected amino acid content of pure peptides.
The underlined italics denote either a [D-Asp] or His - Arg substitution cncn
The absorbance was converted to relative concentration using extinction 
coefficients determined for pure and unscavenged peptides. The following e214, 
e254 were determined: 131-40 = 13400, 11300 M'1cm‘1, 136-25 = 7900, 6800 
M'1cm'1, 131-28 = 9600, 9900 M 'W 1, (38-40 = 10800, 9900 M 'W  respectively.
The Bradford assay (Bradford, 1976) was generally quite reliable for the 
peptides in solutions in mutually supporting data from quantitative amino acid 
analyses. However, with 1326-40, aged peptide solutions () 72 h), and for basic 
solutions, accuracy was hampered due to insolubility, and slight gelling of 
solutions, respectively. Peptide concentrations were measured using 
bicinchoninic acid (Smith et al., 1985). When resolubilization procedures 
required use of guanidine hydrochloride, a modified Bradford protocol was also 
employed (Gotham et al., 1988).
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2.3. Spectroscopic Methods for Structural Studies
The secondary structure adopted by AI3P is greatly influenced by the 
intrinsic and extrinsic factors which were highlighted in chapter 1. In order to 
study the conformations of 131-40 and its derived analogs in aqueous solutions, 
these peptides were studied using circular dichroism (CD) spectroscopy. CD 
was also used to evaluate changes in conformation taking place over time, and
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under the influence of external factors, like ligands which could bind to and/or 
affect the orientation of the peptide backbone. Additionally, the effect of 
aqueous aluminum in peptide solutions was investigated using 27AI nuclear 
magnetic resonance (NMR) spectroscopy. NMR was also used to verify the 
association of aluminum in peptides which were incubated with aluminum over 
a period of time.
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2.3.1. Circular Dichroic Spectroscopy
Circular dichroism spectra were recorded on a Jasco J-720 
Spectropolarimeter using a slit width of 2 mm at 1 nm interval between 190 and 
260 nm. A cylindrical cell with sample path length of 0.05 mm was used for all 
peptide solutions measured on the J-720. An atmosphere of ultrapure nitrogen 
was maintained in the sample chamber at a flow rate of 5 L/min during all 
measurements. The analog time constant was 1 sec, and the scan rate was set 
at 1 nm/sec. Repetitive scans were used to improve the signal-to-noise ratio, 
and an average of four scans were routinely performed. With low peptide 
concentrations, sixteen scans were averaged. No smoothing functions were 
applied on any measured CD data. The raw ellipticity was transformed into 
molar ellipticity and calculations performed on the unsmoothed data. A 
cubic-spline algorithm was used to plot CD spectra for all observed data.
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Far ultraviolet CD (far UV/CD) spectra were measured using the vacuum 
UV/CD spectrometer at the Port U9B of the Brookhaven National Laboratory's 
National Synchrotron Light Source (NSLS) (Sutherland et al., 1992). 
Simultaneous determination of absorbance and CD was possible with this CD 
spectrometer. CD spectra were recorded after routine calibrations of the 
spectrometer using an aqueous solution of (+)-10-camphorsulphonic acid (CSA). 
This was a necessary step to verify the integrity of the light source after every 
'injection' of the UV ring. The ratio of CD for CSA at 192.5 to 290.5 nm > -2.00 
was considered to be satisfactory in keeping with published values (Chen and 
Yang, 1977). The path lengths used for observations were kept low, typically 
0.015-0.050 mm using mylar spacer between quartz windows in the Gray cells 
(Gray et al., 1984). The low path lengths facilitated obtaining good CD spectra 
between 260 and 178 nm, since high concentrations of peptide solutions could 
be used, and the 'background' absorbance was reduced to = 1.5 in the spectral 
region. The boil-off from liquid nitrogen was used to purge the monochromator 
at least for 15 min before opening the spectrometer window to the lamp-source. 
In buffered solutions the signal to noise ratio was poor and data were not 
collected below 195 nm.
Typically, CD was measured with an analog time constant of 4 sec, and 
a scan rate of 1 nm/min. The CD spectra given are given as an average of four 
observations unless specifically stated. For particularly noisy samples, the 
analog time constant was increased to 16 sec with a subsequent sacrifice in the
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number of averaged scans. All CD spectra were corrected for the contributing 
solvent by digital subtraction. Smoothing operations were performed on all 
measured CD taken at NSLS for secondary structure analysis using Varselec.
2.3.2. Nuclear Magnetic Resonance Spectroscopy
27AI NMR spectra were obtained at ambient temperature on JEOL 
FX90Q Spectrometer with a tunable broad band probe operating at 23.30 MHz. 
Pulse recycle times used were 0.5 s, the 90° pulse length was 55 psec, and the 
time between two pulses was sufficient to allow the magnetization to equilibrium 
(Bottero et al., 1980). The free induction decays (FIDs) were accumulated in 1K, 
and Fourier transform (FT) performed on 16K by the zero-filling technique. The 
following sets of accumulation conditions: (a) slow accumulation using a 1 KHz 
window to observe the reference signal, whereby linewidths were measured with 
an accuracy of ca. 0.5 Hz, and (b) fast accumulation with a 3.5 to 10 KHz window 
for observing all other 27Al species (Akitt and Milic, 1984). However, using 
condition (b), the accuracy in linewidth measurements was sacrificed. No 
weighting function was applied to the FIDs and depending on Al(lll) 
concentrations, 1000 to 50000 transients were routinely collected.
Data were collected from samples held in a Wilmad 513-PP coaxial 
10mm tube with AICI3 in H20  as the internal standard. The NMR tubes used in 
this study had no 27AI signal detectable by FX90Q. D20  (10% v/v) was always
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used in the inner tube for field-frequency lock. This ensured the lock integrity by 
avoiding formation of air bubbles when probe temperature increaesd. 
Accumulation times were varied from minutes for concentrated ([Al(lll)] > 70 mM) 
and acidified solutions to 2 h for the dilute ([Al(lll)] = 1 mM) solutions. The 
chemical shifts reported in this study are in relation to the hexaaquo ion, 
[AI(H20 )6] 3+, as reference using the following convention: negative shifts are 
reported for upfield resonances while those downfield are positive.
In order to find the amount of aluminium bound to different species, 
experiments were performed by using reference samples of the ion [AI(OH)4] “ at 
10 '1, 5 x 10'2, and 2 X 10'2 M placed in the annulus of the coaxial 10 mm tube. 
The peak of [AI(OH)4]~ signal was located at 80 ppm from the [AI(H20)6]3+ as 
reference. A simple integration of the peaks was performed to calculate the 
amount of aluminium bound in each detectable species. Alternately, the content 
of Al 3+-bound species was correlated by its relative intensity ratio to the 
reference signal. Anhydrous AICI3, AIBr3 and All3 were used without any 
purification. All solutions were made on a w/v basis using AICI3, AIBr3 or A ll3 in 
an inert atmosphere of nitrogen.
Using the standard inversion recovery sequence, the 7, determined for 
a signal having a linewidth of 85 Hz in an acidified Al(lll) solution was 4.1 ms. 
This value is in close agreement with the value of T2 = 3.7 ms obtained from the 
relation, 72 = 1/(/rAr), where a t  is linewidth, and is consistent with the line 
broadening due to a fast exchange situation. The pH values for each sample
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were measured both before and after recording the spectra using a 5 mm 
Beckman Futura Plus S110A micro-electrode directly inserted into the NMR 
sample tube. The spectrum was considered for data only if the pH values 
agreed to within 0.1 pH units.
2.4. Strategies in Peptide Sequencing
D-amino acids
The D-Asp containing peptide analogs were found to be resistant to 
Edman sequencing at the substituted positions although their chromatographic 
behavior was similar to the L-Asp containing peptides. It was generally observed 
that the L-Asp containing peptides eluted earlier than the corresponding D-Asp 
analogs on RP-HPLC.
When the amino acid compositions of the D-Asp containing peptides was 
found to be as expected, and had identical chromatographic behavior as the l -  
Asp peptide, either the tryptic or staphylococcal protease digests of these 
peptides were subjected to Edman degradation verify the amino acid sequence. 
This strategy was deemed satisfactory since D-Asp was used during the stepwise 
synthesis of these structural analogues. The syntheses of 12.1-40 and (2.6-25 with 
D-Asp amino acids were always identified on their protease digests. A more 
detailed investigation on the chromatographic behavior of the D-Asp substituted 
peptides is given in chapter 3.
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Metal-bound peptides
Al(lll) incubations were studied chromatographically and
spectroscopically as one of the extrinsic factors influencing secondary structure 
of G1-40. Tryptic and CNBr digests of the Al(lll)-incubated peptides were 
chromatographed on Vydac C4 4.2 X 250 mm, and subjected to Edman 
degradation. Before CNBr treatment, peptides were treated with
2-mercaptoethanol (50 pL + 10-20 pg peptide, under helium for 12 hours) to 
reduce methionine sulfoxide. The site of Al(lll) association was confirmed by the 
peptide mapping of the Al(lll)-incubated digests with the corresponding control 
peptides. A similar strategy has been previously demonstrated using R6-25 
which was treated with platinum(ll)terpyridine complex (Vyas and Duffy, 1989). 
The presence of Al(lll) in the incubated peptide fractions was also verified 
independently by 27AI NMR spectroscopy.
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2.5. Materials
The resins for solid-phase peptide synthesis, polyamide-kieselguhr 
(Pepsyn KA), polystyrene-polyethylene glycol (PS-PEG), and the fmoc-amino 
acid esters were purchased from Millipore, Marlborough, MA. Additionally, 
1-hydroxybenzotriazole (HOBt), dimethylformamide (DMF), piperidine (PIP),
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MeCN (HPLC grade) was from Fisher Scientific, and trifluoroacetic acid (TFA) 
was supplied by Pierce Chemical Company, Rockford, IL. HPLC grade 
trifluoroethanol (TFE) and hexafluoroisopropanol (HFIP) were purchased from 
Sigma Chemicals, St. Louis, MO.
The sequencing chemicals, cyclohexylamine, phenylisothiocyanate 
(PITC), TFA, methanol (MeOH), n-heptane, ethyl acetate, were supplied by 
Milligen/BioSearch; N-methylmorpholine (NMM) was from Pierce. Reagents for 
Bradford assay and bicinchoninic acid (BCA) assay were purchased from Pierce 
Chemical Company, IL. All chemicals for quantitative amino acid analyses were 
supplied by Beckman Instruments, Palo Alto, CA. MOPS, HEPES, Tris-HCI were 
purchased from Aldrich Chemicals. Anhydrous Al(lll) salts, anisole, thioanisole, 
ethanedithiol, ethylmethylsulfide, GnHCI, and GnSCN were purchased from 
Fluka Chemicals. Water was collected via a MilliQ system.
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Chapter 3
High Performance Liquid Chromatography Studies of 
ARP and Derived Analogs
Introduction
Chromatographic matrices are adopted universally as effective supports 
for purification of peptides and proteins from a variety of sources. The ever 
increasing use of solid phase peptide synthesis and isolating small quantities of 
bioactive peptides from complex synthetic and proteolytic mixtures require 
efficient isolation protocols. Several investigations have been carried out on 
synthetic peptides corresponding to full length AGP variants, viz., G1-43, (31-42, 
131-40 and 131-39 (Fraser et al., 1991b; Hilbich et al., 1991; Barrow et al., 1992; 
Burdick et al., 1992; Jarret et al., 1993) and on the derived analogs (31-28, 
(326-40, (334-42, and (36-25 of the CV and SP core protein (Hollosi et al., 1989;
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Halverson et al., 1990; Fraser etal., 1991b; Barrow et al., 1992; Burdick et al., 
1992; Inouye et al., 1993; Jarret et al., 1993; Otvos et al., 1993; Sorimachi and 
Craik, 1994).
Synthetic peptides sharing sequences with AGP have been used 
extensively to prepare fibrils with morphology similar to the native amyloid. The 
biophysical studies on the AGP variants and derived analogs have shown the 
importance of two distinct regions to the stability of this protein: (i) the carboxyl 
terminal comprising 1326-42, which includes factors to initiate the purported 
formation of aggregates due to hydrophobic interactions (Halverson et al., 1990, 
1991; Jarrett et al., 1993), and (ii) the amino terminal region comprising (31-28, 
due to ion-pair formation between ionizable amino acids (Kirschner et al., 1987; 
Fraser et al., 1992; Inouye et al., 1993). Therefore, the conformational 
characteristics of the complete AGP could be dependent on the relationship 
between these two regions.
The prolific studies on the conformational stability of AGP in the AD brain 
has prompted many investigators to use a variety of techniques to investigate the 
underlying molecular basis. Some techniques which provide information on the 
structural organization of purified peptides include, but are not limited to, CD, 
EM, NMR, FTIR, and light scattering. As a matter of convenience, most 
preliminary steps in rapid selective separation of pure AGP peptides utilize 
reversed-phase high performance liquid chromatography (RP-HPLC). There 
have been reports that synthetic peptide analogs of AGP and the native AGP
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elute as a broad peak during chromatographic purification (Hilbich et al., 1992; 
Burdick et al., 1992; Otvos et al., 1993; Roher et al.,1993). The inherent 
relationship which exists between the chromatographic behavior of the AGP 
peptides and their primary, secondary or tertiary structures has, however, not 
attracted much attention.
The use of RP-HPLC requires sorption/desorption of the peptide from 
a rigid, microparticulate /7-alkyl bonded stationary phase by using variations in 
the polarity of a mobile phase. Separation of peptides and proteins generally 
utilize gradient elution using aqueous organic cosolvents; and, under optimized 
chromatographic conditions, quantitative recoveries can be made. However, 
with certain peptides and protein mixtures, low recoveries are coupled with poor 
resolution and peak capacities (Hearn and Grego, 1984). The chromatographic 
behavior of biomolecules have led to extensive investigations of the molecular 
basis for the mechanism of observed retention. Recent advances in sorbent 
technology have led to unique evaluations of the physico-chemical interactions 
of proteins and peptides with chemical matrices which are not amenable by other 
approaches (Aguilar et al., 1987). Indeed, the use of RP-HPLC has provided 
insights into the secondary and quaternary structure of tropomysin (Stone et al., 
1975), myosin light chain kinase (Hearn and Aguilar, 1987), the kinetics of 
unfolding of proteins (Benedek et al., 1984; Lau et al., 1984), the process of 
assembling amphipathic a-helices (Zhou et al., 1990), and the relative stability 
and interactive behavior of neuropeptide Y analogs (Aguilar et al., 1993). It is
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obvious from these studies that the spatial organization dictated by specific 
amino acids determines the chromatographic interaction of these biomolecules.
The premise of understanding chromatographic behavior of peptides 
and proteins lies in predicting their retention times based on amino acid 
composition, using the hydrophobicity coefficients of individual amino acids (Guo 
et al., 1986). This approach assumes the movement of the peptide as a rigid 
moiety on its passage through the chromatographic matrix based on the criteria 
of the linear solvent strength and the general plate height theory. The retention 
time of such a solute generally agrees with the prediction based on theoretical 
and mechanistic descriptions (Glajch et al., 1986). However, it has been 
reported that significant discrepancies occur when secondary equilibria between 
the solute and sorbent are established (Hearn et al., 1985). In fact, many 
chromatographic studies present evidence of band broadening and denaturation 
in polypeptides which result from initiation of secondary conformational changes 
at the stationary-phase surface (Hearn and Grego, 1984; Lau et al., 1984; Lu et 
al., 1986; Hearn and Aguilar, 1987). These RP-HPLC observations of retention 
and band broadening behavior of peptides have provided criteria for optimization 
of separation methods (Hearn and Aguilar, 1986). It is now understood that the 
disagreement between the predictions and the observed retention times and 
bandwidths in peptides and proteins is usually the influence of amino acid 
sequence, not the composition (Hearn and Aguilar, 1987). Nonetheless, an 
intimate relationship exists between the primary, secondary and tertiary
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structures of a biomolecule and its chromatographic properties (Hearn and 
Aguilar, 1987).
Spectroscopic techniques like CD, NMR and FTIR provide details on the 
equilibrium conformation(s) of ARP and analogs within the spectroscopic time 
scale. Based on CD and solution NMR evidence, it has been suggested that the 
amino terminal possesses a putative a-helical character (Hollosi et al., 1989; 
Sorimachi and Craik, 1994); the carboxy end is mainly R-pleated sheets 
according to ss-NMR and FTIR studies (Halverson et al., 1990). However, in the 
presence of a hydrophobic reversed-phase matrix, some of these conformations 
can be locked in a "near equilibrium" state (Glajch et al., 1986). Hence, the 
correlation of conformational behavior in terms of the hydrophobic effect and 
ionic interactions involved in the conformational transitions in these regions 
would lead to an important aspect in the structure/function studies of the ARP.
The interactive behavior and relative stability of R1-40 and derived 
analogs with chromatographic matrices is presented in this chapter. 
Chromatographic parameters which include hydrophobic contact area were 
determined to evaluate the influence of the hydrophobic matrix in stabilizing the 
secondary structural components. These are of particular relevance, since the 
toxicity of R1-40 is related to stable tertiary and quaternary structure of ARP 
(Yankner et al., 1990; Pike et al., 1993). Since the higher order structures of 
ARP are extremely sturdy due to intrinsic forces, destabilizing these would 
provide clues to the formation of the soluble form of ARP.
7 9
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3.1. Reversed-Phase High Performance Liquid Chromatography of 
R1-40 and Derived Analogs
From its introduction a decade ago, rapid separation procedures using 
reversed-phase high performance liquid chromatography have seen a vast 
growth. The selectivity in these separations is based on sorption/desorption 
between the solutes and stationary phase using a mobile phase to elute the 
desired component (Hearn, 1983). There are four major factors influencing the 
eluting characteristics of such organic moieties as peptides and proteins on 
reversed-phase matrices:
(a) Peptide composition. The overall hydrophobicity of the polypeptide arises 
from the relative hydrophilic/hydrophobic ratio of its constituent amino acids. 
The key factor in preparative and analytical separation using RP-HPLC is 
essentially based on the relative hydrophobic contact between solutes, in this 
case peptides, and the sorbent, in this case non-polar stationary phase (Hearn 
and Grego, 1984). Conformational constraints notwithstanding, the retention of 
peptides generally follows their predicted value based on the contributions from 
their amino acids (Guo et al., 1986). This is however only valid with small 
peptides up to 15 residues, after which the predictions do not hold (Wilson et al., 
1981; Mant et al., 1988; Zhou et al., 1990).
(b) Primary structure dependency. Several groups have reported that peptides 
with identical compositions but different amino acid sequences have widely 
differing retention times which deviate from the predicted retention times and/or
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elution characteristics (Guo et al., 1986; Hearn and Aguilar, 1987). Since the 
hydrophobic contribution from the amino acids essentially remains unchanged, 
the deviations can be explained by the sequence-dependent effects which 
consist of near-neighbor and conformational effects. The near-neighbor effect 
can be defined as solely sequence-dependent, and the conformational effect is 
one which is due to the peptide favoring a unique conformation or having specific 
interaction with the hydrophobic matrix (Zhou et al., 1990). Thus, the peptide 
having a preferential conformation which interacts with the stationary phase 
experiences an apparent change in the hydrophobic interaction (Benedek et al., 
1984; Lau et al., 1984; Zhou et al., 1990).
(c) Peptide size. Chromatographers have noted that peptides larger than 20-mer 
elute earlier than their predicted times based on hydrophobicity (Wilson et al., 
1981; Wehr et al., 1982; Mant et al., 1988). Such non-ideal behavior is the result 
of certain amino-acids being effectively removed from interaction with the 
hydrophobic stationary phase due to stabilized secondary and tertiary structures 
in these large peptides. However, for more ideal peptides, the retention times 
are linear functions of the length of peptides on a given reversed-phase support 
(Mant et al., 1988; Mant et al., 1989; Zhou et al., 1990).
(d) Residence time and mobile phase. The elution behavior of a peptide may be 
further influenced by its time of residence on the column and the organic modifier 
used (Hearn, 1983; Hearn and Grego, 1984). Such a phenomenon has been 
shown for a-chymotrypsinogen, lysozyme and soybean trypsin inhibitor
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(Benedek et al., 1984), where denaturation processes in RP-HPLC result in band 
broadening (Hearn and Grego, 1984; Hearn and Aguilar, 1987). Indeed, the 
native and synthetic AI3P variants exhibit broad elution profiles during 
chromatographic purification (Hilbich et al., 1991; Burdick et al., 1992; Miller et 
al., 1993; Roheretal., 1993).
It is the contention in this study that 131-40 and derived analogs provide 
a good model to study the effects of conformation on their retention behavior. 
The nature of interaction of 131-40 and derived analogs with the hydrophobic 
stationary phase was evaluated in terms of induced conformational effects within 
the chromatographic parameters. This was done with the following objectives: 
(i) to locate a preferred conformation in the peptides, (ii) to demonstrate the 
relevance of this conformation in the interactive behavior of the peptide on the 
stationary phase, (iii) to evaluate factors which cause band broadening in these 
peptides, and (iv) to gain insight into the dominant hydrophobic effect which 
stabilizes peptide structures in solution. Thus, the interaction(s) of these 
peptides with other hydrophobic surfaces would also provide clues to proteins 
which share similar sequence and structure.
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3.1.1. Experimental Chromatographic Behavior of 131-40 and Derived 
Analogs
Determination o f the oligomeric form o f peptides during RP-HPLC and SEC
Aqueous solutions of 13.1-40, 131-28, 136-25, 138-40, f315-28, 1326-40 and 
1322-35 peptides were prepared and the concentrations determined by 
quantitative amino acid analyses and/or BCA assay. The His -> Arg and L-Asp -> 
D-Asp substituted 131-40, 131-28 and 136-25 analogs were also used to study the 
effects of substitutions on the chromatographic properties. In case the peptide 
was not soluble in water, a solution of 2-10% MeCN in water (v/v) was used. 
Linear gradient elution was performed for each peptide solution using 0.1 % TFA 
(v/v) in MilliQ water (solvent A) and 0-100% of 0.1% TFA in MeCN (v/v) (solvent 
B). The solvents were degassed either by sonication or sparging with helium. 
The retention times of the peptides were determined following their introduction 
on 4.6 X 150 mm Vydac C18 and C8 columns. The gradient was employed over 
60 min at a flow rate of 0.8 mL/min at room temperature. The gradient conditions 
from 0-100% B in 60 min, schematically given in Fig. 3.1 (a), will hereinafter be 
termed as the normal gradient. The chromatographic conditions given in panels 
b-f are discussed in section 3.3.1.
The elution profiles of individually loaded peptides are shown in panel A 
of Fig. 3.2. The homogeneity of these peptides can be easily ascertained from 
the peak profiles. Of the peptides shown, the f3C-pep, which is the carboxy 
terminal of the full length APP, does not share sequence homology with the rest
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of the peptide fragments. It should be mentioned that !3C-pep is a highly 
charged cytosolic domain of APP, is very hydrophilic, and does not possess the 
putative cell-adhesion -R H D S - sequence (Ghiso et al., 1992). When the 
retention times were plotted against theoretical molecular weights as indicated 
in panel B of Fig. 3.2, a log linear relationship with a correlation 
coefficient = 0.91 was obtained. This would indicate that the 131-40 and derived 
analogs were being bound as monomers on the reversed-phase column. An 
exponential relationship between molecular weight and retention times had been 
demonstrated by Zhou et al. (1990) and Lau et al. (1984) for a series of 
amphipathic peptide analogs having the same sequence but different lengths.
The effect of change in the n-alkyl chain length on retention time is 
illustrated in Fig. 3.3. The 131-40 and derived analogs were chromatographed 
under identical conditions to the study done above. It was clear that these 
peptides exhibited similar behavior on C8 matrix (correlation coefficient = 0.92) 
as that observed on the C18 matrix. This figure also compares the retention 
behavior of the Arg13 and Arg14 substituted 131-40 and 136-25 derived analogs. 
The retention times for these analogs are slightly longer on C18 than C8, however 
they follow log linear relationships with respect to molecular weight. Such 
analogous characteristics indicate that these peptides have similar interactions 
with the stationary-phase surface, based on the hydrophobicity of C8 and C18 and 
the length of the peptide chain. The complicating features related to 1322-35 are 
treated under a separate heading later in this section.
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Fig. 3.4 illustrates the influence of mobile phase on retention times for 
(31-40 and derived analogs. When TFE was substituted for MeCN (v/v) in mobile 
phase B, a positive change was seen in the slope of the plot of retention times 
and molecular weights (correlation coefficient = 0.72). From the 
chromatographic behavior between MeCN and TFE, it was evident that these 
peptides experienced variable interactions with the reversed-phase surface 
which were dependent on the sequence. Since the peptides 131-40, 138-40, 
(31-28, (36-25 and (315-28 share the common Gln15-G ly25 sequence, it would 
seem that this common epitope was affected by TFE in the mobile phase.
The propensity of the Asp1-V a l12 sequence at the amino terminal of 
(31-40 to form a-helices in TFE based cosolvents, and the central Glu11-G ly25 
segment to maintain (3-pleated sheet structure in aqueous solutions has already 
been reported (Hollosi et al., 1989; Sorimachi and Craik, 1994). TFE is 
considered to be a non-interactive solvent and benign in chromatographic circles 
(Lau et al., 1984). However, TFE destabilizes the tertiary and quaternary 
interactions in coils producing single stranded a-helices, or more generally 
promotes intramolecular hydrogen bonding (Urry et al., 1971). Taken together, 
it would seem that TFE was more effective in inducing conformational changes 
in (31-40 and derived analogs on the stationary phase support than was MeCN. 
Nevertheless, the log linear correlation of retention times with molecular weights 
suggested that these peptides were bound in their monomeric form on the 
reversed-phase support.
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The disruption of tertiary and quaternary interactions in proteins, or the 
nonspecific peptide aggregation in a nonpolar environment of reversed-phase 
chromatography is not surprising since hydrophobic interactions are the major 
stabilizing forces. Nonetheless, it was necessary to ascertain the monomeric 
nature of these peptide solutes during chromatography. This was accomplished 
by loading peptide solutions on a size exclusion column TSK 300SW using the 
following solvent systems: system 1 was 0.1% TFA in 150 mM KCI as solvent A, 
and solvent B was solvent A with 50% MeCN; system 2 was 0.1% TFA in 150 
mM KCI as solvent A, and solvent B was solvent A containing 50% TFE. The 
inclusion of KCI in the solvents reduces the ionic interactions between the 
column matrix and peptides (Mant et al., 1987). After chromatography of the 
individual peptides, the retention times were plotted against their theoretical 
monomeric molecular weights as depicted in Fig. 3.5. A log linear relation of 
their molecular weights and retention times was observed which indicated that 
these peptides were bound to the column matrix in their monomeric forms. If 
(11-40 and derived analogs interact as monomers in the absence of the 
hydrophobic reversed-phase matrix, then it is assumed that they interact in their 
monomeric form when in contact with it. This observation also suggested that 
the R1-40 and derived analogs of same length (e.g., the His -* Arg substituted, 
and the D-Asp containing peptides) exhibited identical sizes since they had 
identical retention times during SEC.
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Fig. 3.1 R P-H PLC  strategy for on-column incubation experiments. Panel A gives the six 
kinetic experiments by changing the incubation, contact, delay, and gradient times. 
Panel B schematically defines the injection of peptide (circle), /, start of gradient 
(square), S, and the gradient time.
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HPLC of (31-40 and derived analogs on reversed-phase surface octadecyl matrix. 
Panel A gives the elution profiles of singly loaded peptide solutions. Column: 4.6  
X 150 mm Vydac C 1B operated at room temperature; solvent A was 0.1%  TFA, 
solvent B was 0.1% TFA  in MeCN; linear gradient from 0 -1 0 0 %  B in 60 min at a 
flow rate of 0.8 mL/min. Panel B represents the retention time relationship in terms 
of In molecular weight.
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Fig. 3.3 Comparison of RP-HPLC behavior of singly loaded peptides between C„ and C,„ 
matrices. Gradient conditions were as given in Fig. 3.2 with a flow rate of 
1.0 mL/min; columns operated at room temperature. The hollow symbols 
represent retention times for the [Arg13] and [Arg13 '‘’j analogs of (36-25 and (31-40 
on the respective columns.
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Fig. 3.4 Comparison of RP-HPLC behavior as a function of mobile phase; MeCN and TFE.
The retention data using 0.1% TFA in 80% MeCN as splvent B is given by the linear 
regression through data (hollow symbols); the retention data on substituting 80%  
TFE for MeCN in B is given by the solid symbols. The retention times for the His • 
Arg substituted analogs are also indicated. Column: Vydac C 18, operated at 
am bient temperature; flow rate was 1.0 mL/min; normal gradient conditions. All 
data are the mean of three chromatographic runs.
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Fig. 3.5 Verification of monomeric nature of 131-40 and derived analogs in solution by SEC.
Column: Protein Pak TSK 300SW  operated at room temperature; solvent A was 
0.1%  TFA  in 150 mM KCI, solvent B was 0.1%  TFA in 150 mm KCI containing 
either 50% MeCN or TFE; flow rate was 0.25 ml/min. Panel A gives elution profiles 
using MeCN in mobile phase; retention data in terms of molecular weight is plotted 
in B; panels C and D gives corresponding study using TFE  in mobile phase. Data 
for 1322-35 oligomers are not included.
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Equilibrating oligomers of IS22-35 during chromatography
1322-35 in solution exhibited atypical elution behavior as illustrated in 
Fig. 3.6. When a freshly prepared solution containing 10 pg 1322-35 was 
chromatographed on the C18 matrix using identical gradient conditions as the 
previous study, four distinct components having identical peak areas were 
resolved. The nature of the eluting components was examined after collecting 
the individual fractions, concentrating in vacuo and reloading on the column. 
The elution profiles of these solutions are shown in panel A of Fig. 3.7. All 
components for any given re-loading had the same mass as determined by peak 
areas, suggesting that equilibration of these eluting components took place in 
solution and that the components were resolved on the reversed-phase support. 
In another examination, the fractions were collected, lyophilized, the residue 
dissolved and loaded on the column. These solutions also exhibited identical 
elution profiles in terms of retention times and peak areas to the profiles obtained 
for the concentrated fractions. Such chromatographic behavior indicated that 
1322-35 formed equilibrating oligomers in solution.
To verify if the phenomenon observed with (322-35 was indeed 
equilibration of oligomers in the denaturing conditions of the reversed-phase 
surface, size-exclusion chromatography was performed under conditions 
identical to the previous study. A typical elution profile of 1322-35 solution is 
shown in panel B of Fig. 3.7. A broad peak corresponding to a 12 KDa 
component was eluted under SEC conditions which suggested that in the
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absence of a reversed-phase support, 1322-35 existed as an octamer in aqueous 
solution.
The chromatographic profiles on the hydrophobic matrix therefore 
indicated the denaturation of an octamer. When the retention times were plotted 
against the theoretical molecular weights for (l322-35)n, for n = 1, 2, 4, and 8, 
these followed log linear relationship (Fig. 3.6) with a correlation coefficient = 
0.72. The most stable form of 1322-35 in freshly prepared aqueous solution 
therefore seemed to be the octamer which equilibrated into its monomer, dimer 
and tetramer on passage through the reversed-phase column:
(6 2 2 -3 5 )e <RPU (,oMm) (6 2 2 -3 5 ) -  (6 2 2 -3 5 ), -  (6 2 2 -3 5 ),
The observed chromatographic behavior indicates that there must be 
more than just sequence-dependent effects experienced by 1322-35 on the 
reversed-phase support, and that the hydrophobic stationary phase support is 
capable of disrupting intermolecular hydrophobic interactions. A similar effect 
has also been reported for soyabean trypsin inhibitor during chromatographic 
purification (Hearn et al., 1985). The net effect of the reversed-phase matrix on 
these independent and dynamic interconversions of (322-35 was the formation 
of stable oligomers in an otherwise denaturing condition, which gave rise to long- 
lived metastable forms on the chromatographic time scale. These oligomeric 
forms can therefore be analyzed in the same way as an equilibrium process with 
an apparent concentration of the different forms treated as equilibrium 
concentrations (Hearn et al., 1985).
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Fig. 3.6 Characterizing oligomerization of 1522-35 in solution. The separation of the 
respective oligomers of 1522-35 on Vydac C 18 in the top panel; the comparison of 
log linear plot of theoretical molecular weights of 1522-35 versus retention time (□ ) 
with 151-40 and sequence analogs. The log linear relationship for 1522-35 is shown 
by the dashed line. Chromatographic conditions as per Fig. 3.2 for 60 min, then 
100% B till 90 min.
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Fig. 3.7 Elution profiles of 1322-35 oligomers on reversed-phase and size exclusion 
chromatography. The eluting fractions from Fig. 3.6 were collected individually, 
lyophilized, dissolved in 2% HAc and loaded on the Vydac C 18. Panel A shows from  
top to bottom the RP-HPLC of monomer, dimer, tetramer, and octamer 
respectively. Panel B shows the SEC profile of a lyophilized 1322-35 fraction 
corresponding to the monomer eluting at 30 min. The dashed curve represents 
molecular weight markers: myoglobin (17 KDa), aprotinin (6 KDa), and insulin B- 
chain (3.5 KDa).
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3.2. Evaluation of Chromatographic Behavior of IS1-40 and Derived
Analogs During RP-HPLC
As noted before, the chromatographic purification of synthetic and native 
AI2.P preparations on reversed phase supports yield the pure peptides as broad 
peaks (Burdick et al., 1992; Miller et al., 1993; Otvos et al., 1993; Roher et al.,
1993). Several investigations on AGP and its derived analogs have suggested 
the propensity of the carboxy terminal corresponding to residues 34-42 to form 
stable antiparallel G-pleated sheet structure (Halverson et al., 1990; Lansbury,
1992), and the amino terminal residues 1-28 adopts a-helical structure in these 
peptides (Barrow and Zagorski, 1992; Sorimachi and Craik, 1994) due to the 
flexibility of the backbone (Hollosi et al., 1989). Secondary structural content of 
these peptides can also be modulated due to amino acid substitutions, and the 
presence of membrane mimicking solvents (Barrow et al., 1992; Laczko-Hollosi 
et al., 1992; Otvos et al., 1993) These studies show that the organization of 
G1-40 and derived analogs include domains in which the orientations of the 
peptide backbone are predicated by the amino acid sequence.
It can be therefore hypothesized that the polypeptide on introduction to 
the stationary phase support is adsorbed in a specific orientation, along with 
other orientations which are equally likely. Chromatographic parameters related 
to the physico-chemical properties of a solute can then be derived using the 
linear solvent strength model, which under normal reversed-phase gradient
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elution predicts a linear relationship between the median capacity factor, log k* 
and the median organic mole fraction, ^*(Stadalius et al., 1976):
log k* = log kQ — S ■ ip* (1)
According to the solvophobic theory applied to polypeptides (Hearn, 1983), the 
magnitude of the chromatographic contact area projected by the peptide (solute) 
and the predilection which it has for the chromatographic ligands (sorbent) is 
given by log k0 and the slope, S. The application of equation 1 implies that the 
retention behavior does not involve aberrant properties on the part of the solute, 
like differential migration processes due to a medley of competing secondary 
effects. The slope will also be affected for the adsorption/ desorption processes 
which involve participation of different classes of interactive sites on the 
heterogenous sorbent (Hearn and Aguilar, 1987). Thus, in the case of closely 
eluting peptides having constitutionally dissimilar contact area dependencies, the 
manipulation of secondary solution equilibria should result in change in 
interactive behavior.
Determination o f chromatographic parameters as a function o f organic solvent 
concentration
In order to examine the consequence of amino acid substitutions within 
the peptides on interaction with the hydrophobic stationary phase gradient
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elution data were accumulated for f31 -40 analogs. The following set of peptides 
as given in Table 2.1, were studied: (i) 13.1-40, and derived analogs having His — 
Arg substitutions at positions 13 and 14, L-Asp -> D-Asp substitutions at positions 
1, 7, and 23, (ii) (3.1-28, and derived analogs having His -» Arg substitutions at 
positions 13 and 14, (iii) (36-25, and derived analogs having L-Asp D-Asp 
substitutions at positions 7 and 23. Additionally, (31-40 and (36-25 having both 
His _» Arg and L-Asp D-Asp substitutions were also examined.
The peptides were individually chromatographed on the Vydac C18 
column at a flow rate of 1.0 mL/min as per conditions described by Fig. 3A (a). 
The column was operated at temperatures between 25 and 65°C at linear 
gradient times between 30-90 min. Elution profiles were generated, and the 
retention data was analyzed by adopting the Pek'N-ese protocol (Hearn and 
Aguilar, 1987) for the chromatographic parameters highlighted in Appendix B. 
The inherent errors using areas of eluting components having asymmetric peak 
profiles were ± 12% compared to the absolute mass recoveries over the same 
mass range. However, these errors were ± 5% when a strict elution time window 
at the peak maxima was applied. Data collection was in triplicate, and linear 
regression analysis using ANOVA was performed to get the S and log k0 given 
by equation 1 (typical correlation coefficients were between 0.90-0.97).
Fig. 3.8 gives the plots of log k* versus #/* obtained at 22°C which 
represents the elution data as per equation 1. From the observed data, it is 
obvious that there is considerable resolution between all the substituted analogs
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of 131-40 (panel A), (31-28 (panel B) and (36-25 (panel C). The His -» Arg 
substituted peptides generally tended to elute later than the unsubstituted 
peptides while shorter retention times were observed for the peptides having 
D-Asp substitutions at positions 7 and 23. These results show that there is a 
significant change in the interactive behavior of these peptides associated with 
amino acid substitutions. The most significantly longer retentions were for 
peptides having dual substitutions of Arg and D-Asp. The later elution of the Arg 
and D-Asp substituted peptides is therefore more representative of increase in 
the hydrophobic character. To elucidate the role of secondary structure in the 
chromatographic behavior of these derived analogs, the data were analyzed with 
respect to temperature.
Dependence o f S and log k0 on temperature
The implications of the chromatographic parameters, S and log k0, are 
that these are related to the magnitude of the hydrophobic contact area between 
the solute (peptide) and the sorbent (column), and a measure of free energy 
changes associated with the adsorption process in the absence of the mobile 
phase (Horvath et al., 1976). When these parameters are obtained from the 
study of closely related peptides in a range of chromatographic conditions, a 
quantitative elucidation of differences in peptide orientation and affinity for the 
sorbent can be made (Aguilar et al., 1993). The solution conformation of 
peptides is dependent on temperature, a parameter which was easy to modify
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in this chromatographic study. However, a comparatively rigid molecule not 
easily perturbed by the imposed chromatographic conditions was needed as 
control. Angiotensin III, which is a partially-folded heptapeptide, having minor 
secondary structure (Matsoukas et al., 1991), and N-acetylphenylalanine methyl 
ester (N-AcF), which does not possess any secondary structure, were used as 
controls for this study.
Fig. 3.9 illustrates the dependence of the slope parameter, S, and log k0 
for 131 -40 and derived analogs as a function of temperature. There were obvious 
inferences from the observed S values of the peptides compared to the controls: 
(i) S values for the longer peptides, 131-40 and 138-40 were higher than all the 
other peptides, which suggested the chromatographic contact area was higher 
in these peptides, (ii) S increased with temperature, which suggested that there 
was an increase in the interactive region, (iii) S did not change appreciably after 
60°C, indicating that the change in the chromatographic contact area was 
complete. The increase in log k0 followed similar trend to S below 40°C. The 
absence of the first 7 residues in 138-40 significantly altered its interactive 
behavior compared to (31-40. At temperatures higher than 40°C, log k0 
decreased for the longer peptides which would suggest that the increase in the 
chromatographic area was accompanied by a decrease in the interactive 
behavior of these peptides for the sorbent. The chromatographic contact area 
for (36-25 increased in temperature as seen from the S values.
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Plots of log k* versus ^ * fo r  151-40 and derived analogs on C 1B at 2 2 °C . The lines 
represent the best fit analysis to data points (excluded for clarity). Panel A: plots for 
(51-40 (1), [Arg13]151-40 [Arg"]l51-40 (3). [Arg1314]fi1-40 (3A), [D-Asp1]l51-40 (6), 
[D-Asp723](51-40 (7), [D-Asp1,723] (51-40 (8), [Arg14,D-Asp23]l51 -40 (5); panel B: plots 
for 151-28 and its [Arg] derived analogs; panel C: 156-25 (13), [Arg13]l56-25 (14), 
[Arg14](56-25 (15), [Arg1314](56-25 (16).
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Fig. 3.9 Plots of S (A) and log k0 (B) versus temperature for (31-40 and derived analogs, 
angiotensin III and N-acetylphenylalanine methyl ester eluted from Vydac C 18.
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However, the log k0 decreased simultaneously. This suggested that when the 
first 5 residues at the amino and the 15 residues at the carboxyl terminus 
residues were removed, there was a significant reduction in the affinity for the 
stationary phase surface. This was further affirmed with the chromatographic 
behavior of R26-40. There was no significant reduction in the log k0, although 
with an increase in temperature the S value showed an increase. It would, 
therefore, appear that the carboxyl terminal region shows consistency in terms 
of increase in the chromatographic contact area, whereas increasing the peptide 
chain at the amino terminal results in altered interactions with the reversed- 
phase surface.
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3.3. Evaluation of Band Broadening of B1-40 by Gradient Elution 
RP-HPLC
The pivotal dependence of relative retention times and bandwidths of 
polypeptide solutes involves the mole fraction of the organic modifier, c/ j, in the 
mobile phase. It is, however, generally assumed that solute mixtures can be 
resolved in a nicely designed gradient system on a given column with the same 
relative bandwidth. Many chromatographers have noted in practice that this 
requirement, although important for optimized resolution, is rarely achieved for
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
polypeptides and proteins (Hearn and Grego, 1984; Hearn et al., 1985; Stadalius 
et al., 1985; Hearn and Aguilar, 1986). The small diffusion coefficients of 
(macromolecular) peptide solutes in aqueous-organic cosolvent mobile phases 
result in the observed plate number, N, to be significantly smaller and 
consequently, the plate height number, h, to be significantly larger than the N 
values obtained for low molecular weight organic compounds (Snyder, 1980). 
The combined effect of these manifestations results in very steep slopes, S > 10, 
for the linearized plot of capacity factor, k' versus the organic mole fraction and 
generally results in increased bandwidths. Moreover, specific solvation or buffer 
interaction of the silanophilic properties of the heterogeneous n-alkyl bonded 
stationary phase surface and conformational phenomena of these peptide 
solutes bestow band broadening on the eluting component.
In this section, the bandwidth dependency of (31-40 is presented as a 
function of different gradient elutions, column temperature, and the 
chromatographic residence times. Since the chain length of the /7-alkyl ligand 
and the hydrocarbon ligand density influence the chromatographic behavior 
(Hearn, 1983), all examinations were done on the same 4.6 X 150 mm Vydac C18 
column. This study furthers the knowledge of the RP-HPLC of 131-40 and 
derived analogs so that optimum resolving conditions can be employed, peak 
shape can be controlled, and an understanding of the secondary equilibria 
established by the peptide at the reversed-phase surface can be achieved.
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3.3.1. Changes in Band Shape as a Function of Organic Modifier 
Concentration
To obtain detailed data on the rate constants associated with the 
adsorption/desorption kinetics or conformational interconversion of different 
forms of 81-40 on reversed-phase chromatography, a deliberate scouting of 
elution protocols was done. The column was thermostatically controlled between 
20°C and 45°C. The dedicated RP-HPLC setup was modified to increase the 
gradient steepness parameter, and to increase the chromatographic residence 
time. Also, the injector was placed nearer to the column using a 10 cm stainless 
steel tubing so as to reduce the temperature effects on the peptide in the 
injection loop. The mobile phase A consisted of varying amounts of the organic 
modifier (MeCN or TFE) from 0% to 20% v/v in 0.1 % TFA, as demanded by the 
experiment. The gradient reaching the column was adjusted for the delay time 
which was 3.7 min (using a 2 mL sample loop) for the setup. The gradient-setup 
was such that the column was always returned to its initial condition after the 
completion of each run. The gradient conditions are schematically represented 
in Fig. 3.1.
For this study, the following terminology was adopted from Benedek et 
al. (1984). The gradient time was defined as the time necessary to convert the 
solvent in the column from 100% A to 100% B (Fig. 3.1). The start o f gradient 
was defined when % B increased from its initial composition after the peptide 
was introduced on the matrix (S, Fig. 3.1). The contact time was defined as the
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difference between the time of injection and the time of elution of the component 
as detected (not adjusted for time of its passage from column to detector as the 
length of tubing was unchanged throughout the study). The contact time was 
adjusted for the component by verifying the retention for unretained sodium 
nitrate (= 1.8 min). The incubation time, t, was the time from injection to the start 
of the gradient at the column. This is schematically illustrated in Fig. 3.1 
composite, panel B. The residence time of the peptide in the mobile phase was 
considered to be a constant for all elutions. For want of a better term, the native 
peptide in this study denotes the pure synthetic peptide having a preferred 
conformation, and is used to differentiate from its conformation during residence 
on the hydrophobic stationary phase. It is true that both conformers have 
identical sequences and amino acid compositions, but different interactions with 
the hydrophobic matrix (i.e., chemically similar but conformationally distinct).
The peptide content was determined by BCA and quantitative amino 
acid analyses. All elution data were analyzed as per the protocol outlined earlier 
in section 3.2. The following experimental conditions, given in Fig. 3.1, were 
imposed in order to initiate the band broadening studies:
Fig. 3.1 (a) shows the normal gradient protocol with the injection being 
concurrent with start of the gradient. As per criteria in panel (b), 131-40 was 
injected and allowed to incubate for a specific time between 10 and 60 min on 
the column after which the gradient was initiated and the elution of the peptide 
was monitored. Panel (c) indicates the inclusion of the organic modifier (MeCN
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or TFE) in solvent A at the start of the gradient. The incubation experiment with 
solvent A containing the organic modifier is indicated in panel (d). These 
examinations were done in duplicate. The peak areas for the native peptide 
were determined for the given incubation times and compared with those of area 
for zero time from panel (c), and linear regression was performed using ANOVA. 
The implications of the gradient and on-column incubation schemes given by 
panels (e) and (f) will be discussed in later sections.
Fig. 3.10 summarizes the changes in bandwidths as a function of 
incubation times and the nature of solvent A using a constant gradient time. The 
peptide eluted approximately at the same organic modifier content, which was 
between 40 and 45% MeCN or TFE in these experiments. It is evident that as 
the peptide was incubated on the column for longer periods of time, the band of 
the eluting peptide was broadened considerably; the bandwidths for the 
incubation experiment for 0, 10, 30, 60 and 120 mins with solvent A containing 
no organic modifier were respectively 0.8 mL, 4.0 mL, 7.2 mL, 9.6 mL and 
11.2 mL. The flow rate dependency of bandwidths is given in the composite in 
panel B. It is evident that the peak shape was not particularly influenced by the 
flow rate for a given gradient time. The band broadening appeared to occur 
significantly after the on- column incubation time was more than 10 minutes. For 
longer incubation times, there was only a little change in the peak shape. The 
mass recovery from these incubations was approximately 35%.
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Fig. 3.10 Elution profiles of B1-4Q as a function of on-column incubation and organic 
modifier. Panel A gives the chromatographic profiles on the reversed-phase 
column, Vydac C „  as per gradient conditions as per Fig. 3.1 (a) - (d). Panel B gives 
the elution profiles for the flow rate dependency of G1-40 using solvent A  as 0.1%  
TFA in 10% M eCN with a gradient from 0-100%  B in 60  min.
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3.3.2. Rate Constants of Bandwidth Increase for (11-40 During RP-HPLC
According to the linear solvent strength theory, the retention time and 
bandwidth from gradient elution data correlate well with changes in the same 
parameters derived from isocratic elution after adjustments of the experimental 
variables. However, the experimental gradient elution data for 131-40 indicated 
that several mechanisms could influence its chromatographic behavior. To 
determine the rate of band broadening during the imposed chromatographic 
conditions, the elution volumes were compared. The elution volumes for the test 
conditions were normalized to the elution volume for 131-40 obtained under 
normal gradient condition. The mass recoveries from all chromatographic 
conditions were high and ranged between 60 to 85 per cent based on peptide 
assay and quantitative amino acid analyses.
For zero incubation time, the amount of native peak eluted is given by
Vn = Ne'k' ,G (1)
where
l/n = elution volume of native peak in normal gradient conditions,
N = amount of peptide applied to the column, 
tG = time from injection until elution (elution time), and 
k*=  average rate constant for the various conditions involved in the 
gradient.
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In a normal chromatographic run, given by the schematic in Fig. 3.1 (a), 
where the gradient is started when peptide is applied to the column, k*tG is 
constant. However, for the on-column incubation experiments, given by Fig. 
3.1(6) where the gradient is started after the appropriate incubation time, t, an 
additional first-order kinetic expression can be written as
where
V{ = elution volume in experimental condition,
A/j = amount of injected material, 
k = rate constant, and 
t = on-column incubation time.
The normalized elution volume, V, which reflects the band broadening, 
is then given as the quotient of elution volumes obtained using equations 1 and 
2, which is
V, = Nt e ' kt (2)
V = a e *e■k f _  - k '  tG (3)
which after rearrangement, simplifies to
In V -  (In a - k * tG) - k ■ t (4)
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Equation 4 is of the form y  = mx + c, with the term in parentheses being 
a constant for a given setup. Assuming that the injected material was kept 
constant, a plot of In V versus t will yield /c, the rate constant for band broadening 
of 131-40 on the reversed-phase matrix for a given gradient and temperature 
condition. The amount of peptide injected was kept between 20 to 30 pg for 
each chromatographic run, with the injection size varying between 10 to 20 pL 
depending on the concentration. There is, however, the discrepancy in 
determining the exact value of k* since any deviations in chromatographic 
behavior occurring prior to incubation time and zero time will affect the elution 
volume of native peak, and will reflect in the /c*term. Nevertheless, the rate 
constant for the band broadening on the stationary phase can still be determined 
as k.
Fig. 3.11 gives the band broadening data as a function of on-column 
incubation times at various column temperatures. The kinetic plots according to 
equation 4 are linear at the temperatures studied (20° to 45°C) within the range 
of incubation times from 0 to 60 min, as would be expected for a first-order 
phenomenon. Each data point represents the mean of three observations. 
Using least-squares analysis, the first-order rate constant for the bandwidth 
kinetics at each temperature and for each solvent system was determined for 
131-40. These are summarized in Table 3.1. The rate constants for band 
broadening based on elution volumes were reproducible within ±5%.
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It is noteworthy that as the MeCN concentration was increased, the rate 
of broadening was decreased. Also, at low column temperatures the native 
131-40 content was low, which is reflected in the increased slope in Fig. 3.11. 
From Table 3.1, it is also apparent that to achieve similar elution volumes when 
no organic modifier is present in solvent A, the column temperature must be 
increased. From the observed data, the half-life of the band broadening rate for 
131-40 was calculated to be ca. 25 min. Similar study with 138-40 yielded the half­
life of bandwidth increase to be ca. 17 min. Earlier in this chapter, it was 
observed that the chromatographic contact area of 131-40 was not significantly 
changed after 60°C. In light of the data shown above, this would indicate that 
below 60°C, the bandwidth behavior of f31 -40 under given chromatographic 
conditions appears to be consistent with a first order kinetic model for gradient 
elution derived from approximations from the theoretical treatment from linear 
solvent strength concepts. Nevertheless, this model should be able to 
distinguish and differentiate different band broadening phenomena. These 
facets can be inspected from comparisons between peak capacity and 
separation variables or from experimental and theoretical bandwidths.
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Incubation time (min)
Fig. 3.11 First-order kinetic plots of rate constant of band broadening of (31-40 on varying 
column temperatures as function of on-column incubation time, t. The data points 
are the log of mean of at least two elution volumes normalized on the elution 
volume of 131-40 obtained under normal gradient conditions. The lines are the fits 
for best-curve analysis for the observed data as per equation 4.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
114
Table 3.1
Rate Constants for Observed Band Broadening for ft 1-40 on Octadecyl
Surface
Incubation solvent
k (10'5 sec'1) 
at column temperature (°C)
20 25 30 45
0.1% TFA (pH 2.5) 67 61 45 19
0.1% TFA in 4% MeCN 48 42 29 05
0.1% TFA in 8% MeCN 32 21 15 n.d.
0.1% TFA in 12% MeCN 12 10 4 n.d.
0.1% TFA in 20% MeCN 02 03 n.d. —
n.d. not determined
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3.3.3. Bandwidth Relationships
The band broadening phenomena can be further discerned through 
analysis of experimental and calculated peak capacity data. The average 
resolution of eluants has been defined in terms of peak capacity (PC) by 
Stadalius et al. (1985), in terms of the number of peaks that can be 
accommodated in a chromatogram having time tG with a uniform resolution for all 
peaks by
PC = tG - F / 4ov (5)
where ov is the bandwidth measured in volume units within 1 standard deviation. 
The influence of flow rate on the peak capacity for a constant gradient time of 
60 min is shown in Fig. 3.12. The PC increased to a maximum at a particular 
flow rate for each peptide and subsequently decreased. The observed PC for 
each group of peptides was essentially the same. These results further stressed 
the inescapable conclusion that the PC for each peptide was far from optimal at 
both low and high flow rates. It was also very clear that the peak capacity for 
each peptide was distinct.
These results strongly suggest that the band broadening process within 
the reversed-phase matrix cannot be strictly described by kinetic models for 
solutes behaving as rigid moieties during its passage through the column. 
Indeed, even though the peptides were bound as monomers on the stationary 
phase surface as demonstrated in earlier sections, the combined effect of the
115
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
length of the peptide and the amino acid sequence is considerable. The 
influence of flow rates on peak capacities has also been observed in other 
polypeptides of varying sizes; in thyrotropin-releasing hormone, bradykinin, 
neurotensin and somatostatin by Stadalius et al. (1984), in bovine trypsin by 
Hearn et al. (1985), in luteinizing hormone-releasing hormone and growth 
hormone releasing factor by Hearn and Aguilar (1986) and in myosin related 
peptides by Hearn and Aguilar (1987). It therefore reflects on the similarities, or 
dissimilarities, of the retention phenomena for a series of peptide analogs when 
they are introduced on a hydrophobic surface. It can therefore be considered 
that the PC versus F  plots can be used to derive conditions not only for 
resolutions of peptides per se, but also to delineate the retention and kinetic 
behavior with mechanisms of interactions between the solute and the stationary 
phase surface.
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3.3.4. Resolving a Typical Mixture of Synthesis-fragments
The difference in rates of band broadening was used to separate a 
mixture of synthesis-fragments, 1326-40 and (38-40, during chromatographic 
purification of 131-40. The retention times for (31-40 and (38-40 (Fig. 3.2) as well 
as the peak capacities were close (Fig. 3.12) for satisfactory resolution of the 
peptide mixture. The implications of the residence time of the peptides in the
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band broadening is that if the mechanism is fast compared to the phase 
equilibration of peptides on the column matrix, the gradients given by Fig. 3.1 (e) 
or (f) must lead to identical elution profiles for 131-40 and (38-40. Two parameters 
are simultaneously varied in these examinations, the mobile phase into which the 
peptide is injected and the contact time with the stationary phase surface.
Fig. 3.13 illustrates the elution profiles of a mixture of 131-40 and 138-40 
from a typical analytical run obtained under normal gradient conditions (panel A), 
and when the injection was done after the start of the gradient as per conditions 
in Fig. 3.1 (e) or (f). It was difficult to judge the homogeneity of the peptides from 
the elution profile as illustrated in panel A; however, a closer scrutiny of the 
eluting fractions was undertaken. The characterization of the fractions based on 
amino acid and sequence analyses is given in Table 3.2. It was discerned that 
the major peak actually consisted of 138-40 and 131 -40. There was considerable 
resolution of the major peak when the peptide mixture was subjected to the 
experimental gradient as depicted by the profile in panel B. The different band 
broadening rates for 131-40 and (38-40 (section 3.3.2) were therefore successfully 
used for resolving a mixture of these peptides.
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3.3.5. Effects of Extrinsic Factors
The overall process of polypeptide retention under reversed-phase 
conditions can be given as a cumulative effect of three separate events, viz., 
protein solvation in the bulk mobile phase, hydrocarbon ligand solvation by the 
bulk mobile phase components and interaction of the solvated solute with the 
solvated reversed-phase surface. For a thorough understanding of peptide 
retention behavior during RP-HPLC, it is not sufficient to demonstrate the effect 
of various intrinsic factors like nearest neighbor or peptide chain length on 
interactive behavior under various chromatographic conditions; it is also 
necessary to evaluate how the solvation of the peptide influences its residence 
on the stationary phase surface.
The observed change in elution characteristics of 131-40 and derived 
analogs on reversed-phase chromatography was shown to manifest as a major 
change in chromatographic performance. Most often, these changes lead to loss 
of recovered peptide, which in this study was comparatively high, ranging 
between 15 and 40% of the injected mass. However, in some cases, a complete 
retention of the solute has been reported with increase in the ionic strength of 
the mobile phase, for e.g., a-chymotrypsinogen (Cohen et al., 1984). The band 
broadening phenomenon has also been associated with microheterogeneity and 
aggregation (Kerlavage et al., 1983; Hearn and Grego, 1984). In the following 
section, the retention of (31-40 and derived analogs was followed after 
individually introducing them on the reversed-phase matrix and the elution
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profiles of peptide mixtures were plotted to study the effects of induced 
microheterogeneity.
Ionic Strength Effects on Retention Times and Recovery o f Peptides
The popular use of TFA in reversed-phase chromatography is due to its 
high volatility - advantageous during recovery of peptide via lyophilization, and 
its extreme effectiveness in suppressing non-specific interactions of the peptide 
solute with the stationary phase support (Mant and Flodges, 1987). RP-HPLC 
studies of 131-40 and derived analogs were performed on /7-alkyl bonded silica 
with a low-pH water-acetonitrile eluant, where the acidic side chains of Glu and 
Asp are expected to be partially ionized. In lieu of non-ideal behavior, the 
interaction with the stationary phase support would be primarily from the carboxy 
terminal residues 29 to 40, all of which are hydrophobic. To scrutinize the role 
of the column matrix with respect to non-specific interactions with the solute, the 
mobile phase was loaded with increasing amounts of salt and the mass of 
peptide recovered was measured from the C4 and C18 matrices.
Fig. 3.14 summarizes the change in retention times as a function of 
increasing ionic strength of the mobile phase when compared with normal 
gradient. It is evident that there was no significant variation in the retention of 
(326-40 and (322-35(M), however, the slight increase in retention of (31-40, (38-40, 
(31-28, (36-25 and (315-28 on both, the C4 and C18 columns implied an increase 
in their hydrophobic interaction. More striking is the dramatic effect the change
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in elution volumes had on the recovery of the same molar quantity of the 
peptides as illustrated in panel C. There was at least a 33% reduction for (31-28, 
with equimolar recovery of (31-40 accompanied by a 50% reduction in the elution 
volume. These results indicate that the bandwidths were considerably narrower 
when increasing ionic strength to p -  0.200 than those obtained under normal 
chromatographic conditions.
Exogenous Peptides
Investigation of the interaction of (326-40 and (38-40 with (31-40 was 
undertaken with the express aim to explore the interaction of these carboxyl 
terminal variants in the presence of the hydrophobic stationary phase and in 
solution. A mixture of these peptides was allowed to incubate in solution for a 
given length of time, and this incubated mixture was loaded on the column and 
elution performed using normal gradient.
Incubation in Solution: (11-40 with IS26-40 and IS8-40
Incubations of (31-40 with (326-40, and with (38-40 at ambient 
temperatures were loaded as their solutions on the Vydac C18 column under 
normal gradient conditions. The elution profiles for solutions having a 9:1 mole 
ratio of (31-40 and (326-40, and a 1:1 mole ratio with (38-40 which were incubated 
for 48 h are shown in Fig. 3.15. When comparing the profiles with pure peptides 
(profile c), it is evident that extraneous chromatographic peaks were generated.
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The elution profiles obtained on reinjection of the individual components 
are shown in Fig. 3.16. Reinjection of a(1) yielded only a single component with 
retention time and peak profile for 1326-40, while a(2) emerged as a mixture of 
1326-40 and 131-40 within the chromatographic parameters. The reinjections of 
a(3) and a(4) yielded pure 131-40, whereas the reinjection of a(5) indicated a 
component for which the peak identification did not match for either 1326-40 or 
131-40. Similar results were obtained for the reinjection of incubated 131 -40 and 
(38-40 (Fig. 3.15, panel B). These chromatograms demonstrate that the 
microheterogeneity increased at the expense of the pure peptides. 
Subsequently, all the components were characterized by sequence and 
quantitative amino acid analyses which are summarized in Table 3.3.
Based on these analyses, it was of interest to note that the extraneous 
peptide components could be identified as a distinct mixture of pure peptides, 
hetero-oligomers. In conjunction with the chromatograms, these analyses 
indicate that the pure peptides were independently converted to oligomeric 
peptides which were meta-stable within the chromatographic environment. This 
was a very important finding, since this chromatographic strategy was employed 
to stabilize these hetero-oligomers and study their formation over time.
121
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Kinetic Studies: 1126-40 with (11-40 and (18-40
The generation of the major microheterogeneous product formed on 
incubation of the relatively hydrophobic carboxy terminal peptide, 1326-40, with 
131-40 and 138-40 was followed over time. Addition of 1326-40 solution to 131 -40 
in a 1:99 to 1:9 mole ratio, based on quantitative amino acid analyses, was 
studied for 168 h. These mixtures were sonicated briefly immediately after 
preparation and the incubations were performed at ambient temperatures. At the 
end of the test period, periodic aliquots were drawn, centrifuged, and the 
supernatant was loaded directly on the column.
The mass of the eluting hetero-oligomeric component was measured 
was normalized on the peak areas for pure peptides for the same mole ratio. 
The kinetic data are given in Fig. 3.17. In order to verify that the observed 
elution behavior concurred with the process of oligomerization of f31-40 and 
(326-40, the data given in Fig. 3.17 were fitted into an integrated equation for 
irreversible association kinetic model of the form M1 + M2 -  0 ,2, where M 
signifies the monomer and O the oligomer:
\n[O12] = \n[O12]0 - k 1 -t (9)
where
[0 12]Q is the oligomer concentration at zero time,
[Of2] is the oligomer concentration at any time t, and
k1 is the rate constant for oligomer formation in solution.
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Flow rate (mUmin)
Fig. 3.12 Plot of peak capacity as a function of flow rate for 131-40 and derived analogs at a 
constant gradient time of 60 min. The flow rates employed were 0.5, 0 .8 ,1 .0 , 1.25, 
1.50 and 2.0 mL/min; data points have been excluded for clarity. The numbers in 
brackets denote (31-40 and derived analogs according to the designation given in 
Table 2.3:131-40 (1), [Arg13|l31^0 (2), [Arg14]l31^»0 (3), 131-28 (9), [Arg13J(31-28 (12), 
(3-26 (13), [Arg1314]l36-26 (16), and (38-40 (20).
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Elution volume (mL)
Fig. 3 .13  Resolution o f synthesis-fragments 1526-40 and 158-40 from a typical 151-40 
synthesis. The elution profile in panel A was generated at room temperature using 
Vydac C,„ operated under normal gradient conditions at room temperature and a 
flow rate of 1 mL/min. Panel B shows the resolution of the broad more 
hydrophobic fraction during gradient elution using solvent A as 0.1% TFA in 
17.5%  M eC N  and 0.1%  TFA  in 100%  MeCN as solvent B; the column was 
operated at 30°C , using a flow rate of 1.5 mL/min. The gradient was established 
as follows: 0% B for 5 min and then 0-100% B in 30 min. The peptide solution was 
injected exactly 15 min after the start of the run as per conditions given in Fig. 3.1 (I). 
T h e  numbers denote the fractions which were characterized by sequencing and 
amino acid analysis.
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Table 3.2
Sequence and Amino Acid Analysis o f "Impure" (11-40 Synthesis
Fraction Predicted sequence Composition and sequence 
observed
1 1326-40 N K G A IIG LXVG G W
2 B8-40 XGYXVHHQ KLVFFAEDVG...
3 B1-40 D AEFRHDSGYEVHHQKLVFFAEDVG ...
X denotes poor identification during sequencing and less than 20 mole% of that residue 
on quantitative amino acid analyses.
The underlined italics denote the repetitive yield was less than 55 mole % for that cycle. 
When a known sequence was obtained for more than six residues with a good repetitive 
yields, sequencing was not taken further, and this is denoted by
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© -  (31-40; -H 3 - (38-40; - ± -  B1-28;—v — 136-25;
(315-28; - ® -  (326-40; - ® -  I322-35(M)
mM KCI in Mobile phase
Fig. 3.14 Plot of elution behavior as a function of mobile phase ionic strength, p, for 151-40 
and derived analogs on reversed-phase column C„. The data points represent 
retention times using normal gradient with ionic strength variations from, p = 10 to 
200 mmol/L KCI in solvents A  and B containing 0.1 % TFA in 20%  M eCN, and 0.1 % 
TFA  in 80%  M eCN respectively. The flow rate of 0.8 mL/min.
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Fig. 3.15 R P -H P LC  behavior of incubating equimolar 111-40 with 1126-40, and with 88-40  
in-solution on Vydac C 18. The elution profiles for the 81-40 incubation with 826-40  
(a), with 88-40 (b), and the pure peptides (c) were obtained using normal gradient 
conditions. The arrows indicate the corresponding fractions were analyzed by 
quantitative amino acid and Edman sequencing of the numbered components 
(Table 3.3). The concentration of 111-40 was maintained at 200 pM and solutions 
were stood at room temperature with intermittent sonication.
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Table 3.3
Sequence and Amino acid Analyses o f (11-40 Incubations 
with (18-40 and (126-40
Fraction Predicted sequence Composition and 
sequence observed
a(1) B26-40 /VK G A IIG LXVG G W
a (2) B8-40 XG YEVH HQ ...
a (3) none (i) DAEFRHDSGY...
(ii) GYXVXXQKLVFF...
a (4) (11-40 DAEFRHDSGY...
a (5) none (i) DAEFRHDSGY...
(ii) X X G A IIG L X V G G W
b(1) B8-40 GYEVHHQQKLVFF...
b(2) none DAEFRHDXGY...
b(3) B1-40 DAEFRHD...
b(4) none (i) XG YEVH HQ ...
(ii) DAEFRHDXGY...
X  denotes poor identification during sequencing and less than 20 mole% of that residue 
on quantitative amino acid analyses.
The underlined italics denote the repetitive yield was less than 75 mole % for that cycle. 
W hen satisfactory repetitive yields were obtained for six or more cycles for a know 
sequence, sequencing was not taken further and is denoted by
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Fig. 3.16 R P-H PLC  profiles of the pooled fractions of 61-40 incubation with 626-40 and 
68-40. The numbers on the chromatograms indicate the pooled fractions from the 
61-40 and 626-40 (panel A) and 61-40 and 68-40 (panel B) incubations given in 
Fig. 3.15
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Fig. 3.17 Kinetic profiles for solution-incubation of 1326-40 with IS8-40 (A) and 131-40 (B) over 
168 hours expressed as normalized mass of the heterogenous product. The mass 
were determined by on the basis of peak areas obtained for pure peptides injected 
at the sam e mole ratio. The lines are tits to data according to equation 9. Each 
data point represents the mean mass from three chromatograms.
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IJ26-40 (mole percent)
Fig. 3.18 The rate constant dependence of RP-HPLC-determined association o f (326-40 with 
(31-40 and (38-40. The data points represent the rate constant of oligomer 
formation on incubating (326-40 with (31-40 and (38-40 derived from the 
mathematical fits to chromatographic mass given in Fig. 3.17.
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The rate constants for this oligomerization were found for mole ratios 
between 0:100 and 1:9 (326-40: (31-40 and are shown as a function of 1326-40 in 
Fig. 3.18. It was difficult to increase the concentration of 1326-40 in aqueous 
solution beyond 10 mole% because of its insolubility. When the rate constants 
were plotted as the function of mole fraction of 1326-40, a bell-shaped behavior 
was found with the inflexion at 5 mole% of (326-40.
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3.4. Discussion
As is customary with all solutes undergoing slow dynamic 
interconversion under regulated chromatographic conditions, the arduous path 
of a polypeptide is replete with phenomena not experienced by rigid molecules. 
The intent of this study was to delineate the secondary structural components of 
(31-40 by studying its interactive behavior on reversed-phase matrices. In this 
study, 0.1% TFA in MeCN gradient system popularly used in the RP-HPLC of 
peptides and proteins caused (31-40 and derived analogs to interact in their 
monomeric form with the n-alkyl bonded surfaces. The retention times followed 
a log linear relationship in the presence of TFE, as with MeCN, which strongly 
suggested that the peptides were monomeric helices in the presence of TFE. 
In the absence of a solid hydrophobic surface, the amino terminal sequence
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Asp1-V a l12 sequence has a higher propensity for a-helix formation in TFE 
solutions (Hollosi etal., 1989; Barrow and Zagorski, 1991; Sorimachi and Craik,
1994); however, in MeCN, the ARP variants exist predominantly as R-pleated 
sheets (Fabian et al., 1993; Otvos et al., 1993), i.e., although 131-40 can adopt 
an a-helical structure in helix inducing solvents, the helical structure is 
destabilized in the presence of MeCN. Perhaps, the hydrophobic stationary 
phase sorbent induces helix formation in these peptides, and more so on the 
simultaneous substitutions of His -* Arg at positions 13, 14 and L-Asp D-Asp 
at 1, 7, 23 respectively. Studies correlating structural effects of model peptides 
forming amphipathic a-helices on hydrophobic surfaces have also been made 
by other chromatographers (Zhou et al., 1990; Blondelle and Houghten, 1992; 
Aguilar et al., 1993). This would explain the observed chromatographic behavior 
of 131-40 and derived analogs on the reversed-phase surfaces.
However, the denaturant conditions of reversed-phase liquid 
chromatography did not prevent the secondary equilibria which were established 
by these peptides. The magnitude of the chromatographic area of 131 -40 and the 
His —► Arg and L-Asp -> D-Asp derived analogs was dependent on the organic 
modifier, which suggested that the interactive behavior with the stationary phase 
surface was sensitive to the position of substitution. Obviously, the His Arg 
and L-Asp D-Asp substitutions in 131-40, 131-28 and 136-25 significantly 
increased the chromatographic contact region. However, the increased contact 
area was severely affected by temperature, and the thermal transitions were
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associated with a resultant decrease in the predisposition of the peptide for the 
hydrocarbonaceous ligands. The phenomenon of competing equilibria is 
however not unique to 131-40, but has been observed in many proteins and 
model peptides of various lengths (Hearn and Grego, 1984; Hearn et al., 1985; 
Hearn and Aguilar, 1986a; 1986b; 1987). The consensus among 
chromatographers is that changes in interaction of polypeptides with the 
stationary phase during RP-HPLC results in changes in chromatographic 
parameters of these solutes, leading to retention time changes and band 
broadening (Benedek et al., 1984; Hearn and Grego, 1984; Hearn and Aguilar, 
1987). The observed data indicates the extent of secondary structure changes 
which can be induced by the stationary phase, and the importance of the 
immobilized hydrocarbon ligand on the interactive process. It appears that the 
increase in chromatographic contact area and the subsequent decrease in the 
affinity of the comparatively larger 131-40 and 138-40 peptides for the stationary 
phase surface are directly related to significant changes in conformation of these 
peptides. Based on the observed chromatographic parameters between the 
His -♦ Arg and the L-Asp -> D-Asp analogs, it would be safe to assume that the 
stationary phase surface has the potential to perceive changes in the amino acid 
side chains.
The rates of band broadening in 131-40 and 138-40 within the imposed 
parameters differed on the chromatographic time scale. Although it was not 
proven by the approach employed in this study, the role of the amino terminal
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was evident due to the difference in the half-life of bandwidth increase for these 
two peptides. Within the chromatographic elution time, a change in orientation 
due to the interaction with the stationary phase surface ligands, or due to mobile 
phase polarity can destabilize the native conformation; the subsequent 
folding/unfolding of the peptide backbone can cause a change in the interactive 
behavior. The resolution of the mixture of 131-40 and 138-40 was, however, 
optimized by using the chromatographic bandwidth rates as a determinant to 
yield the pure peptides. The inherent tendency of 131-40 to elute as a broad 
component on reversed-phase liquid chromatography observed in other 
laboratories is therefore understandable in light of the data observed here.
It is worth noting that the hydrophobic matrix was instrumental in 
dictating the elution behavior of co-incubated peptide mixtures. The 
chromatographic approach of determining the rate constant for the 
oligomerization of two fragments of the parent Alzheimer (3-protein, viz., (31-40 
and (326-40, employed an approach which is unique for this field. The 
bell-shaped behavior indicated a barrier for the process of oligomerization. The 
presence of a small amount of peptide (326-40 may lower this barrier and shift 
the equilibrium toward the oligomer concentration. At least 5 mole% of (326-40 
was needed to observe hetero-oligomers which were chromatographically 
resolvable. The rate constant for the association (oligomerization) of (31-40 and 
(326-40 indicated that at a low (326-40:131-40 ratio, the association of monomers 
was a slow step. This point was seen clearly when the incubation times were
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long (> 168 h); the oligomers were formed entirely at the expense of the 
respective monomers. The increased turbidity of 1326-40 solutions after 12 h has 
previously been reported (Jarrett et al., 1993). Although the turbidity 
measurements did not indicate hetero-oligomers, the importance of the carboxy 
terminal in amyloid formation was emphasized. Also, strong hydrophobic 
interactions between core helices coupled with weaker hydrogen-bonding 
interactions between (3-pleated sheets have been proposed to be responsible for 
the deposits in systemic amyloidosis (Turnell et al., 1986). From the elution 
profiles of co-incubated 1326-40 and 131-40 and the subsequent amino acid and 
sequence analyses, it would therefore seem that these are meta-stable hetero­
oligomers. The resolution of oligomers of 1326-40 with f31 -40 and 138-40 using 
the chromatographic approach proves that it is possible that 5 mole% 1326-40 
would be sufficient to obtain hetero-oligomers, which could act as nucleating 
sites for aggregation.
Although the approach used in this examination of chromatographic 
structure may not be identical to the biologically relevant "receptor 
interacting structure" of AI3P, analogy with the hydrophobic membrane-interaction 
can be made. Based on examination of 131-40 and derived analogs, 
reversed-phase high-performance liquid chromatography provides a potential 
probe for this structure of the peptides' interaction with membranes. It can be 
hypothesized that the hydrophobic interaction of these peptide solutes is 
maximized, primarily from (i) the hydrophobic carboxy segment 1326-40, and (ii)
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due to secondary interaction from the cluster of hydrophobic residues -LVFFA - 
corresponding to residues Leu17-A la21. The secondary equilibria established 
due to these interactions could then explain the observed chromatographic 
behavior of band broadening and retention. The correlation between these 
synthetic peptide analogs and their chromatographic performance thus provides 
yet another approach to understanding the relationships between peptide 
structure and function. The conformation of the individual peptides on the 
chromatographic surface might not be analogous to the "biologically relevant" 
structure interacting with the cell-receptor. Nonetheless, there is a potential to 
exploit their chromatographic behavior as an experimental approach to studying 
their structure-function relationships.
The gradient elution protocols used in evaluating the interactive 
behavior of 131-40 and derived analogs have provided clues to the dynamic 
nature of these molecules in a denaturing environment. This study reiterates the 
necessity of examining the peptide in the presence of membrane-like matrices, 
so that a better direction to the underlying molecular phenomenon can be 
obtained. ARP is one of the amyloidogenic proteins, but if the interactions of the 
derived analogs with the reversed-phase surface are any indication, similar 
methodology could be employed to lock the meta-stable conformation(s) for 
therapeutic intervention before the curtain call of amyloid formation.
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Chapter 4
Conformational Transitions of ARP - A Far UV/CD 
Spectroscopy Study
Introduction
The importance of knowing the structure of a protein or a peptide in 
relation to its function is central to understanding their biochemical mechanisms. 
The three-dimensional structure of a protein arises from its amino acid 
sequence, i.e., its primary structure. In a general scheme of protein folding, the 
primary structure dictates the secondary structure(s), which leads to formation 
of tertiary, and eventually, quaternary structures. Secondary structures have a 
limited merit compared to the complete three-dimensional protein structure; 
nonetheless, their formation precede most events in protein folding (Kim et al., 
1982; Ptitsyn, 1987; Kuwajima, 1989; Ptitsyn et al., 1990; Lustig and Fink, 1992).
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High resolution techniques like solid state nuclear magnetic resonance 
(ss-NMR) spectroscopy and X-ray diffraction studies provide information on 
biomolecules in a solid state. Application of these techniques is however 
cumbersome and their relevance to the solution structure remains doubtful. In 
the case of AI3P, moderately resolved X-ray diffraction and electron microscopy 
(Castano et al., 1986; Kirschneret al. 1986; Halverson et al., 1990; Kirschner et 
al., 1990; Fraser et al., 1991; Burdick et al., 1992) have provided crude 
information of its quaternary structure. Information on secondary structure of 
AI3P is also gleaned from low resolution techniques, like Fourier transform 
infrared (FTIR) (Halverson et al., 1990, 1991; Fraser et al., 1992) and circular 
dichroism (CD) spectroscopy (Hollosi et al., 1989; Barrow and Zagorski, 1991; 
Hilbich et al., 1991; Barrow et al., 1992; Caputoetal., 1992; Fabian et al., 1993; 
Otvos et al., 1993). These techniques are sensitive to backbone conformation 
and of great practical use. 131-40 is a dynamic molecule with an inherent 
propensity for reorientation of its backbone which is further enhanced by its 
environment. The studies on synthetic AI3P peptides have provided information 
about the conditions favoring aggregation, like pH, salts, and membrane- 
mimicking environments (Barrow and Zagorski, 1991; Hilbich etal., 1991; Barrow 
etal., 1992; Jarrett and Lansbury, 1993; Come et al., 1993; Otvos et al., 1993). 
A mathematical model based on kinetic evidence from light scattering 
measurements indicates that an end-to-end association of 131-40 molecules 
could result in gel formation (Tomski and Murphy, 1992). This phenomenon is
139
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
not in keeping with the process of oligomerization via intermolecular attraction 
to form antiparallel R-pleated sheets. However, this model does not characterize 
the changes in the structural subdomains of 01-40 along the pathway to its final 
folded form.
The studies outlined in this chapter provide qualitative and quantitative 
data of the conformational changes of R1-40 and its derived R6-25 analog in 
aqueous solutions. The peptide backbone conformation was studied 
spectroscopically over time by its absorption in the far UV region using CD 
spectroscopy. Spectroscopically distinct transitions were detected and 
characterized in terms of relative transformations of the secondary structural 
components. This knowledge is of interest in structure-function studies, and is 
discussed in terms of the in vitro aggregation of R1-40 and its derived analogs.
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4.1. Secondary Structure via Far UV Amide Circular Dichroism
It is critical to know how tertiary or quaternary structure formation takes 
place; thus a comprehensive understanding of the folding of the peptide 
backbone necessitates obtaining information on its secondary structure 
organization. It is generally believed that small peptides (« 30 residues) are 
capable of adopting a variety of interconverting conformations in solution
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Blundell and Wood, 1982). This phenomenon however depends on a number 
of extrinsic determinants which include, but is not limited to, time, concentration, 
pH, solvent, and presence of other molecules in solution. It is now understood 
that the environment of the protein molecule is a significant determinant of 
secondary structure (Zhong and Johnson, 1992). AI3P seems to possess smaller 
regions (subdomains) and exhibits different secondary structures that are 
dependent on the amino acid sequence (Hollosi et al., 1989) and pH (Fraser et 
al., 1991b). Although the CD spectra of AGP can be used to detect secondary 
structure transitions, deconvolution of the spectrum does not allow unambiguous 
assignment to specific residues in the peptides. CD studies on 131 -40 have 
demonstrated that conformational changes occur in solution as a function of 
concentration (Burdick et al., 1992; Tomski and Murphy, 1992; Otvos et al., 
1993). The preferred conformation of 131-40 in aqueous solutions is a 13-pleated 
sheet and depends on the degree of self-association (Hilbich et al., 1991). At 
higher concentrations, oligomerization has been suggested to lead to gel 
formation in synthetic peptides (Tomski and Murphy, 1992; Jarret and Lansbury, 
1993; Zhang et al., 1993), a process for which the kinetics of backbone folding 
are not fully established. In this study, the use of fi1 -40 and its derived analog, 
136-25, provide excellent models to elucidate the transformations of secondary 
structure during folding.
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4.1.1. Secondary Structure Studies of R1-40 and Derived Analogs in 
Aqueous Solutions
The peptide backbone, with its amide -CONH- chromophore, rotates the 
plane of polarized light. Circular dichroism is the measurement of the difference 
between absorption for left- and right-circularly polarized light; CD bands are 
generated at wavelengths where absorption takes place. These bands will be 
either positive or negative depending on the strength of absorbed light. The 
difference is generally reported in terms of molar ellipticity at a given wavelength,
[0]x and is given as:
142
[0]A = 3298 (eL - eR) = 3298 0X / C • / - (M /  100) (1)
where
e* is the raw ellipticity,
e is the molar extinction coefficient, for left (L) and right (R) polarized light
C is the concentration of peptide in g/mL,
/ is the path length in cm,
M is the mean residue weight of peptide in daltons.
Circular dichroism spectroscopy in the far ultraviolet region (far UV/CD) 
is very sensitive to the secondary structure of the polypeptide backbone. For 
131-40, this sensitivity is highlighted in Fig. 4.1. The occurrence of various CD 
bands has been explained by Tinoco (1962) as functions of oscillating electro-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Fig. 4.1 Circular dichroism spectra of 250 pM synthetic 131-40 in H 20  at pH 7.5, in 
40% MeCN at pH 7.1 and 40% TFE at pH 7.2. A 50 mM HEPES buffer was used 
for preparing the solutions. The raw ellipticity was measured on a Jasco 
spectropolarimeter, J-720 at a scan rate of 1 nm/sec with an analog time constant 
of 1 sec and the data converted to molar ellipticity. The data are an average of four 
scans; no smoothing functions were applied. The ellipticities were calculated using 
a mean residue weight of 108.3 daltons. A cubic-spline algorithm was used to plot 
the CD curve. The occurrence of the excitation resonance transitions, n -n * and 
n-K*, are explained in the text.
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magnetic vectors, electric transitions, and the dipole and rotational strengths 
characteristic of the peptide moiety. Additionally, polarity changes in the 
chromophore environment due to intrinsic and/or extrinsic factors cause shifts 
in intensities (Urry, 1985; Nicotand Waks, 1989). The CD study done on (31-40 
and its derived analogs is the core of this chapter and a brief review of the 
positions and intensities of the various CD bands in terms of its secondary 
structural components is in order.
For the amide chromophore containing only the pure optical properties 
of an a-helix, an rt-x* transition gives rise to a weak but broad band near 220 
nm. This electronic absorption is assigned on the basis of transition energy, low 
absorbance and high rotational strength. There is another negative band near 
208 nm, crossover to positive ellipticity takes place near 200 nm and a positive 
band near 190 nm (202 and 195 nm respectively in the case of (31-40) which are 
due to excitation resonance interactions. The 220 nm band is polarized parallel 
to and the positive band near 190 nm is polarized perpendicular to the helical 
axis. A predominantly a-helical CD spectrum of (31-40 is denoted by the hollow 
triangles in Fig. 4.1. For a mostly (3-pleated sheet structure, the band near 215 
nm is assigned to the n-n* transition, and the positive band near 195 nm due to 
the splitting of the ;r-;r*band which is due to excitation resonance interactions. 
In the case of (3-pleated sheets, a crossover to positive ellipticity usually takes 
place around 205 nm; in this study for aqueous (31-40 solutions, the crossover 
was at 202 nm. There is also an occurrence of unordered or random structure
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(type C-D, according to contemporary nomenclature) for 131-40 solutions below 
pH 3. The prominent feature of this structural class is the negative band near 
200 nm and no positive CD signal.
The positions of the respective positive and negative bands in the three 
different classes of secondary structures given in Fig. 4.1 are only valid for 
polypeptides that do not possess any interfering electronic transitions in the side 
chains. For most amino acids side chains, these transitions are below 190 nm, 
except for the aromatic functionalities of tryptophan, tyrosine and phenylalanine, 
and histidine and cysteine which appear around 280 nm. When CD is measured 
between 260 and 175 nm, this contribution is minimized. No CD signal was 
detected above 240 nm for (31-40, indicating that the single tyrosine did not 
contribute to the ellipticity of (31-40. 131-40 exhibited mixed a-helical and 
(3-pleated sheet character in aqueous solution as depicted in Fig. 4.1. CD 
spectroscopy therefore, makes it easier to monitor changes in conformation of 
(31-40 that result from changes in environmental parameters. The spectra also 
contrast well with the X-ray diffraction data on oriented fibrils of (31-40 (Inouye 
et al., 1993), and with spectra from other laboratories (Barrow and Zagorski, 
1991; Hilbich et al., 1991; Barrow et al., 1992; Exley et al., 1993; Otvos et al.,
1993).
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Analyses of secondary structural components from CD spectra
Mathematical deconvolution of the experimental CD spectra is 
undertaken to determine the secondary structural content in terms of a-helical 
(/-/), antiparallel (A) and parallel (P) 13-pleated sheets, (3-turns (T) and any other 
unordered (O) structures. The spectrum is then fit with a reference set of CD 
spectra of known secondary structures. The pioneering work by Greenfield and 
Fasman (1969) has set a trend for secondary structure estimation methods, and 
was later extended by Argos et al. (1978). The methods currently in vogue are
(i) the variable selection method (Varselec) of Johnson and colleagues (1987), 
and (ii) those advocated by Fasman and coworkers (1991) viz., the convex 
constraint analysis (CCA). The structural information provided by these 
methods, at least for the a-helical and (3-pleated sheets agrees with that 
obtained from the ellipticities at 220, 215 and 195 nm for the helices (Greenfield 
and Fasman, 1969), and at 215, 190 nm for the sheets (Sarkar and Doty, 1966).
The CD spectra were measured between 260 and 175 nm and were 
digitized every 2 nm for analyses using Varselec, and mathematically reduced 
to a wavelength interval of 1 nm between 240 and 195 nm for CCA. In cases 
where background absorbance was high, CD spectra were truncated when 
absorption exceeded 1.2 AU. The constraint placed on Varselec analyses was 
that the total secondary structure equals 100%. If /"denotes the weighted 
fraction of each secondary structure /, then
If , = 1.0 (2)
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Although both these mathematical analyses provide similar information for the 
five classes of secondary structures, the uncertainty in data varies with the 
structural classes. Data for a-helices and [3-pleated sheets are usually more 
reliable within experimental limits than the other classes. Equation 2 can be 
written in terms of five individual components
[0J* = + + fpQpW + + f0B0W (3)
where
[0]x is the molar ellipticity in deg-cm2-dmol'1,
f  is weighted fraction of the secondary structural component,
0 is the reference ellipticity, and
the subscripts H, A, P, T, and O denote the a-helical, antiparallel (3-pleated 
sheet, parallel (3-pleated sheet, (3-turns, and unordered secondary strucutres 
respectively. This equation can be simplified to a three component analysis:
[ e]x = f0r0(A) + fcrc(A) + f0r0(A) (4)
where fa denotes the a-helical content, fa denotes the fractional antiparallel and 
parallel f3-pleated sheet content, and f0 is the fraction of all other structures that 
are not a-helical or 13-pleated sheet. For simplicity of data treatment, the f3-turns 
(7) and other unordered structures (O) were grouped together as "other," (f0), 
to perform a three component analysis. It is rational to include all the other
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structural components into one spectral class since they are not defined as a 
13-pleated sheet unfolds. Linear least-square fittings were then performed on 
data obtained from equation 4 using the criteria given in equation 2.
Assignments of secondary structural elements gleaned from a CD 
spectrum are based on empirical correlations with pure component spectra 
and/or theoretical calculations (Johnson, 1980; Provencher and Glockner, 1981) 
using model and synthetic peptides (Chou and Fasman, 1977; Yang et al. 1986), 
globular proteins (Hennessey and Johnson, 1981), and pattern-recognizing 
algorithms (Kabsch and Sander, 1983). Contemporary methods using statistical 
procedures give high correlation coefficients compared to the X-ray structure of 
proteins. Varselec is one such method based on a sixteen protein database and 
gives correlation coefficients of 0.97, 0.76, 0.49 and 0.86 respectively for a-helix, 
13-pleated sheet, (3-turn and other secondary structural elements (Manavalan and 
Johnson, 1987). Most often, reliable results are obtained using Varselec when 
the CD data are extended to 184 nm as the lower wavelength (Johnson, 1990). 
Obtaining such statistically significant secondary structural information is 
however, not always feasible due to practical limitations in achieving the low 
wavelength limit in a protein solution.
The decision of using reference proteins remains one of the 
uncertainties in analyzing CD spectra (Venyaminov et al., 1991). Besides, the 
low probability of finding proteins in which one or the other secondary structure
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predominates precludes the study of biomolecules having an abundance of one 
secondary structure (van Stokkum et al., 1990; Perczel et al., 1992).
Deconvolution of CD spectra of polypeptides to extract the pure 
components having very high a-helix content is satisfactory but at best 
questionable when the (3-pleated sheet content is low (Perczel et al., 1992). 
Deduction of spectral contribution of secondary structures by Convex Constraint 
Analysis (CCA) algorithm is done directly from the deconvolution information of 
experimental CD spectra using a larger spectral data base (Perczel et al., 1991). 
This method improvises the standard data set of Yang et al. (1986) by including 
a "beta set proteins" from Kabsch and Sander (1983) to contain the CD curves 
of 23 proteins in the wavelength range between 190 and 240 nm (Perczel et al.,
1992). The CD spectra of a-helices generally vary with the length of the helix 
(Yang et al., 1986), whereas the (3-pleated sheet, which exists in fundamentally 
different forms {i.e., parallel-13-sheets, antiparallel-(3-sheets, twisted and 
extended, and (3-barrels) exhibits significant fluctuations in band intensity 
(Manning and Woody, 1987). Deconvolution of the measured spectra by CCA 
therefore allows a better estimation of secondary structures in proteins with 
(3-pleated sheet structure. Perczel et al. (1992) demonstrated improved success 
by extracting unambiguous information of antiparallel (3-pleated sheet for the 
membrane bound CheY protein using CCA than with other deconvolution 
methods.
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Varselec and CCA methods were used in this study to deconvolute 
kinetic information from the CD spectra of (31-40 and (36-25. When background 
absorbance of solvent or buffer forced truncation of spectra due to poor 
signal/noise ratio below 195 nm, the kinetics were emulated from the variation 
of molar ellipticity. In either case, the secondary structure content was correlated 
by fitting the observed CD spectrum to reference spectra of pure components. 
In cases where the observed CD spectra could not be satisfactorily fit by the 
reference spectra, an alternate reference set was generated using the 
information given in Fig.4.1 as per Appendix C. The interest in the 
conformational studies presented here is to delineate the local conformational 
changes for (31-40 which guide folding of its tertiary structure. Analyses of the 
changes in apparent structural composition then permits one to detect the 
stabilizing components of secondary structure. This information provides an 
avenue for deciphering the pathways leading to organization of the (31-40 
backbone as oligomers from solution.
Concentration-dependent conformational changes for B1-40
The CD spectra of (31-40 solutions at 25 pM, 175 pM, 500 pM and 2.5 
mM are given in Fig. 4.2. The concentration dependence of the CD spectra on 
(31-40 conformation is seen from the change in ellipticity as the minima near 
215 nm red-shifts to 207 nm when the concentration was increased from 25 pM 
to 2.5 mM. The CD spectrum at high concentration is typical of high antiparallel
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(3-pleated sheet content. At low concentration (25 pM), there was considerable 
decrease in the intensity of the minima at 210 nm and, the maxima at 190 nm 
disappeared with a concomitant appearance of a shoulder near 200 nm. At 
concentrations higher than 0.5 mM, the positive band was very prominent and 
the minima near 215 nm was intensified. The presence of a shoulder near 220 
nm at intermediate concentrations indicated a mixture of a-helical and (3-pleated 
sheet conformations. The CD spectra of (31-40 between 25 pM and 2.5 mM 
shown in Fig. 4.2 are nearly isodichroic at 207 nm.
The variation in ellipticity at five wavelength intervals as a function of 
concentration is graphically depicted in Fig. 4.3. There was an overall increase 
in the positive band at 195 nm with an increase in concentration from 25 pM to 
2.5 mM which was followed closely by an increase at 200 nm (bottom panel). 
This correlation is also seen by a simultaneous increase in the minimum 
ellipticity at 210 nm. The intensities of CD at 210 and 215 nm both increased as 
concentration was increased to 250 pM with a greater increase beyond 2 mM 
131-40 (top panel, Fig. 4.3). The changes in 021O were coincident with that of 0215, 
indicating the sensitivity of CD at these wavelengths in terms of concentration.
The spectral changes of (31-40 are reminiscent of interconversion of 
secondary structural components to enhance the antiparallel (3-pleated sheet 
content observed by other laboratories using A(3P derived analogs in aqueous 
cosolvents (Hollosi et al., 1989; Barrow and Zagorski, 1991). The changes in 
ellipticity and the spectral features indicate conformational adaptability of (31-40
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in aqueous solution with respect to changes in peptide concentration to self­
associate to give oligomeric (3-pleated sheets (Kirschner et al., 1987; Fraser et 
al., 1991; Inouye et al., 1993). The propensity of 131-40 to oligomerize in 
aqueous milieu therefore prohibits the exact determination of its secondary 
structural components in its monomeric state.
Deconvolution of CD spectra using Varselec and CCA analyses 
indicated an increase in the 13-pleated sheet content as concentration was 
increased (Fig.4.4). The positive correlation of molar ellipticity at either 210 or 
215 nm with the fa content seen from Fig. 4.4 suggested that these wavelengths 
were suitable indicators of 13-pleated sheet content (Sarkar and Doty, 1966). The 
fa content also showed similar correlation with the ellipticity at 220 nm; however 
the variation was minimal compared to the changes at 210 and 215 nm. The 
poor correlation between molar ellipticity at 220 nm for higher concentrations of 
131-40 and fa could probably be due to the lack of substantial a-helical structure 
at these concentrations. The molar ellipticity at 215 nm was therefore used as 
a measure of the (3-pleated sheet character for (31-40 and derived analogs.
pH dependence o f CD for ft 1-40 and [Arg]ft 1-40 analogs
The CD spectra of pH titrations for a 325 pM aqueous solution of (31 -40 
are given in Fig. 4.5 (panel A). (31-40 exhibited a preference for antiparallel 
(3-pleated sheets at pH values between 4 and 6. The following percentages were 
derived for the secondary structural components:
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Varselec: 13.0 (H), 25.3 {A), 5.7 (P), 56.1 (0);
CCA: 14.8 (H), 32.3 (A), 6.2 (P), 46.7 (O).
The spectrum at pH 2 resembled unordered structure with considerably less 
a-helical and (3-pleated sheet content:
Varselec: 13.3 (/-/), 13.7 (A), 1.9 (P), 71.1 (0);
CCA: 12.8 (P), 14.5 (A), 2.4 (P), 70.3 (0).
At pH 9.1, the CD spectrum resembled an unordered structure although the 
intensities and positions were not coincident with those at acidic pH. In the 
intermediate pH range (6-8.5), the CD spectra suggested that the conformation 
of (31-40 was predominantly (3-pleated sheets.
The peptide concentrations used for this study were rigorously 
controlled and therefore, conformational assignments can be compared in this 
pH range. The isodichroic point was blue shifted as pH was increased from 2.2 
to 7.4, but red shifted as pH was increased to 9.1. This suggested that 
significant rearrangement of the peptide backbone took place to form (3-pleated 
sheets as the intermediate pH range was approached. This observation was in 
keeping with secondary structure prediction methods which identify that residues 
9 - 1 9  are responsible for (3-pleated sheet formation (Argos et al., 1978). The 
acidic Asp23 and the basic His13 are ideally suited to favor self-association in 
(31-40 (Fig. 1.4) by forming ion-pairs; other possible associations include 
glutamates and lysines. The observed pH dependence implies the importance 
the residues at these positions which are predominantly ionized in the
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intermediate pH range. The ion-pair interactions between amino acids on 
neighboring peptide strands must lead to oligomerization in 131-40. Self­
association was also concentration dependent as demonstrated earlier, and now 
the importance of the polar amino terminal region is noted. From these data it 
was deduced that the solution conformation of 131-40 was also effectively 
controlled by pH.
The propensity of f31 -40 to stabilize into oligomeric 13-pleated sheets at 
intermediate pH by salt-bridge formation was further explored by using the 
[Arg13]l31-40, [Arg14]l31-40, and [Arg13/l4](31-40 derived analogs. Significant 
decreases in the CD intensity was observed at 210 and 215 nm for [Arg13], [Arg14] 
and [Arg13,14] analogs (panel B, Fig. 4.5). The molar ellipticity at 215 nm for the 
[Arg13,14]f31 —40 analog was significantly lower as compared to 131-40 at pH 7.4 
(panel A). The CD spectra of the [Arg13]l31-40, [Arg14]f31 -40 and [Arg1314]f31-40 
derived analogs have their minima near 215 nm and a slight inflection near 
220 nm. The crossover to positive ellipticity is near 200 nm and the maxima is 
at 195 nm. This is consistent with a presence of substantial (3-pleated sheet 
structure (Sarkar and Doty, 1966). It is however noteworthy that the isodichroic 
point of these derived analogs is at 205 nm, the same as that of unsubstituted 
(31-40 (panel B, Fig. 4.5; also Fig. 4.2). Although unambiguous assignments of 
secondary structure based on amino acids is difficult, since the CD were 
recorded under identical conditions, the substitution of His Arg at these 
positions becomes relatively important in oligomer formation.
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Fig. 4.2 CD spectra of (51-40 as a function of concentration. The CD spectra of (51 -40 at 
concentrations of 25 pM, 175 pM 500 pM, and 2.5 mM were recorded at ambient 
temperature on freshly prepared solutions in a 50 mM HEPES buffer at pH 7.2. All 
concentrations were determined by quantitative amino acid analyses. The data 
points represent an average of six scans taken on the home built vacuum far 
UV/CD spectrophotometer at NSLS, and were plotted according to criteria given 
in Fig. 4.1. The spectrum for intermediate concentrations resemble a mixture of a -  
helical and G-pleated sheet structures, while the spectrum for 2.5 mM is 
predominantly antiparallel B-pleated sheet.
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[31-40] (mM)
Variation in ellipticity for 131-40 as a function of concentration. The two panels 
represent the data at two scales, betwen 0-5 mM (panel A) and between 0-1.8 mM  
(panel; B). All solutions were freshly prepared and their CD measured at ambient 
temperature on the J-720.
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Fig. 4.4 Spectral decompositions for concentration dependence of CD for IS1 -40 - Analyses 
using Varselec (top panel) and CCA (bottom panel).
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Fig. 4.5 Circular dichroism spectra of 325 pM 01-40  as a function of pH. Data are averages of 
eight scans collected on J-720 with an analog time constant of 4 sec at a scan rate 1 
nm /sec; the spectrum at pH 9 was truncated at 195 nm due to absorption by buffer. 
Panel B compares the CD for the [A rg '^S I^O , [Arg’*](J1—40 and [Argn,4]B 1 -40  analogs 
at pH 7.2. Ellipticities were calculated using a mean residue weight of 109 daltons.
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The CD spectra of the His -  Arg substituted sequence analogs further 
emphasized the role of His13 to ion-pair with Asp23 (cf. Fig. 1.4), and the 
importance of these residues at intermediate pH in stabilizing the intermolecular 
13-pleated sheet structure. Additional ion-pairing could also take place between 
the Lys and/or Glu residues which are partly ionized at intermediate pH, although 
their positions would impede oligomerization to 13-pleated sheets. The estimated 
secondary structure and the changes in CD of the [Arg] derived analogs of f31-40 
are consistent with conformational transitions due to the central 11-25 region 
(Argos etal., 1978; Hollosi et al., 1989; Fabian etal., 1993; Otvos etal., 1993).
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4.1.2. Variation in Ellipticity: Secondary Structure Transformational
Analysis
The following protocol was employed to aid the investigation of 
conformational transitions occurring in peptide solutions over time:
Stock solution of peptide was prepared in 40% MeCN. Quantitative amino acid 
analysis was performed to determine the amount of peptide. Aliquots were 
withdrawn to get desirable amounts in 0.5 mL centrifuge tubes and the peptide 
concentrated in vacuo and lyophilized. The resulting solids were redissolved in 
100 mM NaF in 50 mM HEPES buffer at pH 7.5 and the solutions were rigorously 
vortexed or sonicated. After standing for 10 min, the solutions were centrifuged
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at 12000 rpm using an Eppendorf 421C microcentrifuge. The supernatant was 
assayed for peptide content using control 61-40 peptides which were calibrated 
by quantitative amino acid analyses. CD spectra were recorded at ambient 
temperatures using the light source at Port U9B of the NSLS.
The CD spectra for an aqueous 320 pM 61-40 solution at pH 7.5 and 
room temperature exhibited reductions in ellipticity as a function of time 
(Fig. 4.6). The positions of the CD bands for antiparallel 6-pleated sheets near 
195 and 215 nm showed a slight red-shift with a simultaneous decrease in 
ellipticity over a period of 168 hours. The change in ellipticity at 215 nm was 
used to provide a qualitative basis for 6-pleated sheet content of 61-40 in a 
single conformation (Fig. 4.7). The decrease in ellipticity was minimal in the first 
3 h (lag period), slow during the first 24 hours, and then changed monotonously 
as time progressed to 168 hours. The overall trend in the change of ellipticity 
represented a multiphasic process. Analyses of secondary structure content 
were done using Varselec over the time frame of 168 h and is given in Table 4.1. 
It is obvious that the fractional a-helix content decreased within 24 h with a 
concomitant increase in the other structures, although the 6-pleated sheet 
content was not affected significantly. However, at the end of 168 h, the a-helix 
content increased at the expense of other structures. The fractional 6-pleated 
sheet content showed a varying trend with a subsequent decrease at the end of 
168 h.
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To determine the sensitivity of wavelength-dependence on observed 
CD, the molar ellipticity was also plotted at 210 (Fig. 4.8) and 220 nm (Fig. 4.9). 
At 210 nm, the observed kinetics were also illustrated by multiphasic processes. 
The change in ellipticity was minimal at 220 for 36 hours after which there was 
a slight decrease. The overall decrease in ellipticity at 220 nm was small (1.6 
deg-cm2-dmol'1) as compared with the decrease observed at 210 (17.2 
deg-cm2-dmol'1) and 215 nm (17 deg-cm2-dmol'1).
The kinetics of observed multiphasic variation in ellipticity can be given 
by the nonlinear fit to the equation
0(f) = 0 H - l A e |- ,/t/ (5)
where 0(f) and 0(°°) are the observed ellipticities at any time t and infinite time 
respectively, a0 ,- is the amplitude of the / th phase, and the apparent relaxation 
time associated with this phase is t (. The ellipticity of the 320 pM 131 -40 solution 
did not change significantly after 216 h and was considered as 0(°°).
Using a nonlinear least-squares calculation, the kinetics of ellipticity 
change over a period of 168 h were fit to data in Figs. 4.7 ([0 ]2i 5), 4.8 ([©]2io) and 
4.9 ([0 ]22o) by a two- and three-exponential function of equation 5. This kinetic 
data could be conservatively fit with a two-term equation given by the parameters 
in Table 4.2. The curves for each of these wavelengths provided satisfactory fits 
with the two-term exponential. However, the apparent relaxation times observed
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at 210 and 215 nm for the two-exponential fit are between 2.2 to 8.1 times as 
large as those at 220 nm (Table 4.2). It was therefore likely that such deviations 
could arise due to presence of more than two phases for the variation of 
ellipticity observed at these wavelengths.
To provide a better fit of the kinetic data, three- and four-exponential fits 
were tried for each wavelengths. The calculations for the kinetic curves obtained 
at 210 and 215 nm converged when used with three-exponentials (Table 4.2) 
and did not improve significantly with four-exponentials. The observed 
ellipticities at 210 and 215 nm at the end of the test period matched closely with 
the theoretical values using three-exponentials, better than the equivalent values 
at 220 nm. This is also indicated in Table 4.2 by the higher RMS values for 210 
and 215 nm compared to 220 nm, and in Fig. 4.10 by the residual plots. The 
lower RMS deviations at 220 nm indicated that there might be amplitudes other 
than those observed. The apparent relaxation times for the three phases of each 
exponential fit at 210 and 215 nm were now only 3.4- to 4.9-fold than those at 
220 nm.
From Table 4.2, it is seen that the 0(0) values from the three-exponential 
fit at 215 nm agree with the observed ellipticity (Fig. 4.6). This would suggest 
that all the phases of relaxation are accounted for. It is possible that the 
variation at 220 nm could be due to minor inconsequential amplitudes of some 
phases involving a helical segment of 61-40. The transition to a structure with 
helical content is consistent with the deconvolution methods which predicted
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more fa content than f&. There was also a lag time, a minimum of 3 hours for 210 
and 215 nm, longer for 220 nm, before decreases in ellipticity occurred as 
demonstrated by the plots of variation in ellipticity (Figs. 4.7 and 4.8).
Correlating elution behavior o f 111-40 solutions as a function o f time
To ascertain the cause of the loss in CD intensity, it was necessary to 
verify if there was a physical loss of the peptide. (31-40 solutions studied for 
change in ellipticity over time were therefore characterized by studying their 
chromatographic behavior. These solutions were chromatographed under 
normal gradient conditions (chapter 2) on a Vydac C18 reversed-phase column 
using a linear gradient, with 0.1% TFA as solvent A, and 0.1% TFA in 100% 
MeCN as solvent B at a flow rate of 1 mL/min. Fig. 4.11 shows the elution 
profiles of a 215 pM (31-40 solution which was chromatographed at 0, 24, 96 and 
168 hours. The retention times and peak areas were nearly identical within the 
chromatographic parameters, with a slightly later elution after 168 hours (Rt 
increased by approximately 2 min). This was a clear demonstration that (31-40 
maintained its chromatographic integrity as a function of time. There were 
obviously no loss of peptide from these solutions. This illustrated that the cause 
of loss in CD signal was invariably endogenous.
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Fig. 4.6 Circular dichroism spectra of a 320 pM (i1 -40 solution, pH 7.5, taken over a period 
of 168 hours. The raw data were collected at ambient temperatures using the 
vacuum spectrometer at NSLS with an analog time constant of 4 sec at a scan rate 
of 0.5 nm/sec. The data points represent the molar ellipticity calculated using 
mean residue weight of 108.3, and are an average of four measurements. Spectra 
were recorded every hour for the first 24 hours, and every 4 hours thereafter and 
were truncated at 195 nm after 100 h; only the CD measurements at time, t = 0, 72 
and 168 hours are given for clarity.
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Fig. 4.7 Variation in ellipticity for a 320 pM IS1-40 solution at 215 nm as a function of time.
The open symbols indicate the observed data from the CD spectra shown in 
Fig. 4 .6 . The solid line is the theoretical fit to the kinetic data as per equation 5. 
The kinetic data are plotted to show the changes occurring during the first 24 hr 
(inset) and for 216 hr.
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Secondary Structure Content o f (11-40 as a Function o f Timea
Table 4.1
time
Varselec Analysis
fa (%) fa (%) fo (%)
0 h 13 ± 2 28 ± 4 59 ± 3
12 h 15 ± 3 29 ± 5 56 ± 5
24 h 6 ± 5 27 ±6 67 ±6
48 h 18 + 3 16 ± 7 66 ± 5
72 h 17 ± 4 17 ± 8 66 ± 4
96 h 2 1 + 5 25 ± 6 54 ± 9
144 h 26 ± 4 18 ± 7 56 ± 7
168 h 37 + 5 22 ±8 41 ±8
a CD data was truncated at 195 nm for spectra taken after 100 h.
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Fig. 4.8 Variation in ellipticity monitored at 210 nm for 320 pM IJ1 -40 as a function of time.
The open symbols indicate the mean of the observed kinetic data; the inset shows 
the changes in ellipticity during the first 24 hours. The solid line indicates the 
theoretical fit to the observed C D  as per equation 5.
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Fig. 4.9 Variation in ellipticity monitored at 220 nm for 320 pM 81-40 as a function of time.
T he open symbols show the observed kinetic data which is plotted to show the 
differences in variations during the first 24 hours (inset). The solid line is the 
theoretical fit to the observed data as per equation 5.
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Kinetic Parameters o f Variation in Ellipticity o f (11-40 at pH 7.5
Table 4.2.
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Fig. 4.10 Residual plots for a two- and three-exponential fit of kinetic data for 320 pM 111-40 
at 210, 215 and 220 nm.
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Fig. 4.11 Characterizing (J1-40 solution as a function of time by RP-HPLC. Chromatography 
was performed on a 4 .6  X  300 mm Beckman Ultrasphere ODS column at room 
temperature using solvent A as 0.1% TFA and solvent B as 0.1%  TFA  in MeCN with 
a flow rate of 1.0 mL/min and the gradient from 0-100%B was in 60  min. Aliquots 
(10-20 pL) were drawn periodically from the time-dependent CD study for a 215  
mM (J1-40 solution and loaded on the column without any treatment. The retention 
times increased by approximately 2  min as time progressed; the band broadening 
was insignificant.
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Kinetic difference CD analysis for (11-40: time effects
The good fit observed with three-exponential functions at 210 and 
215 nm provides a basis for evaluating difference CD spectra for the individual 
kinetic phases. From equation 5, the difference spectrum of the / th phase is 
given by the wavelength dependence of the amplitude, a 0,.  Moreover, the 
observed ellipticity, according to equations 3 and 4, is the sum of the ellipticities 
of the individual secondary structural elements. Therefore the difference spectra 
are related to the fractional changes occurring during the respective kinetic 
phases for the secondary structural elements.
The fractional changes in ellipticity for the three phases obtained from 
equations 3 and 4 are graphically represented in Fig. 4.12. The fractional 
changes of the secondary structural elements for the three kinetic phases after 
deconvolution treatment are summarized in Table 4.3. These parameters were 
used to generate the theoretical fits for the experimentally observed kinetic CD 
depicted in Fig. 4.12.
It can be observed from Fig. 4.12 that the t, phase had the smallest 
amplitude of the difference spectra (a©! = -1.15 10 '3 deg • cm2 • dmoi'1) with a 
minimum near 215 nm. Although it is difficult to appraise the secondary structure 
changes taking place in this phase due to the small amplitude, the presence of 
a minimum at 215 nm would suggest changes in the R>-pleated sheet content. 
Overall, the decrease in ellipticity signifies a decrease in the ft-pleated sheet 
content. x2 has a more prominent difference CD centered around 215 nm. This
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suggested that the change in ellipticity was significant change in the (3-pleated 
sheet content. The presence of a positive difference CD during this phase can 
be interpreted in terms of decrease in the a-helical content. Of the three phases, 
t 3 phase has the worst calculated fits of the difference spectrum. However, with 
a stronger minimum around 220 nm and a positive difference around 235 nm, 
this could be interpreted as a significant change in the antiparallel (3-pleated 
sheet content with a simultaneous change in all other secondary structural 
elements, viz., a-helical and other structures. This would mean that significant 
rearrangement between the secondary structural elements was involved in t 3 
phase, mostly indicated by a-helical -  (3-pleated sheet transformation. Since 
these spectral changes are manifested over time without any change in the 
characteristic chromatographic behavior (Fig. 4.11), contributions other than 
changes in secondary structure could be significant for this phase; possibly, 
tertiary or quaternary structure interactions.
Kinetic difference CD of I11-40- concentration effects
Fig. 4.13 illustrates the ellipticity variation at 210, 215, and 220 nm as 
a function of concentration of 131-40 over time. The variations were affected 
differently as concentrations were increased from 25 pM to 4.3 mM. The 
ellipticity at 210 nm was most susceptible to variations in concentrations greater 
than 325 pM. Over a period of 216 h, no such lag in ellipticity was observed at 
220 nm for concentrations below 325 pM (31-40 (Fig. 4.13). Similar behavior was
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also observed over the concentration range studied and the data in Fig. 4.13 
demonstrate the monotonous decrease in the variation in ellipticity at 220 nm. 
This indicates that ellipticity changes at 220 nm were not as sensitive a measure 
of variation as those at 210 and 215 nm for change in secondary structure of 
IS'l-40. It would therefore seem that the variation in ellipticity follows multiphasic 
kinetics which is strongly dependent on concentration. The relaxation times for 
the slow phase of the decrease in ellipticity with respect to concentrations are 
summarized in Table 4.4. It is clear that the change in the relaxation for the slow 
phase was directly dependent on concentration.
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4.2. Kinetic Variation in CD for R6-25 and [D-Asp] Derived Analogs
Conformational changes in a 0.4 mM solution of (36-25 at pH 7.0 were 
studied for 225 h. The CD spectra are summarized in Fig. 4.14. The prominent 
feature of the spectra is the decrease in intensity of the 215 nm minima, and a 
simultaneous increase in the 195 nm maxima. This indicates that the major 
structural change occurs in the ft-pleated sheet content. There was no 
appreciable change in the CD spectrum after 250 h. The kinetics of the variation 
in ellipticity at 215 nm were described by two exponential terms (Fig. 4.15). The 
slow phase in the ellipticity decrease was similar to the slow phase detected for
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Fig. 4.12 Kinetic difference CD spectra for the three phases of ellipticity change for 320 pM 
(J1-40 solution at pH 7.5. The open circles represent the observed difference CD. 
The  theoretical best-fit curves are shown for the Varselec (solid line) and CCA  
(dashed line) analyses.
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Fractional Changes in Secondary Structure Composition o f (11-40 Calculated 
from Kinetic Difference CD Spectra for the Three Phases o f Variation in
Ellipticity
Table 4.3
a
b
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Varselec a CCA a
Afa A/jj A/c RM S b Afa A/)j A/o RM S b
-0 .2 1.1 1.1 115 0.2 1.3 0.8 198
*2 -1 .6 -1 5 .8 -1 2 .3 227 0.8 -1 1 .8 1.1 329
*3 5.5 - 10.2 -1 8 .8 596 2.5 - 5.4 3.3 625
C D  data was truncated at 195 nm. 
Values in deg-cm2 • dmol '1
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Fig. 4.13 Kinetics of ellipticity variation at 210, 215 and 220 nm as a function of 111-40 
concentration. All solutions were maintained between pH 7.2 and 7.7 in 50 mM  
HEPES buffer at room temperature.
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Relaxation Times and Amplitudes of R1-40 as a Function of Concentration
and Time
Table 4.4
[fJ1-40] *1 *2 *3 A0., a 0 2 A 0 3 So e„
(m M) (h) (h) (h) ( X 10'1 deg • cm2 ■ drnot1)
0.025 497.8 89.1 8.90 -0 .8 8 -4 .7 4 -1 .9 5 - 12.22 -4 .6 2
0.215 302.5 75.6 8.21 -0 .9 3 -6 .7 8 -1 .3 5 - 18.55 -9 .4 7
0.320 154.2 57.3 7.57 -1 .1 2 -8 .2 4 -1 .7 4 -23 .11 -1 2 .0 1
0.520 108.8 39.1 5.67 -1 .3 3 -3 .2 5 -9 .5 7 - 24.45 -1 0 .2 3
1.115 75.7 7.9 0.95 -1 .8 7 -7.68 -17 .51 - 27.20 -0 .1 2
2.315 57.1 5.5 0.79 -2 .2 3 -9 .7 7 -1 5 .8 2 - 28.56 -0 .7 5
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13)1-40, with comparable time constants and relative amplitudes (Table 4.5).
A two-exponential fit for the variation of ellipticity furnished difference 
CD spectra of the two kinetic phases for (36-25. These difference spectra are 
shown in Fig. 4.16. The goodness of fit with the two exponential term equation 
converged for 195 and 215 nm. The kinetic parameters of the ellipticity change 
for 136-25 are summarized in Table 4.5. Both phases show the difference spectra 
centered between 210 and 215 nm. This was interpreted as an exclusive change 
in the fa content. The lack of any other maxima or minima for (36-25 strongly 
suggested that any a-helical and other structures remained unaltered.
Elution behavior o f (16-25 as a function of time
136-25 solutions studied for change in ellipticity over time were also 
studied for changes in chromatographic behavior. These solutions were 
chromatographed under conditions identical with studies done on (31-40 
solutions. Fig. 4.17 shows the difference in retention times and elution volume 
of (36-25 solutions as a function of time on reversed-phase chromatography at 
0, 16, 72 and 120 hours. There are insignificant increases in the retention times 
after long periods of incubation in solution. However, the change in elution 
volume was minimal and clearly demonstrated that there was no loss of peptide 
in these solutions and that (36-25 maintains its chromatographic behavior as a 
function of time.
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Equilibrium CD spectra o f [D-Asp]ft 6-25 analogs
Secondary structural analyses of the CD spectra of (36-25 and its 
derived analogs [D-Asp7](36-25, [D-Asp23](36-25, and [D-Asp7'23](36-25 at pH 7.2 
were performed as a function of time. From the CD spectra recorded 
immediately after preparing the solutions, given in panel A of Fig. 4.18, a distinct 
red-shift in both the maximum near 195 nm and the minimum at 210 nm is 
evident for [D-Asp7](36-25, [D-Asp23](36-25 and [D-Asp723](36-25. The overall CD 
intensity range did not change significantly, and it appears that the spectra 
seems to have been displaced with respect to the ellipticity coordinate. Spectral 
decompositions using Varselec gave the following results for percentage 
secondary structures for the (36-25 analogs:
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(a) (36-25: fa = 27±3;
CM+lCMCMII^5 fP = 21 ±3; fa = 30±5;
(b) [D-Asp7]l36-25: fa = 20±5; fA = 20±3; fP = 35±4; fa = 25±6;
(c) [D-Asp23](36-25: fa = 18±4; n CO l+ ro fP = 37±3; f0 = 26±4;
(d) [D-Asp7,23]I36-25: f0 =13±3; fA = 12±3; fP = 45±4; fB = 30±5.
The total fractional (3-pleated sheet content was between 43±3 and 57±4. The 
substitution of L-Asp -  D-Asp at position 23 increased the parallel (3-pleated 
sheet content more than substitution at position 7, while a simultaneous 
substitution at positions 7 and 23 had the maximum parallel (3-pleated sheet 
content. From deconvolution of the respective CD spectra, it follows that the 
increase in the parallel (3-pleated sheet content of the [D-Asp] derived (36-25 
analogs takes place at the expense of their antiparallel (3-pleated sheet content.
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Fig. 4 .14 CD spectra of 0.4 mM IJ6-25 as a function of time. The spectra were recorded at 
room  tem perature every hour for eight hours and then every 4 hours using the 
vacuum U V/C D  spectrometer at NSLS according to conditions given in Fig. 4.6. 
The ellipticity was calculated using a m ean residue weight of 116 daltons.
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Fig. 4.15 Variation in ellipticity at 215 nm for B6-25 as a function of time. The symbols 
represent the average of four scans for two independent samples. The inset shows 
the C D  for the first 24 hours of the kinetic study illustrated in Fig. 4.14.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
183
Table 4.5
Relaxation Times and Amplitudes o f the Two Phases o f Variation o f 
Ellipticity for 0.4 mM (16-25
T, T2
( h )  ( h )
A©1 a 0 2 
(X 10'3 deg •
0o
cm2 • dmol '1)
0 m
CD at 215 nm 
n 0 — 2
264 55 - 1.85 -10.84 -20.27 -7.54
CD at 195 nm 
n = 2
237 49 2.43 14.84 19.74 2.47
The num ber of exponentials in equation 5 necessary to fit the observed kinetic 
parameters.
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Fig. 4.16 Kinetic difference CD spectra for the two phases of ellipticity variation for B6-25.
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Fig. 4.17 Change in chromatographic parameters of 136-25 solutions as a function of time.
The chromatographic data were generated for 10 - 50 pL peptide solutions as per 
conditions given in Fig. 4.11 using samples for which CD were recorded in Fig. 
4.14.
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Fig. 4.18 C ircular dichroism spectra for B6-25 and its [o-Asp] derived analogs. Panel A  
shows C D  data of 0.4 mM solutions of [D-Asp7]B6-25, [o-AspJ3]B6-25, and 
[D-Asp7-23]B6-25 which was measured at time, t = 0 h. Panel B shows the 
corresponding CD data of [D-Asp7]B6-25, [D-AspJ3]B6-25, and [D-Asp7,23]B6-25 
derived analogs alter 168 h.
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The CD spectrum of [D-Asp7,23]86-25 showed a slight decrease in the 
overall intensity after 168 h as illustrated by its spectrum given in panel B of 
Fig. 4.18. However, a red-shift in the positive band was more remarkable. 
Similar behavior was noted for the mono-substituted analogs [D-Asp7]86-25 and 
[D-Asp23]86-25. Comparison of the spectral features from CD spectra in Figs. 
4.14 and 4.18 illustrates that the lack of significant variation in ellipticity for the 
[D-Asp] derived 86-25 analogs was remarkable compared to the native L-Asp 
analog.
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4.3. Effect of Alternative Reference Spectra
In order to fit the observed kinetic data better, an alternate reference 
spectrum set was generated using the procedures outlined in Appendix B. 
Deconvolution results for 81-40 using the alternate reference spectra set are 
summarized by the kinetic difference CD spectra in Fig. 4.19. It is clearly seen 
that a better fit was obtained for all the phases of ellipticity change in 81-40, 
including x3. The minimum near 220 nm with a corresponding maximum near 
235 nm is very characteristic of transformation of a-he licah8-pleated sheet 
content. Fig. 4.20 shows the corresponding kinetic plots for the two-exponential 
fits for 86-25. The residual plots using the alternate spectra as the reference
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spectra for fitting the kinetic difference spectra fits better than those provided by 
using parameters provided by the deconvolution methods.
It is noteworthy that the secondary structure decomposition using CCA 
provided results similar to those obtained from Varselec analyses when CD 
spectra were obtained in the 260 to 178 nm range (Fig. 4.4). However, when 
data were truncated due to experimental limitations of samples, and when the 
experimental kinetic difference data were analyzed, there were disagreements 
between these methods, and these did not agree with the observations 
(Table 4.3). Reliable estimation of fractional secondary structure is dependent 
on the wavelength region, and also on the spectral shape and intensity 
(Kuwajima et al. 1985; Johnson, 1990). The unequivocal determination of 
secondary structure in a monomeric state is hampered by the inherent 
propensity of 12.1-40 to self-associate (Fig. 4.5). Thus, these deconvolution 
analyses are at best qualitative, and quantitative accuracy cannot be stressed 
without apprehension. There is no known spectrum available which bears any 
resemblance to the kinetic difference CD spectra obtained using these methods. 
The unsatisfactory calculated fits based on the kinetic parameters obtained from 
the deconvolution methods are therefore understandable. The possibility that 
spectral contributions other than those arising from the secondary structure also 
exists. Nonetheless, it was necessary to consider the accuracy of the estimated 
secondary structure fractions obtained on Varselec and CCA analyses.
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Small distortions in the lower wavelength region results in lower 
fractional secondary structure components (Toumadge and Johnson, 1993). The 
most pronounced effect is for the negative bands; this was also indicated by the 
moderate RMS values for 215 nm (Table 4.3). The Varselec method always 
gives the total secondary structure content near 100% indicating a successful 
analysis rather than the goodness of fit to observed data. In the case of a 
predominantly antiparallel 6-pleated sheet protein, CheY, CCA provided 
unambiguous assignment of fractional secondary structure from the CD spectrum 
(Perczel et al., 1992). However, the changes in the antiparallel 6-pleated sheet 
content with change in intensity of the negative bands does not consistently 
show any definite trend (Venyaminov et al., 1991; Perczel et al., 1992) and 
therefore, more uncertainty exists. In any case, both these deconvolution 
methods gave unsatisfactory fits to the kinetic difference spectra for t 2 and t 3 
phases of 61-40.
The deconvolution approach, using equations 1 to 5, implies that:
(7) the fraction (1 - fa - fB) derived from equations 2 and 4, remains as an 
"other" secondary structural component;
(77) contribution from changes in the vicinity of aromatic amino acids are 
negligible;
(iii) application of the reference spectra used assumes that any secondary 
structural component will exhibit the same CD irrespective of the partial 
shielding of peptide backbone by the solvent.
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In this study, there was no CD signal observed beyond 240 nm which 
indicated the contribution of the aromatic residues was negligible. However, 
assumptions (i) and (iii) were violated, since the CD spectra changed with time 
even when there was no loss of peptides from solution. The CD contribution of 
a flexible random-coil peptide chain may be different from that of an unordered 
structure; also, intermolecular oligomerization could exclude the solvent and 
consequently affect the CD contribution due to this phenomenon. The reference 
spectra for the "pure" secondary structure components used by Varselec and 
CCA methods were therefore abandoned and replaced by the measured spectra 
of 131-40 and 136-25. Equilibrium difference CD spectra generated by the three 
secondary structural components used in this study were verified according to 
treatment given in Appendix B to satisfy assumption (i). To distinguish the 
fractional secondary structural components obtained using the measured CD 
spectra, these are now expressed as apparent fractional secondary structural 
components.
If the modulation of the backbone conformation of (31 -40 depends on the 
environment then the apparent fractional secondary structural components of 
these peptides will result in the following:
(a) spectral fits will be better than those using reference spectra,
(b) the apparent fractional fa content will not be significantly affected by the 
choice of alternative spectra,
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(c) the apparent fractional fa content will have a greater effect on the 
difference spectra of 61-40.
Deconvolution results for 61 -40 using the alternate reference spectra set 
are summarized by the kinetic difference CD spectra in Fig. 4.19. It is clearly 
seen that a better fit was obtained for all the phases of ellipticity change in 
61-40, including x3. The minimum near 220 nm with a corresponding maximum 
near 235 nm is very characteristic of transformation of a-helicah6-pleated sheet 
content. Fig. 4.20 shows the corresponding kinetic plots for the two-exponential 
fits for 66-25. The residual plots using the alternate spectra as the reference 
spectra for fitting the kinetic difference spectra fits better than those provided by 
using parameters provided by the deconvolution methods. It follows therefore, 
that the deconvolution treatments had overestimated the a-helix content of these 
peptides, and as a result assessed a lower 6-pleated sheet content.
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4.4. Discussion
The CD spectroscopy in the far UV region for 61-40 and 66-25 
undertaken here provided information about the conformational changes for the 
polypeptide backbone in aqueous solutions. The methods used here furnished 
new evidence about the kinetic variations in ellipticity which occurred as a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A 
0 
X 
10
'3 
de
g.
cm
2.d
m
o!
'1
192
Wavelength (nm)
Fig. 4 .19 Kinetic difference CD spectra for the three phases of ellipticity variation of 
B1-40 based on alternate reference C D  spectra. The alternate reference 
spectra were generated according to Appendix B and the spectral fits to the 
observed CD data are shown by the solid line.
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function of concentration, pH, time, and amino acid substitutions. The main 
purpose of this study was to garner knowledge about the kinetics of stable 
structure formation of 131-40 in terms of its constituent secondary structural 
components. On the basis of the spectral data presented above, three distinct 
secondary structural components can be defined. These components will be 
qualitatively labeled a,, 13,, and (32 for the sake of discussion. The entire 131-40 
peptide can now be denoted by oc1f31!32, and the observed kinetic behavior 
explained in terms of the apparent relaxation times. Comparison of the observed 
changes for 131-40 and 136-25 permits the specification of these spectroscopically 
and kinetically distinct moieties (or domains) within the peptide molecule.
The characterization of pH dependence of 131-40 and its derived analogs 
illustrated that acidification disrupted the 13-pleated sheet structure which was 
predominant in the intermediate pH range. At basic pH values, the most 
dominant secondary structure represented that of random-coil. Disruption of 
ion-pairs at pH extremes causes a pronounced rearrangement of the peptide 
backbone. Inspection of the ion-pairing residues suggest that the ionizable 
amino acids are located within the first 28 residues of the peptide chain. 
Ion-pairing is however not an absolute requirement for stable antiparallel 
13-pleated sheet formation in f31 -40, other contributions include van der Waals 
forces and, interstrand and intersheet side-chain packing. The sensitivity of 
[Arg13JI31 -40, [Arg14]l31-40 and [Arg13,14]l31 -40 derived analogs at intermediate pH 
suggest that the ion-pairing residues involve positions 13 and/or 14 with Asp/Glu;
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this finding also supports the contention that oligomeric 13-sheet in fibrils took 
place at intermediate pH (Fraser et al., 1991a; Fraser et al., 1992; Inouye et al., 
1993), and the popular observation of increased viscosity in aqueous peptide 
solutions leading to irreversible gellation and aggregation (Jarret and Lansbury, 
1992; Tomski and Murphy, 1992; Sorimachi and Craik, 1994). The His -  Arg 
substitutions at positions 13 and 14 therefore weaken the possible ionic 
interactions. These residues are located in the central portion of the peptide and 
based on empirical secondary structural parameters given in Fig. 1.5, it could be 
postulated this region bestows the observed 13-pleated sheet component. This 
component is qualitatively represented as 13,.
The assignment of 13, is further affirmed by the CD spectra of 136-25. 
From Fig. 4.14 it is clear that 136-25 does not exhibit any CD band near 220 nm, 
a characterisitic which is seen in a-helical structures and is a prominent feature 
in the 131-40 spectra taken in aqueous and 40% TFE solutions (Fig. 4.1). The 
CD spectra for (36-25, however, always resemble that of (3-pleated sheets. The 
fibrils formed by (36-25 were observed as "well-oriented" (Fraser et al., 1991; 
Inouye et al., 1993), which also recommends the suitability of this central region 
as the (3, component. The f3, therefore qualitatively resides within (36-25. This 
element is mandatory for (3-pleated sheet formation and possesses the maximum 
amplitude change of the three structural elements. The kinetic difference CD for 
(36-25 had minima centered around 215 nm which suggests the conformational 
change is limited to the antiparallel (3-pleated sheet content.
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The component which gives rise to the a-helical characteristics in the 
CD spectrum can be labeled a,. The a, component must reside in that region 
of 111-40 exclusive of the central 116-25 region. The kinetic difference spectra for 
these resemble helix -  sheet transitions, both of which have faster relaxation 
times (Table 4.2). The amplitude of the third phase is approximately 10% of the 
total change in ellipticity, but is necessary for a good fit to the experimental CD 
(Fig. 4.10 and Table 4.2). This faster phase involves the a, component resulting 
in the minimum near 220 nm and the maximum at 235 nm. The lack of helix -  
sheet transitions in the kinetic difference spectra of 116-25 suggest the absence 
of an a., component in this peptide. In organic cosolvents, the helical structure 
appears to be stabilized only for peptides which include the first 11 residues of 
the amino terminus (Hollosi etal., 1989; Hilbich etal., 1991; Barrow etal., 1992). 
It is therefore possible that a, is located within the first seven residues of the 
amino terminus of 111-40.
The carboxyl terminal of 111-40, exclusive of the central 6-25 region, is 
the qualitative (12 component. The location of l l2 component is indirect and relies 
on spectroscopic data from other laboratories. The (1-pleated sheet forming 
sequence in the full-length AflP was attributed to residues 34-42 using FTIR 
(Halverson et al., 1990). Peptides having residues 10-43 (Hilbich et al., 1991), 
and residues 29-42 (Barrow and Zagorski, 1992) show substantial fl-pleated 
sheet structure in organic cosolvents. Thus, the H2 component can be expected
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to reside at the carboxyl terminal of (11-40. This would also suggest that only 
(1-pleated sheets are involved during the observed decrease in ellipticity.
The a, and (12 components in the complete (11-40 sequence needs all 
three amplitudes of relaxation a 0 t , a 0 2 , and a 0 3 . The kinetic difference spectra 
fit the observed data better when the third phase was included. The (It 
component needs only two amplitudes of relaxation. The apparent relaxation 
time constant for the fastest phase, x3, for (11-40 was 2.23 hours. The kinetic 
difference spectra demonstrate that changes occurring during zu t 2, and i 3 for 
(11-40 are fundamentally different. Although the amplitude for x., is small, 
rendering assessment difficult, the presence of minimum around 220 nm 
indicates that antiparallel (1-pleated sheet structure increases at the expense of 
other structures. The minima near 220 in the x2 and x3 phases is enhanced also 
supports this fact. The appearance of positive differences in the kinetic spectrum 
highlights the decrease of a-helical structure with a concomitant increase in the 
antiparallel (1-pleated sheet structure. This suggests that a mutual 
rearrangement of the a., and Il2 components takes place entirely due to intrinsic 
factors, which consequentially increases the process of oligomerization due to 
intermolecular attraction. Alternately, this phenomenon can be enhanced due 
to external factors which include inoculation of preformed oligomers which could 
act as nucleation sites (Jarret et al., 1993).
These results demonstrate that the CD spectra for (11-40 and (16-25 
involve a significant rearrangement in the three structural components over a
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period of 168 hours. While it can be postulated that the presence of the (32 
component is mandatory to impart antiparallel 13-pleated sheet structure to the 
peptide backbone, it is seen from the above studies that a substantial change in 
the a, component is needed. In the case of (36-25 the only changes are in the 
antiparallel (3-pleated sheet structure indicated by the substantial amplitude near 
220 nm for both phases. It can be recalled that the unfolding kinetics for (31-40 
seen on a reversed-phase support had a half-life of approximately 25 min. This 
would suggest that in the presence of a hydrophobic matrix, the peptide 
backbone "relaxes" faster than in a solution environment. These observations 
are in keeping with Otvos et al. (1993) who noted the increase in the (3-pleated 
sheet nature for 131-40 in the presence of membrane-mimicking agents. The 
chromatographic behavior did not change, even though considerable 
rearrangement of the secondary structural components took place in solution. 
This suggests very strongly that the process of oligomerization is reversed by the 
presence of a reversed-phase matrix.
The presence of D-Asp in the (3, element causes an antiparallel -  
parallel (3-pleated sheet conversion. The increase in the parallel (3-pleated sheet 
content with an increase in D-Asp substitution in 136-25 is striking. The shifts in 
the CD bands can be accounted for by considering the change in polarization 
experienced by the peptide backbone (Tinoco, 1962). The observation of 
ion-channel formation by (31-40 has been made by Arispe et al., (1993). The CD 
of these analogs resemble spectra exhibited by the ionophore, gramicidin A, a
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D -, L- alternating cyclic pentadecapetpide, in a micellar environment (Salom et 
al., 1992). The conformation exhibited by the [D-Asp]66-25 analogs would 
indicate that the 6-25 region could form ion-channels in 61-40. The current 
understanding among CD spectroscopists is that there is no unique CD spectrum 
for any peptide having structures like 61-40. The CD data presented above 
provide further verification that a proper reference is mandatory for quantitative 
accuracy of structural changes, especially with comparatively flexible peptides 
which are capable of interconverting between a gamut of available 
conformations. The theoretical curves generated by parameters provided by 
Varselec and CCA did not account for the observed difference CD spectra. In 
contrast, alternate reference spectra generated using 61-40 and its derived 
analogs provided a better fit. The three qualitative components, derived from the 
kinetic data, mutually exert a stabilizing influence on the secondary structure, 
and therefore lead to tertiary structure formation.
This chapter presented evidence for the conformational change in the 
peptide backbone which was entirely due to intrinsic factors. The demonstration 
that the ellipticity change of 61-40 over time was a dynamic process, affected by 
concentration and minor modifications in the chemical structure was significant 
in comprehending how the peptide backbone rearranges in solution. The kinetic 
observations made here provide critical information concerning the soluble 61-40 
which forms gels in solution. This information is necessary to understand the 
molecular mechanisms of stable aggregates formed by A6P in AD brains.
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Chapter 5
Interaction of Aluminum(lll) with ARP and Derived 
Analogs in Aqueous Solutions
Introduction
The exact function of aqueous aluminum in physiological systems has 
been the subject of intense investigation, and is still an open question. 
Aluminum accumulates in brain and in soft and skeletal tissues in such 
pathological disorders as Parkinsonism with dementia (Hirano et al., 1961), 
amyotrophic lateral sclerosis (Stanhope et al., 1972), Alzheimer's disease 
(Crapperet al., 1973; Perl and Brody, 1980), dialysis encephalopathy (Mahurkar 
et al., 1973), osteodystrophy (Ott et al., 1982), and microcytic anemia (Prior et 
al., 1982). Aluminum levels in the normal brain are also found to increase with 
age (Katzman et al., 1978). The bioavailability of aluminum increases with acid
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leaching (Tam and Williams, 1986) and therefore, its toxic potential in the 
environment has increased. The association of aluminum with AD was 
independently observed in the mid sixties, by Klatzo and colleagues (1965) and 
Terry and Pena (1965). The increased interest in the role of aluminum, however, 
has led some AD researchers to design experiments which overlook the 
bioinorganic chemistry of this ubiquitous ion, and thus propose mechanisms for 
its action which are inconsistent with its physical properties. There is yet no 
known biological function of this third most abundant element in the earth's crust.
The preferred coordination number for aluminum is six and exists in vivo 
as trivalent ions which form octahedral complexes. As a hard Lewis acid, Al(lll) 
is very electropositive and therefore not easily polarized (Huheey, 1983). 
Coordination takes place with ligands which donate electrons to the vacant 
orbitals of Al(lll) such as OH ", F", PO 4 s", S04 2", CH3C02 ", ROH, RO ", and 
RNH2. Most negatively charged oxygen donor groups are effective Al(lll) 
chelators, but coordination via nitrogen also occurs. In general, most chelators 
form very stable, water-soluble octahedral complexes with Al(lll) which do not 
hydrolyze at physiological pH. Ligand exchange in solution is usually slow, 
either due to the covalent distribution of the A I-0  and Al-N bonds, or due to the 
dissociative mechanism of ligand exchange (Burgess, 1978). The slowness of 
such an exchange exemplifies the caveat in underestimating the effects of Al(lll) 
in short-term experiments. These effects however cannot be accelerated or
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augmented by increasing Al(lll); such actions usually result in formation of 
polynuclear species of Al(lll) (Bottero et al., 1980).
A review of available literature on aluminum action indicates that the 
mechanism of aluminum action in its neurotoxicity is not clear; however, it is 
widely recognized that it depends on the chemical forms in which aluminum is 
transported and stored in tissues. The presence of aluminum silicate was 
reported in the senile plaques where amyloid deposits are found (Candy et al., 
1986), and in neurofibrillary tangles (Perl and Brody, 1980). In post-mortem 
human AD brains, appearance of elevated levels of aluminum is at best, 
uncertain. This could arise due to the sensitivity of different analytical 
techniques employed for aluminum detection, and the mode of preparation of 
samples. McDermott et al. (1979) used atomic absorption spectrometry and 
reported no significant differences in aluminum content of Alzheimer brains and 
controls. Stern et al. (1986) used laser microprobe mass analysis to investigate 
silicon and aluminum and did not find any pronounced levels in brain tissue. 
Using the more sensitive ion and electron microprobe, Chafi and coworkers
(1991) found absence of aluminum from the frontal cortex and lysosomes of AD 
brains. However, intracellular localization of aluminum was traced to lysosomes 
by Schuurmans Stekhoven et al. (1990). Masters et al. (1985) have reported 
detection of aluminum in neuritic plaques from AD patients, a finding which is in 
agreement with the increased aluminosilicate levels in the senile plaque cores 
found by Candy et al. (1986). Many patients with Creutzfeld-Jakob's disease, a
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neurological disorder, on the other hand, do not have elevated brain aluminum 
(Traub et al., 1981).
It must be noted here that the amyloid core protein from AD brains has 
racemic aspartic acid and serine contents higher than other short-lived proteins 
(Shapira et al., 1988; Roher et al., 1993). An increased racemization of D-Asp 
in the brain protein(s) of rats fed with aluminum-rich diet was found by Anderson 
et al. (1990). Using dynamic secondary ion mass spectrometry, Candy et al.
(1992) showed co-localization of aluminum with the amyloid in cortical pyramidal 
neurons, while on the other hand, Landsberg et al. (1992) failed to demonstrate 
the presence of aluminum in untreated amyloid plaque cores from brain tissue.
As highlighted above, there are many indications which point to Al(lll) 
as a culpable etiologic agent in many neurological disorders, including AD. 
However, the skepticism of most researchers on its accumulation in the afflicted 
neuronal tissue arises in part due to the wide variations in the modes of 
preparation of brain tissue. Even though the exact mode of accumulation and 
transport of Al(lll) in the brain is not known, complexation seems to be the most 
favored. Also, Al(lll) uptake by the brain is slow compared to other organs and 
therefore not amenable for short term studies (Ganrot, 1986). Most age-related 
diseases and disorders lack definite etiology but show features which favor 
putative A l(lll) related diseases, and these changes are manifested over a 
lifetime of the tissue or organ.
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Having gained notoriety as an etiologic agent, aluminum salts are used 
by many researchers without full appreciation of its solution chemistry. In acidic 
solutions (pH < 5), Al(lll) exists as an octahedral hexahydrate complex, 
[AI(H20 )6]3+ Successive deprotonations occur as pH is increased, and AI(OH)3 
precipitates in neutral solutions. The precipitate is redissolved at basic pHs, 
forming a tetrahedral complex, [AI(OH)J At physiological pH the highest 
allowed hexahydrate concentration derived from the solubility product of AI(OH)3 
is given by [AI(III)]/[H+] 3 = 10107( [Al(lll)] -  10 ~1M) (Martin, 1986b). The 
ensuing total Al(lll) concentration is 8 pM. It is necessary to reflect on the 
implication of this result. Even though the total Al(lll) is as high as 8 pM, 
approximately 10"12 M is available, the rest appears as [AI(OH)4] “ (Martin, 
1986b). Speciation due to ion-solvation further reduces the available Al(lll) 
(Martin, 1988; Harris, 1992). It therefore follows that at physiological pH, 
obtaining available Al(lll) higher than nanomolar concentrations is only possible 
in solutions supersaturated with AI(OH)3, and it is the available Al(lll) 
concentration that is consequential for biomolecules. These ideas have been 
summarized in Appendix C. Disregard to the aqueous chemistry of A l(lll) has 
therefore lead to debatable conclusions in the literature on the toxic levels of 
Al(lll).
The knowledge of chemical properties of Al(lll) facilitates the prediction 
of the effective functional groups for chelation. Plasma Al(lll) is usually 
associated with citrate, phosphate and transferrin (Martin, 1986a). Citrate (cit),
2 0 4
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a tridentate carboxylic acid ligand, forms a soluble neutral Al(lll)-cit complex 
between pH 2 and 5 which could increase its gastrointestinal absorption. 
Transferrin (Tf) in blood plasma is another effective complexation agent for Al(lll) 
and prevents its precipitation from physiological fluids (Martin, 1986a; Harris and 
Sheldon, 1990). Tf binds Al(lll) in a non-specific manner at its end terminals and 
given sufficient time, extracts more than 80% Al(lll) from the Al(lll)-cit complex 
(Martin et al., 1986b; Harris, 1992). Oxygen and nitrogen are good donor 
ligands, and the AI(lll)-complexes once formed are metastable under 
nonequilibrium conditions (Karlik et al., 1983). The most effective Al(lll) ion 
complexing amino acids in peptides and proteins are aspartic and glutamic 
acids, histidine, and cysteine (Charlet et al., 1984). The importance of Asp/Glu 
and His residues in the secondary structural stability of 61-40 oligomerization 
was demonstrated in chapter 4. these amino acids to form ion-pairs in 61-40 
oligomers was demonstrated in chapter 4. The presence of L-glutamate has 
been shown to increase the ability of Al(lll) to enter erythrocytes in vitro and rat 
brain (Deloncle et al., 1990). It has also been proposed that Al(lll) could form 
stable complexes with two adjacent glutamates or aspartates which might be 
found in proteins (Anghileri, 1992). In phosphorylated proteins, Al(lll) has been 
proposed to form intrachain and interchain complexes (Hollosi et al., 1994).
In spite of technological advances in analyses, the presence of 
aluminum in the Alzheimer brain is ascertained only by post-mortem 
examination, often assayed by destructive digestion of the tissue. Many powerful
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techniques are available to spectroscopists for investigating isolated biochemical 
species. By virtue of 100% natural abundance of the 27AI nucleus and good 
sensitivity (20% relative to 1H), 27AI nuclear magnetic resonance (NMR) 
spectroscopy is valuable in the study of Al(lll) complexation. The quadrupole 
moment of the 27AI nucleus (/ = 5/2, Q = 0.149 X 10'28 m2) gives rise to efficient 
quadrupolar relaxation which in severe instances result in resonances having 
large linewidths, sometimes up to kilohertz. Moreover, the relatively large 
shielding range 200 ppm) offers scope for simultaneous determination of 
chemical shifts for octahedral and tetrahedral complexes. The chemical shifts 
and linewidths of Al(lll) complexes also depend on its chemical character, viz., 
coordination geometry, symmetry of the complex, and exchange rates of Al(lll) 
with its environment. In aqueous solutions at acidic pH, Al(lll) exists as 
hexa-coordinated species, [AI(H20 )6] 3+, and at pH > 7 the tetrahedral complex 
predominates, [AI(OH)4] “ (Haraguchi and Fujiwara, 1969; Hinton and Briggs, 
1978; Bottero et al., 1980; Martin, 1986b; Martin, 1988). In a general sense, in 
complexes of type AIL4 27AI resonates downfield of octahedral Al(lll) complexes 
of the type AIL6 by 80 ppm (Haraguchi and Fujiwara, 1969; Akitt and Farthing, 
1978; Bottero et al., 1980; Wehrli and Wehrli, 1981; Akitt, 1987). The exceptions 
are the tetrahedral iodo-complexes which resonate in the octahedral region of 
27AI NMR spectrum (Haraguchi and Fujiwara, 1969; Hinton and Briggs, 1978; 
Akitt, 1987). Nonetheless, each type of complex exhibits slightly different 
chemical shift which is dependent upon the coordinating ligand (Haraguchi and
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Fujiwara, 1969). The linewidths of the resonances on the other hand, provide 
information on the symmetry of the complex and reflects the quadrupole 
interactions. Taken together, these two parameters furnish reliable data on the 
contribution of various chelating ligands to the environment of Al(lll).
27AI NMR spectroscopy has been used by Canet et al. (1973), and other 
spectroscopists (Wehrli and Wehrli, 1981; Akitt et al., 1981, 1984, 1985; 
Mazurguil et al., 1982; Karlik et al., 1983) to determine the complexation of Al(lll) 
in solutions. 27AI NMR spectroscopic investigation of aluminum binding with 
[Leu5]-enkephalin (Mazurguil et al., 1982), with serum proteins, albumin (Fatemi 
et al., 1992) and transferrin (Aramini et al., 1993) has shed light on the nature of 
the metal-binding sites in biomolecules. 27AI NMR spectroscopy was used in this 
study to elaborate the role of Al(lll) binding to 131-40 and its derived analog, 
136-25. The experiments were designed to study A l(lll) association to 131-40, the 
site(s) of complexation, and its influence on the peptide backbone. 
Chromatographic and spectroscopic strategies were employed to outline the 
possible role of Al(lll) in the aggregation of (31-40 and derived analogs. 
RP-HPLC was used to "purify" AI(lll)-bound peptides, which were subsequently 
characterized by sequence and amino acid analyses, and by 27AI NMR 
spectroscopy. The influence of trivalent metal ions on the secondary structure 
of (31-40 and (36-25 derived analogs was evaluated by far UV/CD spectroscopy. 
The spectroscopic investigations of the Al(lll) association reveal mutually 
supporting data for metal-binding sites in (31-40 and (36-25. These data, when
2 0 7
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considered collectively, provide unequivocal evidence for the mutual effect of 
Al(lll) and 61-40 in solution with respect to the stability of its secondary structure.
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5.1. Al(lll) and 61-40 Derived Analogs: Chromatographic Analysis
The reversed-phase matrix was shown to influence the retention 
characteristics of 61-40 and its derived analogs based on the studies given in 
chapter 3. It was also pointed out that the behavior of the peptides was primarily 
governed by hydrophobicity. The peptide backbone studies in chapter 4 showed 
the role of charged residues and the solution environment in secondary structure 
stability. This section outlines an experimental design to selectively isolate 
AI(lll)-associated peptide fragments using RP-HPLC and the characterization of 
the modified amino acid residues by Edman degradation. The kinetics of the 
formation of AI(lll)-associated 61-40 and derived analogs is also highlighted.
5.1.1. Incubation of Al(lll) and Fe(lll) with 61-40: Time-dependency
Exposure of 100 pM solution of 61-40 to 200 pM AICI3 at pH 6.2 and 
37°C initiated HPLC-detectable microheterogeneity after 24 h. Fig. 5.1 shows 
the generation of Al(lll)-induced effect on the elution of 61-40 over a course of 
168 h when the metahpeptide mole ratio was 2:1 . This study was carried out at
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pH < 6.5, where free Al(lll) ions exists in solution as [AI(H20 )6] 3+ and the 
precipitation of AI(OH)3 is prevented. When the incubated mixture was applied 
to the reversed-phase surface, the microheterogeneity seen during the first 24 
h increased as time of incubation increased.
Verification of chromatographically pure AI(lll)-H1-40 peptide fractions
Determination of the compositions of AI(lll)-(31-40 incubation were 
performed by quantitative amino acid analyses on lyophilized pooled fractions. 
Typical results for a mean of three such analyses are shown in Table 5.1. 
Except for serine, histidine and methionine residues, there was no significant 
difference in the amino acid content with respect to control.
In order to identify the nature of the eluting components, the 
chromatographically-pure fractions (A, B, and C, Fig. 5.1) were collected and 
attached to a Sequelon-AA membrane for amino acid sequencing. The 
sequencing data for these fractions is given in Table 5.2. Edman degradation 
did not proceed beyond (i) the sixth cycle for fraction A, corresponding to 
blocking at Asp7, (ii) the thirteenth cycle for fraction B, indicating blocking at 
His14, and (Hi) the 22nd cycle for fraction C, which would signify a block at Asp23. 
The method of using Edman degradation to identify sites of blocking for 
chemically modified (31-40 has been reported before (Vyas and Duffy, 1989) and 
was therefore considered significant. In order to obtain the complete internal 
sequence, peptide mapping was performed. The chromatographically-pure
209
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Fig. 5.1 RP-HPLC of H1-40 incubation with Al(lll), as a function of time. The metahpeptide 
mole ratio was 2:1, and the solutions were maintained at 37"C, in 50 mM Tris 
buffer at pH 6.2. Chromatography was performed on a 4.6 X 150 m m  Vydac C l8, 
operated at room temperature using an AB gradient; solvent A was 0.1% TFA  and 
solvent B was 0.1%  TFA in 80% MeCN; flow rate was 1.0 ml/min, with a gradient 
time of 60 min. The volume of solution loaded varied between 10 and 50 pL. The  
dotted chromatogram in the top panel shows the 111-40 control.
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Table 5.1
Quantitative Amino Acid Analysis on Microheterogeneous Products o f 
AI(lll)-lncubation with R1-40B
Expected
C om position Fraction Ab Fraction B b Fraction C b C ontro l1
D (4)2 2.62 2.54 2.73 3.76
E (4) 3.44 3.59 3.65 3.64
S (2) 0.19 0.15 0.21 0.29
G (6) 5.57 5.75 5.81 5.73
H (3) 1.89 1.92 1.99 2.12
R (1) 1.01 0.94 0.89 0.95
A (3) 2.75 2.63 2.73 2.89
Y  (1) 0.79 0.85 0.81 0.89
V (  6) 5.88 5.88 5.74 5.92
M (1 ) 0.33 0.39 0.24 0.41
1(2) 1.72 1.69 1.65 1.69
L (2) 1.79 1.72 1.75 1.82
F (3 ) 2.65 2.56 2.59 2.73
K (2) 1.67 1.72 1.61 1.74
Mean of three analyses each from two independent incubations. 
Pooled fractions as per Fig. 5.1.
Control B1-40 incubated for 168 hours.
Values in parentheses represent the expected amino acid content.
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Summary o f Sequence Analyses o f Chromatographically-pure 
Al(lll)-lncubated Ii 1-40 Fractions
Table 5.2
Preparation Sequence Assignm ents
Fraction A
Tryptic Digest
C N B r Digest
DAEFRHX*
(i) DAEFR
(ii) LVFFAEX*
(iii) XAII G L X V G G W
(i) DAEFRX*
(ii) l /G G W
Fraction B
Tryptic Digest
C N B r Digest
DAEFRHDSGYEVW X*
(i DAEFX  
(ii) XDSG YEVHX*
(iii LVFFAEX*
(iv) XAII G L X V G G W
(i) D AEFRHXXXXEVHX*
(ii) V G G W
Fraction C
Tryptic Digest
C N B r Digest
DAEFRHDSGYEVHHQKLVFFAEX*
(i) DAEFR
(ii) XDXXYEVXXQ X  
(iii LVFFAEX*
(iv) X A IIG L X V G G W
(i) DAE FRXDSX. YE VXXQ  KLVFFAEX*
X  Denotes that the PTH-amino acid was not identified.
X* Denotes that sequencing cycles did not proceed beyond that cycle.
The underlined italics denote that the yield of the PTH-am ino acid was less than 0.25 relative to 
P TH -P he4 or P TH -Leu17 during the sequencing cycle.
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fractions A, B and C were pooled individually and subjected to CNBr and trypsin 
digests as described in methods (section 2.6). The tryptic digests of these 
pooled fractions were concentrated on Immobilon membranes and subjected to 
automated sequencing. The results obtained for the internal amino acid 
sequence of these fractions are summarized in Table 5.2. The digestion maps 
of these analyses indicated the desired sequence for each fraction. The CNBr 
digests of all the chromatographically-pure peptides indicated the -V G G W - 
sequence which was expected for cleavage at Met35.
F e 3+ is an effective competitor of A l3+ in plasma due to similar ionic 
sizes (Crumbliss et al., 1988). Ca2+ has a much larger ionic radius than A l3+ and 
the binding pocket in Ca2+-binding proteins is large enough to accommodate 
A l3+. Mg2+ is easily displaced by A l3+ in physiological systems since A l3+ binds 
107 times more strongly to ATP4_, and nanomolar quantities of Al 3+therefore 
effectively compete for phosphate (Martin, 1986b). Subsequently, metal ions 
Fe3+, Ca2+, M n2+ and Mg2+ were individually incubated with B1-40 to study the 
specificity of their association to the peptide. When these incubations were 
chromatographed on a reversed-phase column, only Fe(lll) showed any 
significant generation of microheterogeneity. The elution profiles for the Fe(lll) 
incubations are shown in Fig. 5.2. The observed chromatographic behavior of 
Fe(lll) ions in generating microheterogenous products with &1-40 is comparable 
to that of Al(lll). The elution profiles for Mg2+, Z n 2+ and C a2+ incubations with
2 1 3
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G1-40 on RP-HPLC and the subsequent characterization of eluting fractions by 
sequence and amino acid analyses are given in Appendix D for comparison.
5.1.2. Effect of pH on Microheterogeneity Production
The aqueous chemistry of Al(lll) is controlled by pH. The predominant 
soluble form of Al(lll) at pH 7.5 is [AI(OH)4]" and the concentration of available 
Al(lll), i.e., [AI(H20)6]3+ is 10'115M (Martin, 1986b). The caveat of overestimating 
the available Al(lll), and therefore its complex formation at any given pH was 
highlighted earlier. It is important to use conditions which mimic a physiological 
milieu like phosphate buffered saline, however, the formation of polynuclear 
complexes makes it very difficult to study the A l-P04 system. The use of 
phosphate buffers was therefore avoided in this pH based examination of Al(lll) 
and &1-40 and derived analogs. It has been demonstrated that in phosphate 
buffers, Al(lll) forms its insoluble phosphate salt above pH 5 (Harris, 1992).
With the Al(lll):fi1 -40 mole ratio fixed at 10:1, the pH of incubating 
mixture was varied between 2 and 10. All incubations were allowed to stand with 
occasional vortexing for 4 days. After incubating for 100 hours at room 
temperature, these solutions were chromatographed. The elution profiles of 
these solutions are given in Fig. 5.3. There was increase in microheterogeneity 
between pH 3 and 5, while incubations above pH > 7 did not have any significant 
increase of the AI(lll)-CJ1-40 fraction (compare pH 7 and 9).
2 1 4
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To test if the observed chromatographic behavior was due to influence 
by interfering polyatomic aluminum species which are usually generated at 
pH > 5, incubations were performed in citrate buffer. The chromatographic 
profiles of these incubations are shown in Fig. 5.4. More microheterogeneity 
was observed over longer times in citrate than in tris buffer.
The corresponding incubations using pure peptide preparations of 
131-28, 136-25, and f38-40 were also studied chromatographically for Al(lll) and 
Fe(lll) association. The elution profiles after 120 hours incubation are shown in 
Fig. 5.5. A distinct effect of Al(lll) and Fe(lll) in generating microheterogeneity 
was observed for (31-28, (36-25 and (38-40.
2 1 5
5.1.3. Temperature Effects
Metal and peptide solutions were incubated in varying mole ratios at , 
several different temperatures for 24 h and the mixtures applied individually 
without any treatment to the Vydac C18 reverse phase under normal gradient 
conditions. The chromatograms for a 10:1 AI(lll):(31-40 mole ratio for the solution 
incubation temperatures between 22° and 65°C are shown in Fig. 5.6. In 
general, all the solution incubations of (31-40 and its fragments followed similar 
trends, i.e., as temperature was increased, the microheterogeneity increased.
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The results obtained with (31-40 were exciting and inspired similar 
studies with its derived analogs, (38-40, 136-25, and 131-28. Subsequently, these 
derived peptide analogs were incubated under optimal conditions and their 
elution from reversed-phase surface monitored. Fig. 5.7 depicts the 
chromatographic profiles of a 10:1 mole ratio incubation between A l(lll) and 
(38-40, 136-25, and (31-28 at 45°C after 24 h. Characterization of these eluting 
components were done by (a) sequence analyses using Edman degradation, and 
(b) quantitative amino acid analyses. The sequence data for pooled fractions 
from Fig. 5.7, and after their tryptic treatment are summarized in Table 5.3. The 
quantitative amino acid analyses results of chromatographically-pure 
components are given in Table 5.4.
Fraction 8A indicated a block at position 14, and after tryptic mapping 
revealed modifications at positions 14, and 23. This suggests that Al(lll) 
association in (38-40 was at His14 and Asp23. Fraction 8B was blocked at position 
22, and subsequent tryptic digest revealed the modified residue position as 
Asp23. Mapping of this fraction indicated only one modification. Similar 
treatment for the 1A and 1B fractions demonstrated that modifications had taken 
place at positions 7 and 23 which corresponds to Asp residues. The (36-25 
fraction, 6A initially yielded no sequence information, but its tryptic digest 
indicated a blocked residue at position 23. This was interpreted as blocking at 
Asp7 and Asp23, which is in keeping with the observations with (31-40. Fraction 
6B was not amenable to sequencing beyond position 13, which indicated
2 16
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modification at His14. Its tryptic digest however revealed a block at Asp23. All 
fractions indicated blocking at which was due to association of Al(lll) and 
sequence analyses of the tryptic digests confirmed that termination of Edman 
degradation was due to irreversible blocking of the amino acid. It was interesting 
to note that only aspartic acid and histidine residues at Asp7, His14 and Asp23 
were modified in all these peptides, even though other candidates for 
modification exist. Modifications at Asp1, Glu3, His6, Glu11, His13, Glu22, and the 
adjacent pair of Glu22-Asp23 in any of these peptides were not observed by the 
methods employed in this study.
Quantitative amino acid analyses of pooled fractions 8B, 6B and 1B are 
given in Table 5.4. The calculated serine content was lower than expected for 
all the peptides. The calculated methionine content for 138-40 was also low, 
while the histidine content was poorly detected for these fractions.
5.1.4. Kinetics of Microheterogeneity of Al(lll) incubations with (31 -40 and 
Derived Analogs
The time-course of microheterogenous products' generation was also 
followed at room temperature for varying ratios of Al(lll) with f31-40, 136-25, 
131-28, and 138-40. The Al(lll):peptide ratios were based on quantitative amino 
acid analysis. The kinetic profiles of mass increase in microheterogenous
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products are depicted in Fig. 5.8. Since the generation of microheterogeneity 
was slow compared to the elution time, the increase was considered to be an 
accurate assessment of its proportion in the incubation medium which was 
resolved on the reversed-phase surface. To verify that such a behavior actually 
corresponded to a process of association of Al(lll) with 131-40, control runs for 
13)1-40 solutions were also performed (dotted chromatogram, Fig. 5.1). The 
difference in the areas for the control and AI(lll)-incubations were normalized to 
fit an irreversible associative kinetic model, which can be schematically given as 
M -  (k) Mh:
In [Mh] = In [Mh]0 + k ■ t (1)
where
[Mh]0 is the initial mass of peptide based on amount injected, (i.e.) at zero time
this is corresponds to area for pure 131-40 (control),
[Mh] denotes the normalized mass of the microheterogenous product at time
t,
k is the rate constant of the association of Al(lll) with 131 -40 in solution.
When the kinetic profiles for varying Al(lll):peptide ratios shown in 
Fig. 5.8 were fitted to equation 1, good mathematical fits were obtained (shown 
by the lines) for the metal:peptide ratios of 10:1 to 1:10 studied.
2 1 8
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It is seen from the kinetic profiles for Al(lll):peptides that at least 25 mole 
percent microheterogenous product can be generated after 72 h for (31-40 
incubation, when the metal:peptide ratio was greater than 4:1. However, greater 
mole percentages were achieved with (36-25 at the same metal.peptide ratio.
The plot quantifying production of the AI(lll)-associated peptides under 
optimum conditions is given by the histogram in Fig. 5.9. This histogram 
demonstrates that the mole percent yield for the AI(lll)-associated product was 
maximum for (36-25 followed by (31-28, then (38-40 and finally (31-40.
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5.1.5. Discussion
The RP-HPLC strategy was employed to obtain chromatographically- 
pure fractions of metal ion-associated (31-40 and derived analogs. Incubations 
of (31-40 and derived analogs with Al(lll) and Fe(lll) showed considerable 
microheterogeneity which was resolved on reverse-phase chromatography. The 
microheterogeneity on Mg2+, Zn2+ and Ca2+ was comparable to that observed 
with Al(lll) and Fe(lll) ions, however, none of the chromatographically-pure 
fractions indicated any amino acid block on sequence analyses (Appendix D). 
The generation of microheterogenous components increased with temperature 
and time. Optimum incubation conditions included increase in incubation 
temperature to 45°C, for 24 hours. The chromatographic behavior of these
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Fig. 5.2 RP-HPLC elution profiles of Fe(lll) incubation with fi1 -40 as a function of time. The 
incubation conditions were identical to the Al(lll) incubations given in Fig. 5.1. The 
control incubation of metahpeptide at the end of 175 h incubation is indicated by the 
elution profile in the top panel by dots.
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Fig. 5.3 R P-HPLC  elution profiles of Al(lll) and IL1-40: effect of incubation-pH.- The 
incubations done at 2 5 °C  for 100 h, the solution s were introduced without any 
treatment on Vydac C 18 as per conditions given in Fig. 5.1. The elution profiles for 
control runs are given for comparison (dots). The peak eluting around 32 min for 
the pH 2 incubation arose from an external impurity.
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Fig. 5.4 R P-H P LC  elution profiles for IJ1-40 and Al(lll) incubation as a function of buffer.
Incubations were done at room temperature in 100 mM Tris buffer at pH 7.2 (panel 
A) and in 100 mM citrate buffer at pH 7.5 (panel B). The AI(lll):(S1-40 mole ratio 
was 10:1. The samples were periodically drawn and chromatographed without any 
treatment according to conditions given in Fig. 5.1.
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Fig. 5.5 RP-HPLC elution profiles for Al(lll) and Fe(lll) incubations with 156-25, (51-28, and 
(58-40 after 120 hours. The metalipeptide mole ratios were 10:1; Incubations were 
pH 5.8 and ambient temperature a t2 8 °C .
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Fig. 5.6 RP-HPLC of AI(lll):B1-40 as a function of incubation-temperature at a mole ratio 
10:1. All solutions were incubated for 24 hours between 22° and 65°C  and were 
loaded without any treatment.
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Fiy. 5.7 RP-HPLC of Al(lll) incubations with IJ8-40, IS1-28 and R6-25 after 24 hours at 45 °C
and mole ratio 10:1. All solutions were loaded without any treatment. The labels 
indicate the fractions which were collected at times marked by arrow. These  
fractions were characterized by sequence and quantitative amino acid analysis.
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Summary o f Sequence Analyses for Al(lll) Incubations 
with fi 1-28, (16-25 and (i 8-40
Table 5.3
Fraction Sequence Assignm ent
8A XGYEXHX*
On tryptic treatment (i) XGYEXHX*
(ii) XGYEVHHQ X
(iii) XVFFAEX*
(iv) X A IXX LX VG G W
8B XGVXXQKLVFFAEX*
On tryptic treatment (i) XGYEVHXQ
(ii) LVFFAEX*
fiii) XAIIGLMV G G W
1A DAEFRHX*
On tryptic treatment (i) DAEF
(ii) LVFFAEX*
1B DAEFRHDSGYEVHX*
On tryptic treatment (i) DAEF
(ii) XXXGYEVHX*
(iii) XVFFAEX*
6A XX*
On tryptic treatment (i) XVFFAEX*
6B XDSGYEVHX*
On tryptic treatment (i) XVFFAEX*
X Denotes that the PTH-amino acid was not identified.
X* Denotes that sequencing cycles did not proceed beyond that cycle.
The underlined italics denote that the yield of the PTH-amino acid was less than 0.25 relative to 
PTH-Phe" or PTH -Leu17 during the sequencing cycle.
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Quantitative Amino Acid Analyses on Chromatographically-pure Al(lll) 
Incubated Fractions of 88-40, H1-28 and 116-25a
Table 5.4
Residue
Fraction 8B
Preparation  
b Fraction 1 B b Fraction 6B b
D 1.62(2)1 3.47(4)’ 1 .42(2)’
E 2.64(3) 3.49(4) 1.55(2)
S 0.39(2) 0.19(1) 0.18(1)
G 5.77(6) 1.74(2) 1.70(2)
H 1.49(2) 1.74(3) 1.35(3)
R 0.09(0) 0.93(1) 0.19(0)
A 1.85(2) 1.77(2) 0.83(1)
Y 0.91(1) 0.82(1) 0.93(1)
V 5.89(6) 2.79(3) 2.67(3)
M 0.39(1) 0.17(0) 0.14(0)
1 1.77(2) 0.09(0) 0.05(0)
L 1.69(2) 0.89(1) 0.85(1)
F 1.75(2) 2.54(3) 1.53(2)
K 1.69(2) 1.77(2) 0.72(1)
Mean of three analyses each from two independent incubations. 
Pooled fractions as per Fig. 5.8.
Values in parentheses represent expected amino acid contents.
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Fig. 5.8 Kinetic profiles (or microheterogeneity production on incubation of Al(lll) with tJ1 -40, 
8-40 , (J1-28 and B6-25 by varying metal:peptide mole ratio. The mass increase 
(symbols) was normalized on the relative areas of the eluting components with 
respect to control runs. The broken lines are mathematical fits to the observed 
data according to equation 1. The fractions labeled A, B, and C were analyzed 
individually for their quantitatively amino acid analyses.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2 2 9
Fig. 5.9 Summary of yields for chromatographically-pure Al(lll) associated pooled peptide 
fractions. A metahpeptide ratio of 10:1 was used for incubations which were 
performed at 45°C  and pH 6.5-7.0. The solutions were chromatographed after 24 
hours, the eluting fractions were pooled as per Fig. 5.8 and the resulting mass 
characterized by sequence and amino acid analyses. The yields represent the 
mean mass of each peptide from two incubations and three chromatographic runs, 
and were determined by normalizing elution volumes and quantitative amino acid 
analyses on the corresponding controls.
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peptides in the presence of these trivalent metal ions demonstrate that 
microheterogeneity can be induced in peptide solutions by association. The 
verification of the nature of fractions which were resolved indicate modifications 
of amino acids only at positions 7, 14 and 23 which correspond to association of 
Al(lll) with Asp7, His14 and Asp23. The kinetic profiles suggest that modification 
of the amino acids took place at a higher rate for the shorter than the longer 
peptides. One explanation of this observation could be that the 86-25 fragment 
possesses the maximum number of Al(lll)-chelating residues for its length. The 
similarities observed in elution profiles and sequence analyses suggest that 
these peptides must associate with Al(lll) in a similar fashion.
Aspartic acid residues in proteins have been known to undergo 
nonenzymatic structural modifications spontaneously with age giving rise to 
unusual residues (Robinson and Rudd, 1974). This modification usually results 
from hydrolysis of the labile cyclized succinimide which is formed due to the 
intramolecular attack by the backbone nitrogen on the side chain carbonyl 
carbon (Stephenson and Clarke, 1989). The racemization of L-Asp residues in 
protein to form D-Asp, L-iso-Asp D-iso-Asp is enhanced by presence of the 
Asp-Gly and Asp-Ser sequence (Stephenson and Clarke, 1989). This 
modification however does not alter the mass of the resulting protein. External 
factors which accelerate amino acid racemizations include chelation, 
temperature, and to a lesser extent, higher pH levels (Buckingham et al., 1967; 
Bada, 1985). The intractable nature of amino acid sequencing observed in this
2 3 0
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study, before aspartic acid residues at positions 7 and 23, and histidine at 
position 13 would imply that these residues had undergone structural alterations, 
which was facilitated by chelation with Al(lll) and Fe(lll). Interestingly, the 
amyloid core proteins from brain parenchyma were also resistant to Edman 
degradation and constituted a mixture of D- and L-stereoconfigurations of 
aspartates and iso-aspartates at positions 1 and 7 (Roher et al., 1993).
Shapira et al. (1988) had earlier observed 5% D-Asp and 2% D-Ser in 
their amyloid preparations. The modification of serine hydroxyl groups in 81-28 
has been documented (Orlando et al., 1992). The significantly low serine 
content found on quantitative amino acid analyses of all chromatographically- 
pure fractions from the Al(lll) incubations with 81-40 and its derived analogs is 
therefore understandable. The propensity for aspartate isomerization is also 
dependent on the adjoining carboxyl terminal amino acid (Stephenson and 
Clarke, 1989). This confirms the observations of altered amino acids observed 
by Roher et al. (1993) and Shapira et al. (1988), however, it does not explain the 
resistance to Edman degradation at His14 and Asp23 seen in this study. Neither 
does it explain the Edman reaction at position 1 of 81-40. Perhaps, there are 
other local factors which take place in solution. It was therefore necessary to 
elucidate the effect of metal ion and peptide in solution by other means in order 
to characterize the nature of their interactions.
Anderson et al. (1990) used Al(lll) salts to demonstrate in vivo 
racemization of aspartic acids within ten weeks in rat brain proteins. They
231
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reported a significant increase in the D-Asp content which correlated with 
increase in brain aluminum levels. With higher brain aluminum levels however, 
there was saturation of aspartate racemization. An excess of [Al(lll)] in the brain 
environment may act as a metal-ion buffer which effectively removes OH", and 
this apparent decrease in pH checks the racemization. This present study 
employed high pH (> 6), higher temperatures, and comparatively long incubation 
times. In vitro Al(lll)-induced catalysis of D-Asp from L-Asp usually takes place 
within two weeks (Anderson et al., 1990). It is possible that with factors 
favorable for structural modification, the presence of Al(lll) and Fe(lll) provided 
the necessary impetus for racemization of amino acids in 81-40 and its derived 
analogs.
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5.2. Al(lll) and 81-40 Analogs:27Al NMR Examination
The 27AI nucleus occurs at 100% natural abundance with good 
sensitivity versus 1H, although its quadrupole moment confers broadened 
resonances with respect to other spin-% systems. The quadrupolar broadening 
however amounts to a few hertz in most cases, which has made 27AI one of the 
popular metal nuclei in NMR spectroscopy (Akitt, 1987). The width factor 
(=Q2(2l+3)/l2(2l-1)), which is the nuclear contribution to quadrupolar relaxation,
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provides 27AI with good relative sensitivity (0.207), demonstrating the offsetting 
influence of high spin on quadrupolar broadening (Akitt, 1987). Of the four 
magnetically active quadrupolar nuclei of group III, 27AI is easily observed with 
respect to 69Ga, 71Ga and 113ln or 115ln. At room temperature, linewidths of 10 to 
14 Hz for [AI(H20 )6] 3+ were routinely obtained on the JEOL FX90Q NMR 
Spectrometer used in this study.
The large charge-to-radius ratio of Al(lll) enhances its interaction with 
ligands, especially oxygen and nitrogen, which is exceptionally strong; and, 
therefore, ligand exchange is rather slow on the NMR time scale. For instance, 
the H20  exchange from hexaaquo Al(lll), [AI(H20 )6] 3+, is 0.6 s'1 at 298 K even 
though the protons exchange independently at a rate of 10s s'1 which is also the 
rate at which A l3+ changes environment during hydrolysis (Akitt and Elders, 
1985). The most prominent species in solution, viz., [AI(H20 )6] 3+, however 
undergoes hydrolysis which is dependent on (i) its concentration, and (ii) pH of 
solution. The linewidths for [AI(H20 )6] 3+ are known to range from a couple 
of hertz to several kilohertz, depending on the experimental conditions (Akitt, 
1987). Line broadening is observed if concentrated solutions are heated, but 
narrowing takes place on addition of acid (Akitt and Milic, 1984). Bottero et al. 
(1980) studied very dilute solutions of pure aluminum salts and determined a 
broad27Al resonance of 150 Hz for 1 mM AICI3. The linewidth increase was also 
attributed to the presence of polymeric cation which takes place at higher 
temperatures.
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Additionally, the chemical shift of the 27AI nucleus also varies with the 
ligand. It is generally assumed that the hexahydrate, [AI(H20 )6] 3+, resonates at 
0 ppm irrespective of its method of preparation, a condition which has never 
been tested (Akitt, 1987). While this cation is very visible in all aqueous 
solutions and therefore used as a reference, the broader resonance of [AI(OH)4]~ 
at 80 ppm is also used by some NMR spectroscopists as reference although 
solutions need to be prepared carefully. Karlik and colleagues (1983) 
determined that with citrate as a ligand, 27AI resonates at 8 ppm at pH 2, 10 ppm 
at pH 3, and at 12 ppm between pH 5 and 8. They also observed that EDTA in 
A l(lll) solutions gave a complex with a broad signal near 32 ppm, while in the 
presence of lactate the chemical shifts were dependent on the way the solutions 
were prepared, and the pH. The source of line broadening seen with these 
ligands can also simply be due to the likelihood that the solution contains a 
"NMR visible" Al(lll) species which is exchanging with a broader nonvisible 
species. The phenomenon of changes in linewidths of a quadrupolar nucleus as 
a function of chemical exchange rate is however common to all NMR active 
nuclei. 27AI NMR spectroscopy therefore offers a unique perspective on Al(lll) 
solutions in the presence of competing ligands, especially with complexes whose 
stability can be modulated by solution conditions.
It was clear that the changes in linewidths and chemical shifts were a 
good source of information of the ligand geometry of Al(lll) in solution, the caveat 
being knowledge of the involved species. The complexation geometry of
2 3 4
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aluminum can be divided into two regions depending on the chemical shifts: (i) 
the octahedral complexes, with coordination number 6, generally resonate 
upfield at 0 ppm, (ii) the tetrahedral complexes, with coordination number 4, are 
found downfield, at 80 ppm for AI(OH)4” (Hinton and Briggs, 1978). The few 
exceptions to this general behavior are iodo-complexes (Haraguchi and Fujiwara, 
1969), and solution-complexes of Al(lll) in mixed solvents (Wehrli and Wehrli, 
1981). In a nonaqueous solvent like MeCN, there is a upfield shift to -34 ppm for 
the octahedral [AI(MeCN)6] 3+ species. The tetrahedral [All J1' also resonates 
much upfield at -27 ppm, while [AICIJ" resonates downfield at 104 ppm. Even 
though there are regions for the two types of complexes in a given solvent 
system, there is considerable overlap of chemical shifts and an exact 
interpretation of the coordination geometry of Al(lll) then becomes slightly 
speculative.
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5.2.1. 27AI Interaction with 81-40 in Aqueous Media
All Al(lll) solutions were prepared in keeping with the ideas highlighted 
in the earlier sections and compiled in Appendix C. The association of Al(lll) 
with 81-40 was measured at ambient temperature, varying the metakpeptide 
mole ratio. For each NMR sample, the external reference was prepared 
simultaneously and at the same Al(lll) concentration for Al(lll):81 -40. All
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solutions of Al(lll) were freshly prepared, allowed to equilibrate for 4 hours then 
centrifuged before introducing the peptide. Spectra were usually taken 6 hours 
after treating Al(lll) solutions with 81-40 and centrifugation. Typical spectra 
obtained for 1024 transients of various Al(lll) concentrations on treatment with 
10 mM 81-40 at pH 4.5 are given in Fig. 5.10.
The NMR spectrum corresponding to Al(lll) in aqueous buffer solution, 
i.e., no 81-40, is given at the bottom of Fig. 5.10, exhibits the major NMR-visible 
species of 27AI at pH 4.5. The strong signal at 0 ppm corresponds to 
[AI(H20 )6] 3+, had a linewidth of 14 Hz, and was fixed as the reference. The sharp 
small signal just downfield of [AI(H20 )6] 3+ resonance was assigned to a spinning 
side band. The resonance of the tetrahedral species [AI(OH)J “ was located 
nearly 80 ppm upfield of the [AI(H20 )6] 3+ signal. A weak signal was seen at 
63.1 ppm and was assigned to a tetrahedrally coordinated polymeric Al13 
complex, according to Bottero et al. (1980).
On adding 10 mM 81-40, two significant changes were obvious from the 
NMR spectra: (i) there was a new, relatively broad, downfield signal having a 
linewidth of 850 Hz, near 15 ppm as 81-40 was introduced, and, (ii) significant 
broadening of this downfield signal to 1250 Hz took place as the A l(lll):81 -40 
ratio was increased. The signal near 15 ppm occurred only on introduction of 
81-40 in the samples, and was therefore attributed to Al(lll) bound to 81-40, i.e. 
the AI(lll)-81-40 species. The position of the Al(lll)-81 -40 signal did not change 
but was considerably broadened with increase in [Al(lll)]. Chemical shift and
2 3 6
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linewidth data for small ligands, e.g., citrate, oxalate, lactate and EDTA, which 
form octahedral complexes with Al(lll) are given in Table 5.5. The chemical shift 
of the Al(lll)-81 -40 resonance was in the octahedral region of the spectrum.
Relative Intensity o f the Al(lll)-fl 1-40 Resonance
The spectra in Fig. 5.10 illustrate that as the concentration of Al(lll) was 
increased relative to 81-40, there was an increase in intensity for the 
Al(lll)-81 -40 resonance. The presence of relatively broad resonances precluded 
interpreting peak integration data to detect the amount of aluminum bound in 
each observed species (Bottero et al., 1980; Fatemi et al., 1992). To quantitate 
the concentration of the species giving rise to the various resonances observed 
in the spectra, their intensities were measured relative to the reference. The 
ratio of intensities of Al(lll)-81 -40 and [AI(H20 )6] 3+ resonances against the 
respective mole content of metakpeptide is plotted in Fig. 5.11. The intersection 
of the titration curves from the plot of relative intensities suggests the 
stoichiometry of the observed species. If it is assumed that all the detectable 27AI 
species were observed, then within these limits there are between 4 to 6 Al(lll) 
bound to each 81-40. The pH of these samples was verified both, before and 
after the NMR spectra were recorded to insure maintenance of the [AI(H20 )6] 3+ 
species.
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EDTA titration o f Al(lIi)-!i1 -40
EDTA, a mixed oxygen and nitrogen ligand system, is a very effective 
chelator of metal ions and is routinely employed in Al(lll) studies. The interest 
in choosing an AI(III)-EDTA system in the NMR study arose out of curiosity to 
verify the effectiveness of EDTA in chelating Al(lll) in presence of 81-40. The 
following conditions were of interest: (a) introduction of 81-40 solution in an 
equilibrated solution of AI(III)-EDTA; (b) addition of EDTA to a solution 
containing the AI(lll)-81-40 species; and finally, (c) adding an Al(lll) to solution 
containing both 81-40 and EDTA. It was necessary to generate the AI(lll)-bound 
species, and the pH of the solutions were rigorously controlled.
Fig. 5.12 depicts the NMR spectra recorded for the verifying conditions 
stated above. A 10 mM equimolar mixture of AICI3 and EDTA was maintained 
at pH 4.5 for 4 h to satisfy conditions given in (a) according to Appendix C. After 
centrifugation, NMR spectrum was recorded as illustrated by the dotted line in 
the bottom panel. There are two prominent signals, a sharp signal at 0 ppm, and 
a very broad signal downfield resonating near 38 ppm having, a v  = 900 Hz. The 
resonances were assigned to the reference hexahydrate and AI(III)-EDTA 
respectively. Equimolar 81-40 was added to the equilibrated mixture of 
AI(III)-EDTA, and after 24 h another spectrum recorded. This is illustrated by the 
solid line in the bottom panel of the 27AI NMR spectrum in Fig. 5.12. On addition 
of 81-40, there was a small reduction in intensity of the hexahydrate signal at 0 
ppm. This decrease occurred with a simultaneous increase in linewidth
2 3 8
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Fig. 5.10 27AI NMR spectra of Al(lll) binding to synthetic IJ1-40. The spectra were recorded 
on JEOL FX90Q operating at 23.30 MHz. All Al(lll) solutions were aged for 4 hours 
before addition of 10 mM IS1-40 solutions at pH 4.5. Measurements were taken at 
room temperature 6 hours after introducing 10 mM IS1-40. The metakpeptide mole 
ratios are indicated. The sharp signal at 0 ppm is the reference signal for the 
hexahydrate, [AI(H20)g ]3* and the signal corresponding to the hydroxide is seen 
near 80 ppm. The weak resonance near 63 ppm corresponds to polymeric Al13 in 
the neat solution. The broad resonance near 15 ppm arises on introducing IJ1-40 
in the sample.
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Fig. 5.11 Relative intensity of the 27AI NMR resonance for A1(III)-(S1 -40 as a function of 
AI(lll):G1-40 mole ratio. The intensity of the signal near 15 ppm was measured with 
respect to the external [A lfH jO )^3* reference signal at 0 ppm. The data points are 
from spectra recorded at room temperature, pH 4.5. The inset shows titration 
curves for three separate measurements of relative intensities over a 100-fold 
excess of metahpeplide.
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27Al NMR Chemical Shifts and Linewidths for Ligands at 23.30 Mhz 1
Table 5.5
Ligand Chem ical Shift 
(ppm 3)
Linewidth
(H z)
Coordination
v iab
Citrate (1:3) O H ', C 0 2'
pH 2.5 0 18
9 = 1000
pH 6.0 18 = 1200
E D T  A  (1:1) n h 2, c o 2-
pH 2.5 0 14
38 = 900
pH 6.0 38 = 1200
Oxalate (1:3) 18 N.D. c o 2-
Lactate (1:3) OH-, C 0 2'
pH 2.5 12 -  1100 N.D.
pH 7.1 25 v.broad N.D.
'Spectral data obtained on JEOL FX90Q.
The numbers in parentheses signify the AI(lll):Ligand ratios found in the octahedral complexes. 
aThe chemical shifts for resonances with large linewidths (a v  ? 100 Hz) are approximate. 
b Information reviewed by Kragten (1978), and Akitt (1987).
N.D. not determined.
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Fig. 5.12 Evolution of 27AI NMR spectra for a 10 mM solution of AI(lll)-IJ1-40 on addition of 
equimolar EDTA. Bottom spectrum was taken 24 h after addition of S1-40 to 
(A I(III)+EDTA); spectrum in the middle was taken 6 h after addition of EDTA to 
(AI(lll)+IS1-40); spectrum at the top is for Al(lll) addition to a mixture of 
(B1-40+EDTA). EDTA and Al(lll) were equimolar, with a mole ratio of 10:1 with 
IS1-40.
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( a v  ~ 1600 Hz) for the broader resonance. An AI(III)-EDTA solution without 
addition of (3.1 -40 maintained the chemical shifts and linewidths of its two Al(lll) 
species. A slight upfield shift of the broad resonance (5 = 24 ppm) is also 
evident from these two spectra. The AI(lll)-l31-40 species resonates near 15 
ppm, and the increase in linewidth for the AI(III)-EDTA resonance on introducing 
131-40 indicated that these two Al(lll) species were in a fast exchange situation.
The middle panel in Fig. 5.12 shows the 27AI NMR spectrum which 
evolved 6 h after equimolar EDTA was added (solid line) to an equilibrated 
AI(lll)-f31-40 (dotted line). It is clearly seen that this spectrum reverted to that 
observed when 131-40 was added to AI(III)-EDTA (compare the solid line spectra 
in the middle and bottom panels) with a prominent broad signal. The linewidth 
of the broad resonance near 24 ppm was found to be av ~ 1200 Hz, which was 
comparable to the observed linewidth on adding 131-40 to AI(III)-EDTA. The 
disappearance of the resonance at 15 ppm with the simultaneous increase in 
linewidth for the broad signal indicated that the AI(lll)-f31-40 species must be in 
a fast exchange situation with the AI(III)-EDTA species.
To study the situation given by conditions in (c), an equimolar solution 
of A l(lll) was added to a solution of 131-40 and EDTA which was allowed to 
equilibrate for 4 h. These 27AI NMR spectra are given in the top panel of 
Fig. 5.12. The spectrum taken 4 h after addition of Al(lll) is denoted by the 
dotted line. It is evident from the spectrum that there were no resonances other 
than that for the hexahydrate at 0 ppm. After 24 h, the 27AI NMR spectrum
2 4 3
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resulted in a broad resonance centered near 25 ppm and a complete 
disappearance of the reference signal (solid line). Although the chemical shift 
for this broad resonance could not be accurately determined, the linewidth was 
in excess of 1500 Hz which was comparable to those observed for the other two 
experiments. The eventual disappearance of the reference signal could be 
accounted by assuming, either (a) that all Al(lll) was bound to the two ligands, 
or (b) A l(lll) formed a nonvisible species in the presence of (31-40 and EDTA. 
When the pH of this solution was decreased to 2, the spectrum reverted to the 
one observed before Al(lll) addition to equilibrated solution of 13.1-40 and EDTA 
(dashed line). This suggested that all Al(lll) was bound to 131 -40 and EDTA, and 
was released as [AI(H20 )6] 3+ at low pH.
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5.2.2. Al(lll) Interaction with (36-25 in Aqueous Media
(3.6-25 was investigated primarily for the following reasons: (i) it is more 
hydrophilic than (31-40 and has greater solubility, (ii) the coordinating ligands are 
potentially the same as (31-40, viz., two histidine, two glutamate, and two 
aspartate residues, (iii) (36-25 has a longer lag time of conformational change in 
solution.
The 27AI NMR spectra of Al(lll) and (36-25 with incremental amounts of 
Al(lll) are shown in Fig. 5.13. Solutions of Al(lll) were equilibrated for 4 h and
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then centrifuged. Spectra were taken on centrifuged samples which were 
equilibrated for 8 h at room temperature after adding 136-25 in the desired ratio. 
The pH was diligently maintained at 6.0 and was again verified after 
accumulating the FIDs. A weak but broad resonance near 15 ppm ( a v  = 770 Hz) 
appeared for samples containing (36-25. The intensity of this resonance 
increased as the Al(lll):f36-25 ratio was increased. This advent of this 
resonance, which was distinct from the reference signal, matched in position and 
intensity to that observed for AI(lll)-(31-40, and was therefore assigned to the 
generation of AI(lll)-(36-25 species. The intensities of the AI(lll)-f36-25 signal 
relative to [AI(H20 )6] 3+ are plotted in Fig. 5.14. The intersection of the titration 
curves of relative intensity versus the metal:peptide mole ratio indicates that 
there are approximately 6 Al(lll) bound to each 136-25 molecule. The chemical 
shift of this resonance indicates that Al(lll) must be in an octahedral environment 
with (36-25.
pH Titration of AI(lll)-H6-25 Species
The 27AI NMR spectra of Al(lll) containing (36-25 were immensely 
affected by changes in pH of the solutions (Fig. 5.15). As the pH was increased 
from 6.1 to 7.5, there was an immediate reduction in the intensity of the signal 
near 15 ppm which disappeared within 2 h of change in the pH. There was a 
simultaneous appearance of a fairly sharp resonance ( a v  = 120 Hz) in the 
tetrahedral region of the spectrum at 80 ppm, which corresponds to the
245
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generation of the aluminate. This result implied that all (36-25 which was bound 
to Al(lll) was exchanged by OH' as the ligand. The maximal exchange in ligands 
occurred at pH 4.8 for 136-25, while the equivalent change for (31-40 indicated pH
4.2 to be more effective in the ligand change.
When the pH was decreased 6.1 to 1.5 by adding small increments of 
HCI, the intensity of the reference signal increased sharply (Fig. 5.15, panel B). 
There was a simultaneous reduction in linewidth which approached that of Al(lll) 
salts in acidic environment ( a v  ~ 20 Hz). The signal near 15 ppm gradually 
disappeared as the pH was lowered and below pH 3.5, was not detectable. 
These results imply that the hexaaquo species dominated in the acidic range. 
The presence of two separate resonances in the spectra between pH 4 and 6 
indicates that the hexaaquo Al(lll) was in slow exchange with (36-25 in the ligand 
sphere.
The spectra also reveal a non-Lorentzian shape for the resonance near 
15 ppm when the pH was between 4 and 6. The linewidth changes for the 
reference and the AI(lll)-l36-25 signals as a function of pH are shown in Fig. 
5.16. These observations suggest that Al(lll) was in slow equilibrium between 
the hexaaquo ion and the 136-25-bound species. The maximal linewidth occurred 
near pH 6 indicating slow exchange occurring with the hexaaquo Al(lll) below 
this pH and with the aluminate at higher pH. An upper limit for this slow 
exchange was calculated to be = 104 Hz. The change in linewidths was 
asymmetric as a function of pH, which meant that in the presence of 136-25, the
2 4 6
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hydroxide was a more effective ligand in exchanging the coordination sphere of 
Al(lll) than water as a ligand. However, both these ligands displace 136-25 from 
ligating Al(lll) when 3.5 < pH > 6.
When the pH was further increased, slight turbidity was observed 
beyond pH 7.5, and eventually a precipitate was formed. The solution was 
centrifuged and it was found that the precipitate dissolved only in acidic medium. 
The 27AI NMR of this solution showed the exclusive presence of the hydrated ion 
resonating at 0 ppm. The spectrum did not change even after overnight 
equilibration. The dissolution characteristic of the precipitate strongly suggested 
that aluminate was formed.
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5.2.3. 27AI NMR of Chromatographicaily-pure AI(lll)-bound Peptides
The microheterogeneous peptides observed on chromatographic 
analyses were studied for the presence of AI(lll)-bound species. All observations 
were taken immediately after the peptides were prepared by RP-HPLC (section
5.1.3.). The 27AI NMR spectrum of the chromatographicaily-pure fraction A (cf. 
Fig. 5.1) from the incubation of Al(lll) and f31 -40 is shown in Fig. 5.17 
(spectrum A). A moderately strong but broad resonance was located near 20 
ppm was the most prominent feature in the NMR spectrum. This was assigned
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Fig. 5.13 27Al N M R  spectra for Al(lll) binding to 10 mM 1S6-25 solution at pH 6.0. The  
solutions were equilibrated for 8 hours at room temperature before recording 
the spectra.
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Fig. 5.14 Relative intensity of the AI(lll)-(16-25 resonance as a function of [Al(lll)]. The  
intensity of the 27AI NMR signal was measured against equivalent 
concentration of Al(lll) resonating at 0 ppm. The relative intensity for the 
resonance near 15 ppm was at least 50% higher for IS6-25 than the equivalent 
mole ratio with IS1-40. The intersection of the straight lines gives the amount 
of Al(lll) bound to each peptide molecule.
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Fig. 5.15 27AI NMR spectra of Al(lll) binding to 10 mM IS6-25 solution as a function of pH.
Panel A denotes change in spectrum from pH 6.1 7.5; panel B denotes the
change in spectrum from pH 3.5 _> 1.5. The predominant Al(lll) species at higher 
pH (?  6) is the tetrahedral hydroxide, [AI(OH)4] '  as seen from the resonance near 
80 ppm, and at pH lower than 3.5, only the hexahydrate, [AI(H20)g ]3+ is observed 
from the reference signal at 0 ppm. At slightly acidic pH (3.5 - 6), the resonance 
for the AI(lll)-IJ6-25 species can be observed near 15 ppm besides the hexahydrate 
signal.
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Fig. 5 .16  Plot of linewidth change for [A lfHjOJJ3' and AI(lll)-IJ6-25 as a function of pH. The  
linewidths of the hexaaquo ion were measured according to spectral methods 
specified in chapter 2. The linewidth of the A!(lll)-IJ6-25 resonance was measured 
within 100 Hz.
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Fig. 5.17 27AI NMR of chromatographically-pure AI(l!l)-bound peptides. The top spectrum (A) 
is for AI(lll)-fJ1-40 corresponding to Fraction A from Fig. 5.1. The spectrum (B) 
shows the change after heating the peptide in vacuo with 100 pL of constant boiling 
HCI. (C ) and (D) give the corresponding study with Fraction 6B from Fig. 5.7 
corresponding to AI(lll)-l56-25.
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to the Al(lll)-I31 -40 species present in fraction A. The relatively low concentration 
of the peptide fractions mandated longer accumulation times. At least 20 h were 
required to get satisfactory signal-to-noise ratio for a 0.5 mM solution. The 
signal/noise ratio did not improve after 20000 FIDs accumulations, and the 
linewidth was determined to be at least 1000 Hz. On addition of 100 pL of 
constant boiling HCI to the sample and heating in vacuo for 2 hours in an inert 
atmosphere, the resonance near 20 ppm disappeared and a sharp signal 
( a v  ~ 24 Hz) appeared at 0 ppm (spectrum B). This demonstrated that the Al(lll) 
coordinated to 131-40 in the chromatographically-pure product was completely 
displaced to give the hexahydrate species on acid treatment. The bottom panel 
in Fig. 5.17 shows the corresponding 27AI NMR spectrum for fraction 6A (cf. Fig. 
5.7) before (spectrum C) and after heating (spectrum D) with HCI and results 
similar to AI(lll)-l31-40 treatment were obtained.
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5.2.4. Discussion
27AI NMR spectroscopy provides an alternative avenue to explore the 
association of Al(lll) with 131-40 and 136-25. The range of chemical shifts 
observed in these solutions is of interest since these variations provide clues to 
the geometry of the Al(lll) associated species. The linewidths observed for the 
various Al(lll) species are also of interest since these, along with information in
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literature, indicate the ligand exchange taking place, a phenomenon which is 
popular among all NMR active nuclei. However, the finding of the 27AI NMR 
resonance for chromatographicaily-pure peptide preparations very clearly 
demonstrated that Al(lll) was complexed to -40, very likely in 6:1 
stoichiometry. The Edman reactions observed during sequence analyses must 
therefore be due to complexation of Al(lll).
Oxygen and nitrogen are the principal donor groups involved during 
Al(lll) complexation. It is seen that with oxygen as the principal donor ligand, the 
chemical shifts are usually upfield, whereas with nitrogen as the coordinating 
ligand, resonances are shifted to higher frequency (Wehrli and Wehrli, 1981; 
Akitt, 1987; Table 5.5). Of the ligands studied here, EDTA, with four carboxyls 
and two nitrogens, has the capacity to simultaneously occupy the coordination 
sphere of an octahedral metal ion (Kragten, 1978), giving rise to an inner-sphere 
complex. When coordination involves all six positions in an octahedral metal 
ion, the complex is usually very stable and exhibit resonance for one bound 
species. The signal located near 15 ppm on addition of 81-40 and 86-25 to 
A l(lll) solutions presumably has all six ligand sites on Al(lll) complexed by the 
peptides in a similar fashion.
It is therefore conceivable that complex formation in the Al(lll)-peptides 
must be via the carboxylate groups of aspartates and/or via the imidazole side 
chain of histidine. The determination of at least four Al(lll) binding per peptide 
molecule affirms the blocked sequencing sites at Asp7, Asp23 and His14 in the
2 5 4
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(31-40 and its derived analogs on incubations with Al(lll). Furthermore, the 
Al(lll):peptide species is most possibly a symmetric octahedral complex. These 
Al(lll)-peptide complexes were metastable within the experimental conditions but 
were affected by changes in pH. Moreover, these complexes existed only at pH 
between 3.5 and 6.1, i.e., in the acidic range. At pH greater than 6.5, a strong 
presence of polymeric aluminum ion and the aluminate was detected. The lack 
of observation of any other resonance in the upfield region would suggest that 
any intermediate species did not exist.
A possible scenario for the complexation of Al(lll) with (31 -40 and (36-25 
can now be visualized as taking place by simultaneous displacement of the 
ligands in the first coordination sphere of Al(lll). Another possibility is that these 
are outer-sphere complexes. The line broadening observed as a function of pH 
suggests that the previous condition is more likely. There is a prominent broad 
resonance near 15 ppm between pH 3.5 and 6.1, which is not detectable beyond 
this pH range. Evidently, coordination by (31-40 and (36-25 results in displacing 
the water ligands from the hexahydrate, [AI(H20 )6] 3+. In the same token, at 
higher pH, the peptide ligand is displaced by the hydroxide. The structure of 
these complexes, however, needs to be verified by other techniques. It is also 
possible that due to the quadrupolar 27AI nucleus giving rise to exceptionally 
broad resonances in an asymmetric ligand field, and the low field employed in 
this study, some Al(lll)-peptide species were not detected, in which case other 
methodology needs to be developed. A similar observation was made by Fatemi
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et al. (1992) after their study of aluminum complexes with albumin and transferrin 
using high frequency 27AI NMR. Among processes besides quadrupolar nuclei 
which contribute to broadening, comprehending such data for Al(lll) is marred 
with viscosity effects which are still not fully understood (Akitt and Milic, 1984). 
The linewidth data were therefore not exclusively interpreted here.
The study presented here also brings into question the validity of studies 
done by some researchers about the significance of trivalent metal interactions, 
especially Al(lll) and Fe(lll) with biomolecules. It was noted by Mantyh et al.
(1993) that 1 mM Al(lll) enhanced the aggregation of radioiodinated synthetic 81 - 
40 within 2 h at pH 7.4 by at least 100 fold. More recently, Kawahara et al.,
(1994) have demonstrated a direct effect of aluminum in aggregation of 81-40 
at pH 7. Their conclusions are particularly important to the study presented here 
in an attempt to discover the action of Al(lll) in etiology of neurological disorders. 
However, the predominant Al(lll) species above pH 6.5 are either the polymeric 
Al13 or the tetrahedral aluminate, neither of which are capable of providing Ai(lll) 
for complexation with 81-40 and its derived analogs.
The discrepancy between observations made here and those currently 
available in the literature is however not mystifying in light of the following 
plausible explanations: (i) [AI(OH)4]~ is the predominant species in solution at 
pH ) 6, even in the presence of buffer, (ii) the binding of A l(lll) is maximum 
between pH 4 and 6 where free [AI(H20 )6] 3+ exchanges with 81-40- and 86-25- 
bound A l(lll), (iii) given sufficient time, Al(lll) is eventually released by the
2 5 6
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AI(III)-EDTA complex when (31-40 is present. In keeping with the bioinorganic 
chemistry exhibited by aluminum salts in solution, the Al(lll) interaction studied 
here calls for reassessment of Al-induced aggregation experiments performed 
near physiological pH.
In spite of high quadrupole moment, the unique NMR properties of the 
27AI nucleus provided unequivocal evidence for its association with (31-40. The 
low field 27AI NMR investigation of f31 -40 and (36-25 demonstrated that 
quadrupolar NMR spectroscopy can provide unique information about metal 
binding sites when used in conjunction with other studies. However, high 
frequency NMR can provide better determination of linewidth and chemical shift, 
which could be correlated to the nature of Al(lll) bound in the complex. The 
observation of distinct Al(lll)-peptide complexes provide protocols for 
non-invasive techniques in studying Al(lll) interaction with peptides and proteins 
of biological importance.
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5.3. Al(lll), (31-40 and (36-25: Circular Dichroic Spectroscopy
The effect of aluminum at physiological concentrations (micromolar) on 
the conformation of (31-40 was to decrease the a-helical and (3-pleated sheet 
content, (Exley et al., 1993). The importance of available aluminum has already
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been emphasized in the interpretation of its solution effects (Martin, 1986b). The 
chromatographic evidence presented earlier demonstrate that the aluminum 
effects were manifested over time. It was also shown spectroscopically that 
between 4 and 6 Al(lll) were bound with 81-40 and 86-25 only in the acidic 
region. Aluminum salts irreversibly block the calcium ion-channels formed by 
81-40 (Arispe et al., 1993). High molecular weight aggregation of 81-40 was 
shown to be promoted in vitro at physiological pH by aluminum salts (Mantyh et 
al., 1993; Kawahara et al., 1994). These data indicate that the presence of 
aluminum greatly influences 81-40 in solution.
Recently, substitution of D-Asp at positions 7 and 23 in the 81-35 
derived analogs was shown to hasten precipitation of these peptides from 
solution (Tomiyama et al., 1994). An increase in the aspartate racemization of 
brain proteins by aluminum was demonstrated (Anderson et al., 1990). In this 
section, the effects of Al(lll) on the solution conformation of 81-40 and 86-25 
derived analogs is presented. Titration curves of the ellipticity data were used 
to determine the number and nature of Al(lll) binding sites. The importance of 
D-Asp at positions 1, 7 and 23 in 81-40 and in 7 and 23 in 86-25 was studied 
with respect to Al(lll)-induced conformational change.
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5.3.1. Effect of Al(lll) on CD of 131 -40
The CD spectrum of a freshly prepared 250 pM solution of 131-40 at pH
7.2 exhibited a predominant minimum at 210 nm and a shoulder at 224 nm 
(Fig. 5.18). This spectrum corresponded to the presence of 26% a-helix, 38% 
13-pleated sheet, and 36% of other (as defined in section 4.1) structures on 
Varselec analyses (Table 5.6), Analyses using CCA yielded 23% a-helix, 42% 
(3-pleated sheet, and 35% of other structures. On addition of 0.5 mM Al(lll) 
solution which was allowed to equilibrate for 4 h, another CD spectrum was 
recorded 4 h after addition and centrifugation of solution. The minimum at 
210 nm was intensified while the shoulder at 224 nm disappeared. 
Deconvolution of this spectrum indicated that there was an increase in the fa 
content with a concomitant decrease in the fa content (Table 5.6). On addition 
of equimolar, in terms of Al(lll), EDTA solution and recording another spectrum, 
it was evident that the effect of EDTA itself was minimal between 200 and 
260 nm.
It was the purpose of this study to ascertain the effect of Al(lll) on the 
secondary structure of the (31-40 and derived analogs, but poor signal-to-noise 
ratio were usually obtained on addition of Al(lll) and EDTA for all wavelengths 
below 240 nm. Most spectra were subsequently truncated at 195 nm, below 
which the noise level was not conducive for any meaningful CD determination. 
The changes in ellipticities at 210 and 224 nm with increase in Al(lll) 
concentration are illustrated in Fig. 5.19. The plot shows a sigmoidal behavior
2 5 9
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for the effect of Al(lll) on ellipticities measured at 210 and 215 nm. Since the CD 
at 210 nm was more sensitive to change with Al(lll) concentration and had good 
signal-to-noise ratios than that observed at any other wavelengths, ellipticities 
at this wavelength were titrated with Al(lll).
The differences in observed mean residue ellipticities after addition of 
0.5 mM AICI3 solution, and after addition of equimolar EDTA were calculated. 
When the fractional change in the mean residue ellipticity was plotted against 
the A l(lll) concentration, a pseudo-sigmoidal dependence was noted as shown 
in Fig. 5.20. The fractional change is the ratio of the change in the mean residue 
ellipticity at any given Al(lll) concentration to the ellipticity measured after 
equilibration with equimolar EDTA. The observed pseudo-sigmoidal behavior 
suggested that there was a cooperative effect of A l(lll) on B1-40. This titration 
curve can be considered to represent binding data in the same 
phenomenological sense as given by the Hill equation. The Hill equation for the 
change in ellipticity on Al(lll) addition was thus defined as
log K + n log C = log {R /1  - R) (13)
where
K is a constant
n is the Hill coefficient,
C is [Al(lll)] concentration, and
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R is the change in [0]A at any given concentration of [Al(lll)] divided by 
value of [0]A on addition of equimolar EDTA after which no further 
change is observed.
A linear regression of the data near the midpoint of transition for the plot of 
fractional change versus Al(lll) gave a straight line for the mean residue ellipticity 
at 210 nm (Fig. 5.21). When deducing the effect of concentration of [Al(lll)] on 
the observed CD at 210 nm, a straight line (r = 0.881) was obtained with a slope 
of 1.67. The titration of CD of 131-40 thus calculated the binding of at least 2 
Al(lll) with an apparent association constant of 150 pM. Additional Al(lll) could 
be complexed to 131-40, as derived from the NMR observations. However, the 
change in secondary structure due to this binding was not detectable by the CD 
method applied here. The aluminum-induced change in (3-pleated sheet 
character suggests that the complexation of aluminum is associated with 
conformational change.
Effect o fA I(lll) on CD for [D-Asp] Analogs of (11-40
The primary evidence from sequence data from Al(lll) incubations with 
(31-40 and derived analogs was modifications at Asp7, His14, and Asp23. When 
these were studied by NMR, the presence of aluminum was observed in the 
chromatographically-pure fractions. Also noted was the complexation of between 
4 and 6 Al(lll) per (31-40 molecule in solution. Since it has been shown that 
D-Asp residues impart structural stability to the amyloid peptides, it was
261
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imperative to verify the role of Al(lll) for this modification on the peptide 
backbone. Subsequently, [D-Asp7]fl1-40, [D-Asp7,23](l1-40, and [D-Asp1'7,23]fl1-40 
were synthesized and studied for conformational effects induced by Al(lll).
Fig. 5. 22 depicts the spectral changes in CD of [D-Asp7]H1-40, 
[D-Asp7'23]H1-40, and [D-Asp 1,7,2ftl1-40 solutions at pH 7.1 associated with 
addition of 0.5 mM Al(lll) solution after 4 h. The following interesting features are 
seen from these spectra: there is a distinct minimum intensity between 210 and 
215 nm, and no shoulder near 224 nm for any of these three derived analogs, 
compared to native H1-40. The overall CD intensity varied with the number of 
D-Asp substitutions, being maximum for the triply substituted [D-Asp1,7'23]fl1-40. 
On the introduction of Al(lll), all these D-Asp analogs showed a distinct 
blue-shifting of the minima. The influence of Al(lll) was maximum on the triply 
substituted analog which showed a significant reduction in the minimum near 210 
nm and a simultaneous increase in the maxima near 200 nm. Exact 
quantification of overall CD intensity on addition of Al(lll) was limited due to 
solvent absorbance. The influence of Al(lll) on the spectral features shown by 
[D-Asp7]H1-40, [D-Asp 7'^I11-40, and [D-Asp 1'7,2^ I11-40 are consistent with the 
changes seen in native (11-40, but opposite.
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Fig. 5.18 Circular dichroism spectra of 250 pM R1-40 at pH 7.2 with 0.5 m M Al(lll) and 
EDTA . A id ,  was added to IS1-40 after equilibration for 4 hours at room  
temperature. The C D  spectrum after 0.5 mM EDTA addition was taken 4 
hours after addition of Al(lll) to R1 -40. The concentrations are after dilution. 
Spectra for Al(lll) and EDTA solutions were truncated at 197 nm due to 
excessive background absorbance. Each symbol represents the average of 
four individual CD measurements. The lines are generated on application of 
a cubic-spline algorithm to the observed data.
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Secondary Structure Content o f (11 -40 in Presence o f Al(l 11) and EDTA
Table 5.6
k
Varselec
k
(%)
k RM S2 k
CCA
k
(%)
k RM S2
131-40, pH 7.2 26±3 38±4 36±3 654 23±3 42±3 35±3 975
+ 0.5 mM Al(lll) 18±4 46±4 36±4 865 12±3 58±4 30±3 1119
+ EDTA 31 ±3 40±3 29±3 525 21 ±2 40±3 39±4 865
+ 0.25 mM Al(lll) 23±4 35±4 42±4 645 21 ±3 48±4 30±3 819
+ EDTA 31 ±3 36±3 33±3 385 22±2 40±3 38±4 775
+ 0.10 mM Al(lll) 18±4 46±4 36±4 854 12±3 58±4 30±3 1225
+ EDTA 24±3 35±3 41 ±3 475 18±2 39±3 43±4 965
All fractional percentages from Varselec analyses were normalized to 100. 
RMS values are in deg • cm2 • dmol'1.
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Fig. 5.19 Comparison of the mean residue ellipticity at 210 and 224 nm on addition of Al(lll) 
to 250 pM solution of IJ1-40. The observed ellipticity is given as an mean of four 
individual measurements, open symbols are for 210 nm and solid symbols for 224 
nm. The molar ellipticities for the wavelengths are given at two different scales.
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Fig. 5.20 Fractional change in mean residue ellipticity at 210 and 215 nm for Al(lll) titration 
of CD of the CD spectra of IJ1-40. Each data point represents the average of four 
spectra. The fractional change in mean residue ellipticity is the ratio of ellipticity at 
the given [Al(lll)] and the observed ellipticity after addition of equimolar EDTA  to the 
solution of AI(III) and B1-40.
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Fig. 5.21 Hill plot of CD data near midpoint of pseudo-sigmoidal transition of the fractional 
change in mean residue ellipticity titration of (51-40 with Al(lll).
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Fig. 5.22 CD spectra for [oAsp?]fi1-40, [o-Asp7-23]fi1-40 and [D-Asp1723](i1-40 on addition of 
0.5 mM AI(III) after 4 hours. These measurements were taken on 130 pM solutions 
of the peptide analogs. The symbols represent the mean residue ellipticity for four 
scans: open symbols (no Al(lll), + EDTA), solid symbols (after addition of Al(lll)).
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5.3.2. Effect of Al(lll) on (36-25 and Derived Analogs
The (2.6-25 analog includes the ion-pair forming component of 13.1-40 
which forms the putative oligomeric 13-pleated sheet structure. The mole percent 
yield of the aluminum induced microheterogeneity was maximum in the case of 
(36-25. It was also seen from the NMR spectra that there were between 4 and 
6 Al(lll) bound to (2.6-25, which was similar to (2.1-40, and which were released on 
treating the peptides with acid. The [D-Asp7](36-25 and [D-Asp723]l36-25 derived 
analogs were synthesized to investigate the influence of aluminum induced 
conformational change on D-Asp substituted (36-25 backbone.
For the Al(ll!)-induced conformation change study, initially the CD 
spectra for unsubstituted (36-25 derived analog were recorded. Typical CD 
spectra for a 325 pM solution of (36-25 at pH 7.1, and after addition of 0.5 mM 
A l(lll) solution are given in Fig. 5.23. There is a prominent minimum near 
215 nm which increases in intensity with Al(lll) addition. This effect is removed 
when EDTA is added. Subsequently, the titration of ellipticity at 215 nm was 
plotted in terms of fractional change in ellipticity when no further change 
occurred on addition of EDTA against Al(lll) concentration (Fig 5.24). The 
titration curve for A l(lll) titration of fractional change in ellipticity was pseudo- 
sigmoidal for which the midpoint of transition was achieved at a free Al(lll) 
concentration of 66 pM. When linear regression was performed in this region, 
in keeping with equation 13, a straight line having a correlation coefficient = 0.93 
was obtained. The slope for this fit was 1.88 (Fig. 5.24). This would indicate
2 6 9
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that f36-25 has capability of binding more Al(lll) than 131 -40, since the equivalent 
number for 131 -40 was 1.67.
Effect ofA I(lll) on [D-Asp] Analogs of (16-25
The CD spectra of [D-Asp7]f36-25 and [D-Asp7,23]l36-25 derived analogs 
on addition of Al(lll) are shown in Fig. 5.25. Distinct variations in ellipticity at all 
wavelengths are immediately evident for these analogs before addition of Al(lll). 
There is an intense minimum at 216 nm for the mono-substituted analog and at 
224 nm for the di-substituted analog. The overall CD intensity was however not 
significantly different. On introduction of Al(lll), minima for both these derived 
analogs were blue-shifted to 212 nm and 218 nm for [D-Asp7]f36-25 and 
[D-Asp7,23]f36-25, respectively. A distinct reduction in intensity of the minimum 
was also noticeable in the presence of Al(lll) for both peptides. The spectra for 
added Al(lll) were truncated at 195 nm, however, the overall CD intensities were 
not significantly changed. The similarities in trend with an increase in the D-Asp 
content between 131-40 and 136-25 was striking.
2 7 0
5.3.3. Effect of Fe(lll) on 131 -40 and B6-25
The change in the mean residue ellipticity at 210 nm was measured with 
increasing amounts of Fe(lll) with 131-40 and 136-25. This was then calculated
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as fractional change in ellipticity and is given in Fig. 5.26. On performing a linear 
regression at the midpoint of transition on the Hill plots for Fe(lll) (Fig. 5.27), a 
straight line with a fairly good correlation was obtained (r = 0.82) which yielded 
a slope of 1.28. A comparison of the effect of Fe(lll) titration with Al(lll) titration 
of the change in mean residue ellipticity at 210 nm indicate that these follow 
similar trends. Thus, Fe(lll) and Al(lll) both exert similar effects on the backbone 
conformation of 81 -40.
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5.3.4. Discussion
In this section, characterization of the behavior of 111 -40 and 86-25 
backbone was carried out using their respective D-Asp substituted analogs in the 
presence of trivalent aluminum and iron salts. The CD methodology used here 
required that all freshly prepared salt solutions be equilibrated for at least 4 h to 
get the desired available Al(lll) (Appendix C; Martin, 1986b), the implications of 
which will now be addressed.
The CD spectrum of 81-40 in this study generally resemble the spectra 
obtained for aqueous solutions of 81-42, 81-40, and 81-39 by other laboratories 
(Barrow and Zagorski, 1991; Hilbich etal., 1991; Barrow etal., 1992; Exley etal., 
1993). Deconvolution of the CD spectrum using Varselec and CCA agree with 
the estimation of various secondary structural components, but did not exactly
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Fiy. 5.23 Circular dichroism spectra of (16-25 solution in the presence of Al(lll). The  
concentration of 136-25 was 325 pM and he pH was maintained at 7.1. The spectra 
were recorded under conditions given in Fig. 5.18. Each symbol represents the 
average mean residue ellipticity of three measurements; truncation at 195 and 200  
nm respectively was necessary for EDTA and Al(lll) additions because of high 
background absorbance.
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Fig. 5.24 Fractional change in mean residue ellipticity at 215 nm (or Al(lll) titration of CD  
spectra of (16-25. The Hill plot of CD data near the transition midpoint of fractional 
change in mean residue ellipticity is given on the right-side panel. The fractional 
change is the ratio of mean residue ellipticity at a given [Al(lll)] and the observed 
mean residue ellipticity after addition of EDTA.
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Fig. 5.25 Circular dichroism spectra for [o-Asp] analogs of R6-25 in presence of Al(lll). These are 
average spectra of four measurements. Only the effect with Al(lll) are shown. The  
concentrations of [D-Asp723]86-25 and [o-Asp7]fl6-25 were 325 and 420 pM respectively.
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Fig. 5.26 Fractional change in mean residue ellipticity at 210 nm as a function of Fe(lll) 
titration of CD spectra of 111-40. Hill plot of Fe(lll) of CD data near the transition 
midpoint of fractional change in ellipticity as a function of [Fe(lll)]. The fractional 
change represents the ratio of change in mean residue ellipticity at any given 
(Fe(lll)] and the ellipticity after addition of EDTA.
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Fractional change in mean residue ellipticity at 210 nm of Fe(lll) titration of CD  
spectra R6-25 (A). The fractional change denotes the ratio of change in ellipticity 
at the given concentration of Fe(lll) and the ellipticity after addition of EDTA. (B) Hill 
plot at midpoint of transition of CD data.
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match corresponding values obtained in other laboratories. This may partly be 
due to peptides obtained using different protocols, and also due to the 
concentrations studied. However, analyses of the spectra obtained on addition 
of aluminum estimate an increased fB content with a concomitant decrease in fa. 
This is in contradistinction to observations made by Exley et al. (1993) who 
reported a decrease in the a-helical and (1-sheet structure with an increase in 
the remainder secondary structures. While the fa estimated here using Varselec 
and CCA was in keeping with their observation of reduction in a-helical content, 
changes in the (1-pleated sheet content did not agree. Application of the 
deconvolution methods thus reveal the caveat associated with secondary 
structure estimations: the reference protein data base must provide a good 
representation of the sample under investigation. Varselec and CCA use 
reference spectra of proteins which do not resemble the (11 -40. Therefore, 
deconvolution procedures were abandoned, in lieu, the aluminum-induced 
change in ellipticity was used as a good measure of aluminum binding in (11-40 
and (16-25 in this study. The ellipticity at 215 nm provides a good estimate of 
antiparallel (1-pleated sheet content (Sarkar and Doty, 1966). Reliable 
deductions about the number of metal-binding sites were therefore done from the 
ellipticity change at 215 nm.
Aluminum titrations of the CD of (11-40 and 116-25 estimated that close 
to 2 Al(lll) were bound with an average association constant of 150 pM and 
66 pM, respectively. Additionally, the effect of Al(lll) on the CD indicated
2 7 7
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cooperative binding with (31-40 and (36-25 in solution. Using 27AI NMR, these 
peptides were shown to bind between 4 and 6 Al(lll) per peptide molecule. The 
poor signal to noise ratios from the solvent precluded accurate determination of 
CD which would account for the disagreement between the two spectroscopic 
determinations. The NMR evidence indicated that the peptide molecule 
competes with EDTA for complexation with Al(lll); this was also observed in the 
CD study by the reversal of the Al(lll)-induced effect with EDTA.
The contribution of peptide concentrations used in this study in affecting 
the available A l(lll) concentration was considered to be minimal. However, if it 
is assumed that 4 Al(lll) are complexed per molecule in the time frame of the CD 
experiment, an assumption based on the observed chromatographic and NMR 
data, then the transition midpoint for titration of CD for (31-40 will be achieved at 
200 pM. The equivalent value for (36-25 will be 97 pM. These correspond to an 
underestimation of transition midpoint by 25% in the case of (31-40 and 32% for 
(36-25, which translate to 2.21 and 2.76 Al(lll) per peptide molecule, respectively. 
When the upper limits of complexation are considered these values can be 
improved still further. It therefore follows that, in determining the nature of 
species which forms complex(es) with aluminum, the contribution from the 
peptide as a competing ligand cannot be ruled out.
The presence of aluminum in the peptide milieu significantly altered the 
CD spectra which suggested, but did not prove, that aluminum binding was 
associated with conformational changes. However, the addition of EDTA almost
2 7 8
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completely abolished the conformational changes induced by aluminum, which 
was in agreement with the NMR observations. Therefore, when the data was 
used in conjunction with the complex aqueous nature of Al(lll), supporting 
conformational evidence for the chromatographic and NMR data was obtained. 
The spectroscopic methodology used here provided an insight into the nature of 
aluminum-binding sites and the conformational effects of aluminum on (3>1 -40.
The CD spectra of the D-Asp analogs of 111-40 and (16-25 were distinctly 
different than those for the corresponding native peptide. These spectra are the 
first ones to show the importance of the amino acid side chain at positions 1, 7, 
and 23 in the peptide backbone. Secondary structure predictions based on 
primary sequence do not suggest any conformational differences; while analysis 
of CD spectra using CCA revealed "hidden" secondary structures (Perczel et al.,
1992), reference spectra for peptides or proteins with d -  configuration are not 
used by any of the deconvolution methods. Racemization leading to aspartic 
and iso-aspartic acids having l-  and D-stereoconfigurations have been shown to 
occur spontaneously (Stephenson and Clarke, 1989), and these structurally 
modified aspartates were found in the amyloid protein (Roher et al., 1993). 
Kirschner et al. (1987) have proposed the putative (1-pleated sheet formation in 
(11-28 due to ion-pairing between His13 and Asp23 These side chains were 
partially charged under the conditions of the study, and therefore expected to 
form oligomeric (1-pleated sheets.
2 7 9
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Although done in different laboratories, the spectral differences between 
[D-Asp1](l1-40 studied here and the commercially available synthetic 111-40 used 
by other researchers are immediately evident. Substitution of a single amino 
acid, e.g., L-Asp -* D-Asp, or Arg -» His, inflicts a very significant perturbation in 
the backbone, suggesting its key role in the folding of peptide. The presence of 
D-Asp1 was reported in amyloid core protein preparations and was suggested as 
one of the factors for the structural stability of the AflP (Roheret al., 1993). The 
conformational change in D-Asp substitutions at position 23 in the H1-40 derived 
analogs observed here, further emphasizes the role of Asp23 in the formation of 
H-pleated sheets. Interestingly, as the number of D-Asp substitutions in H1 -40 
was increased, the minimum intensity was blue-shifted as seen with the triply 
substituted [D-Asp1,7'23]H1-40. However, since the overall CD intensity was not 
changed, it was deemed safe to assume there was no loss in secondary 
structure. The current optical rotation theory limits the explanation of the shifts 
in CD bands based on D-amino acid substitution. However, since the 
polarization of the peptide backbone affects the electronic transitions (Urry, 
1985), it would seem that the change in the orientation of the side-chain from a 
L- configuration to a D-configuration significantly affects the polarization of H6-25 
and H1-40, and this effect is enhanced by the presence of Al(lll) in the peptide 
environment.
The conformational changes in the D-Asp substituted (16-25 were more 
impressive than those observed for the D-Asp analogs of (11-40 due to the
2 8 0
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red-shifting in the CD minima. The secondary structure in these amyloid 
peptides depends on the length of the peptide backbone (Barrow et al., 1992), 
and conclusions based on CD can only be drawn on peptides with same chain 
lengths. The behavior exhibited by [D-Asp7]l56-25 and [D-Asp7,23]l56-25 can be 
justified on the basis of their comparatively shorter length which provides more 
flexibility, and more hydrophilic nature compared to 151-40. The well-defined 
fibrillar assembly of (56-25 and extensive 15-pleated sheet formation has been 
emphasized in the EM and X-ray scattering studies (Fraser et al., 1991; Inouye 
et al., 1993). The red-shift of the CD minima in the D-Asp derived analogs of 
(56-25 increased with the number of substitutions. This phenomenon is 
comparable to the blue-shifts observed for the D-Asp derived analogs of (51-40. 
However, the very large red-shifting in the [D-Asp7,23](56-25 analog solicits more 
comment. Among the CD spectra available in the literature, the spectrum 
exhibited by the [D-Asp7,23](56-25 analog closely resembles gramicidin A in 
inverted micelles (Salom et al., 1992) with respect to the CD bands. Gramicidin 
A is an antibiotic with an alternating d - l-  pentadecapeptide backbone which acts 
as a transbilayer monovalent cation channel. The substitution of L-Asp D-Asp 
caused significant change in (56-25 backbone which then conformationally 
resembled an ionophore. Work done by Arispe et al. (1993) has shown that 
(51-40 forms calcium channels in bilayers which are blocked by aluminum. The 
CD spectrum for the [D-Asp7,23](56-25 in this study suggests that the peptide
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
which is the sequence analog of the intermediate region is likely to form ion- 
channels in U1-40.
The study of aluminum-induced effects on H1-40 and H6-25 
demonstrated that: (i) the antiparallel U-pleated sheet content increased at the 
expense of all other secondary structural components, (ii) this effect was almost 
completely reversible - by chelating aluminum, (ii) at least 2 aluminum ions each 
are bound to H1-40 and f!6-25 in solution, (iii) it was necessary to ascertain all 
ligand species when dealing with aqueous aluminum solutions to obtain a 
credible estimate of aluminum ions with peptides, (iv) derivations based on 
observed ellipticity provide reliable evidence than those derived from 
deconvolution methods.
2 8 2
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Summary
The current understanding of the role of AGP in the neuropathology of 
Alzheimer's disease has been like a roller coaster ride, making some 
researchers skeptics, while the others become IZAPtists. Since its discovery by 
Glenner and Wong (1984), this ride has been plagued with unresolved 
arguments about whether amyloid deposition is the cause, or an effect of the 
neuronal degeneration in AD. At the heart of the matter lingers the contradictory 
evidence of the neurotoxicity of AGP (Whitson et al., 1989; Yankner et al., 1990), 
and the apparent protection offered by exogenous factors (Wisniewski et al., 
1993; Zhao et al., 1993), where the key issue is the aggregated state of the 
protein. Moreover, AGP disrupts calcium homeostasis (Hardy and Higgins, 1992) 
by forming ion channels in membranes which are inhibited by aluminum (Arispe
283
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et al., 1993). Keeping these concepts in mind, answers to two questions 
pertinent to the pathway leading to amyloid deposition were sought: (i) how does 
soluble AHP form aggregates over time?, and (ii) what is the role of aluminum in 
the stability of A&P in solution?
The study presented in this thesis capitalized on the utilitarian approach 
of chemically obtaining 111-40 and derived analogs toward understanding their 
behavior in solution. While not unique, the stepwise assembly of fmoc-amino 
acid esters required considerable manipulations of synthetic conditions before 
satisfactory yields of pure peptide analogs could be obtained. The growth of 
truncated peptides was avoided by using low resin substitutions, and by 
maintaining the growing resin-peptide solvated by a mixture of polar organic 
cosolvents; this approach allowed for a total synthesis of 111-40. The Mtr 
protecting group for the guanidine of Arg proved to be the most unyielding during 
TFA cleavage and required optimized use of specific scavenging agents.
The chromatographic approach used in this study permitted the 
determination of the parameters related to the hydrophobic contact area of (11 -40 
and derived analogs, the resolution of hetero-oligomers of (126-40 with (11-40 
and (18-40, and the manufacture of AI(lll)-bound peptides. Interestingly, the RP- 
HPLC study demonstrated that the elution of (11-40 as a broad band was due to 
secondary retention - a phenomenon which is also found in many other peptides. 
Except (122-35, all sequence analogs of (11-40 were bound in their monomeric 
form on the reversed-phase matrix. This is an important finding since the
2 8 4
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monomeric form of (51-40 is not neurotoxic (Yankner et al., 1990; Pike et al., 
1993), nor does the constitutively produced and secreted (51-40 generate neuritic 
plaques (Haass et al., 1992; Seubert et al., 1992).
It was fascinating to find that (526-40 oligomerized with 151-40 and (58-40 
if incubated in solution prior to introduction on the reversed-phase surface. This 
observation has implications on the nucleation hypothesis of amyloidogenesis 
(Jarrett and Lansbury, 1992; Jarrett et al., 1993). The subunit structure for the 
systemic amyloid combines strong hydrophobic interactions between core 
helices and weaker hydrogen-bonding interactions between G-sheets (Turnell et 
al., 1986). A similar phenomenon with G26-40 and G-40 incubations could have 
resulted in the observed chromatographic behavior; however, it was surprising 
that these hetero-oligomers were stable in the denaturing conditions of RP- 
HPLC. The clustering of these hydrophobic moieties could form nucleation sites 
which are necessary for aggregation of G1-40. The close association of apoE, 
phospholipids and proteoglycans with the CV deposits (Snow et al., 1987; 
Wisniewski and Frangione, 1992) suggests a high probability that these 
exogenous factors might also act as the seed which causes aggregation of 
soluble G1-40. Nonetheless, it was of interest to find that oligopeptides of AGP 
containing complementary sequences spontaneously assembled to form 
macromolecules, independent of any external assembly or instruction code.
The conformational state of AGP has raised the thorniest issue in the 
pathway to understanding its neurotoxicity. Although many in vitro studies on
285
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synthetic (11-40 homologs have demonstrated the formation of amyloid-like fibrils 
under the influence of pH, metal ions, and tissue specific factors (Castano et al., 
1986; Kirschner et al., 1987; Halverson et al., 1990; Kirschner et al., 1990; 
Fraser et al., 1991a, 1991b, 1993), none had demonstrated the gradual loss of 
secondary structure over time. The circular dichroism study done here 
demonstrated that in the absence of any external stimuli, the kinetic change in 
molar ellipticity of aqueous (11-40 and (16-25 solutions took place as a function 
of time, and concentration. The resultant conformational variations suggested 
a gradual loss in secondary structure by a rearrangement of secondary structural 
components. The data presented here provides proof necessary to support the 
conformational theory of amyloid deposition, and bridges the section from the 
relatively benign soluble (11-40 to the pre-amyloid state, before the final toxic 
state of (11-40 is attained. The proceedings on this route would explain the 
neurotoxicity found by some (Yankner et al., 1990; Pike et al., 1991; Zhao et al., 
1993), but not others (Whitson et al., 1989, 1990). This study provided the first 
kinetic evidence of the secondary structural changes in any amyloidogenic 
proteins in aqueous solutions; since many proteins having little or no sequence 
homology form amyloid fibrils, these investigations fills up an important hole in 
the path toward comprehending the recalcitrancy of amyloid deposits.
The evidence presented here also implies that aluminum ions play an 
important role in the relative orientation of the (11-40 peptide backbone in 
solution -  a role which is intensified when D-Asp amino acids constitute the
2 8 6
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peptide. The presence of aluminum all but abolishes the "ion-channel-like" 
conformation of the di-substituted D-Asp derived analog of G6-25. Thus, it would 
seem that the (56-25 segment could play a prominent role in the ion-channels 
formed by (51-40 (Arispe et al., 1993). Also, since racemization takes a slow and 
arduous route within physiological parameters (Stephenson and Clarke, 1989), 
chelation with aluminum could accelerate the spontaneous catalysis 
(Buckingham et al., 1967) of AGP, eventually resulting in racemized Asp residues 
in core amyloid protein (Roher et al., 1993).
The implications of considering the aqueous chemistry of aluminum to 
gain insight on nature of interaction with the peptides proved to be advantageous 
in interpreting its association with the peptides. A better agreement between the 
CD and NMR spectroscopic data was achieved when the available aluminum 
was taken into consideration. Although, the nature of the Al(lll)-peptide 
complexes formed was not determined, it was evident that A l(lll) induced 
conformational changes in G1-40 and G6-25 which could be partially reversed by 
EDTA. The stabilizing effect of Al(lll) on the secondary structure of G1-40 and 
its fragments support the conformational change hypothesis that A l(lll) could 
contribute to the structural stability of amyloid in AD. Al(lll) can form both, 
intermolecular and intramolecular complexes with G1-40 and derived analogs, 
the latter could be stabilized by potential salt-bridges (Kirshner et al., 1987; 
Hollosi et al., 1994). In spite of the evidence in favor of Al(lll) ions in the 
conformational stability of G1-40 and derived analogs, this study does not negate
2 8 7
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the role of other factors, like paired helical filaments (Perl, 1988), neurofibrillary 
tangles (Perl and Brody, 1980; Candy et al., 1992), and phosphorylated tau 
protein (Lee et al., 1991), which play a prominent role in the etiology of 
Alzheimer's disease. Evidence on synthetic model peptides from neurofilament 
proteins suggest that phosphorylation of these proteins leads to their eventual 
deposition as paired helical filaments (Otvos et al., 1988; Lang et al., 1992; 
Hollosi et al., 1992; Fasman and Moore, 1994). It is possible that the Al(lll) 
implicated in the makings of these tangles and filaments could have indeed been 
carried by the circulating 111-40. Based on the observations made in this study, 
the following scenario could now be visualized: 111-40 gradually procures a 
higher order in structure, and simultaneously provides an anchor for aqueous 
Al(lll) to bind, from which Al(lll) can orchestrate the chaotic events - disrupting 
chemical homeostasis, racemization of amino acids in the complexed peptide, 
and sabotaging the tau-machinery. Collectively, these events lead to a gradual 
deposition of amyloid and other factors in the neuronal milieu.
The findings from this study are provocative at best and raises more 
questions than provide answers. To rephrase Sherrard (1991) in light of the 
current data, "Is it time to throw away grandma's time-tested aluminum pot?" 
Not necessarily! Although inhaling aluminum is another matter (Beyreuther,
1993), especially if there is soluble 111-40 which is available freely. Implications 
of the strategy employed in this study using the selectivity of aluminum toward 
bioactive ligand peptides, like H1-40, to gain insight on how the conformational
288
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nature can be modulated in aqueous solutions, however, deserve further 
consideration. The mechanism of prohibiting the conformational change of 
soluble AGP will also be necessary if therapeutic intervention is to be successful. 
The chromatographic studies which were used to characterise the ligand-peptide 
interactions with a reversed-phase surface could also be used to develop a 
model for stabilizing the conformation of G1-40 and derived analogs. Other 
future directions in brain amyloid research will most probably include methods 
to prohibit the interaction of soluble G1-40 with exogenous protein factors. In any 
case, unravelling the tangles, or conserving the solubility of G1 -40 will most likely 
also involve aluminum. Be as it may, this study provides one more brick on the 
wall of neuronal degeneration; yet another direction in navigating the labyrinthian 
pathways of structure-function relationships in proteins and peptides, leading to 
a better understanding of the conformational stability of soluble AGP, and other 
amyloidogenic proteins.
2 8 9
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Appendix A
Evaluation of Interactive Chromatographic Parameters During Gradient 
Elution RP-HPLC
The chromatographic parameters related to the hydrophobic contact 
area of 111 -40 and derived analogs on the reversed-phase surfaces were 
determined by using the concepts outlined by Horvath et al. (1976), Hearn et al. 
(1985) and Hearn and Aguilar (1987). To determine the chromatographic 
parameters, mathematical transformations using SigmaPlot 4.1 were performed 
by adopting the Pek'N-ese protocol (Hearn et al., 1985). The retention 
coefficients of amino acids were obtained from Guo et al. (1986).
Retention relationships
The retention time, fg, for a polypeptide chromatographed under ideal 
gradient elution conditions is related to the gradient steepness parameter, b, 
through the expression
ta = (t0/b )  [log 2.3 k'0b] + t0 + tc
where
b = f0 log fl / [fg1 - (tg2 / H) + t0(tG 1 - tG2) / tG2]
Alternatively, when gradient times are maintained constant, using 
rates F 1 and F2, then b can be determined as follows:
b1 = ( log(F2/ F , ) ) / [ X ) - X 2(F2/F , ) ]  (3)
where
X, = (fg1- W / ' o . i  (3a)
X2 = (t92-to.2)lto.2 (3b)
Evaluation of b values from retention data obtained for various gradient times
290
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(1)
(2 )
different flow
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Evaluation of b  values from retention data obtained for various gradient times 
and solvent flow-rate conditions allows the calculation of the median capacity 
factors, k*, and the corresponding organic mole fraction ip*
Provided the retention of the polypeptide in question follows an ideal 
linear solvent strength behavior, k* and ip* can be derived, to a first 
approximation from equations 4 and 5, namely
A- * = 1 /1.15b (4)
i p * = [ t g1 - t 0 - ( t 0 l b ) \ O Q 2 ] / ( t G / A i p )  (5)
The parameters k* and ip* are equivalent to the isocratic parameters k' and ip* 
under regular reversed-phase elution conditions are empirically related through 
the expression
log k' = log k'0 - Sip (6)
The tangent (or slope) S to the curve obtained in a plot of log k* versus ip* is 
determined at any particular value of k * and the value of log k* at ip* = 0, (i.e., 
log k'0) are obtained by extrapolation using regression analysis.
The relations summarized in equations 1-6 give rise to a number of
predictions related to the retention behavior of peptide solutes under linear
solvent strength gradient conditions:
Firstly, the corresponding gradient form of equations 6 predicts linear 
dependencies of log k* on ip* provided the solutes are eluted under regular 
reversed-phase conditions and their retention behavior does not involve any 
significant participation of slow secondary equilibria associated with either 
ionization, surface-adsorption or conformational effects.
Secondly, as the b  value is changed through alteration of t G or F, 
selectivity changes should become evident for those peptides with different S 
values in which the processes of their adsorption-desorption result in different 
association constants or kinetic rate constants, either through participation of:
(i) different classes of binding sites on the heterogenous stationary-phase 
surface (i.e., through different binding mechanisms), or
(ii) through the involvement of different topographic regions on the solute surface 
(i.e,. via the same mechanism but different effective hydrophobic contact areas), 
or
(iii) through hybrid combinations of both processes.
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With solute analogs in which identical molecular regions are involved 
in the interaction with the stationary-phase surface, coincidental retention 
behavior with parallelism in the log k* versus ip* plots should be observed. In the 
case of closely eluting peptides, with fundamentally different contact area 
dependencies, manipulation of secondary solution equilibria through, for 
instance, pH, ion-pairing or solvation effects, should result in selectivity changes 
due to alteration of the topographical dimensions of the interactive region of the 
solute.
Bandwidth relationships
The peak capacity, PC, for a chromatographic separation of gradient 
time fGand average resolution, Rs, equal unity for all peptide pairs can be given 
by
PC = tG ■ F / 4 ov (7)
where ov is the bandwidth measured in volume units (1 S.D.). Furthermore, the 
relationship between ov and k* for linear solvent systems can be expressed as
° v,ca,c = P * / 2 )  + 1]G- Vm N -05 (8)
where G is the band compression factor which arises from the increase in
solvent strength across the solute zone as the gradient develops along the 
column, and is given by the expression
G2 = [1 + 2.3b + 1/3(2.3b)2] / (1 + 2.3b)2 (9)
where Vm is the column void volume ( = t0 ■ F ). Linder the typical flow-rate
conditions used for separations of peptides in RP-HPLC, the plate number, N, 
can be approximated by
N = Dm ■ t0l  C ■ dp2 (10)
where dp is the mean particle diameter, and C is the Knox equation parameter 
which accounts for resistance to mass transfer at the stationary-phase surface 
and can be estimated by
C = [{(1 - x + k * ) /(  1 + k *)}2] / [15pa'+ 15pb'k* -19.2px] (11)
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where x is the interstitial column volume fraction, was taken as 0.67 for the 
Vydac C18 column, a' was taken as 1.1, b'is the surface diffusion parameter and 
p  is the restricted diffusion parameter.
The diffusion coefficient of a solute in the mobile phase (D J  can be 
expressed in terms of the solute molecular weight and evaluated from 
equation 12,
Dm = [ 8.34 X 10'10 • T ] l [  n- M W 033 ] (12)
where T is the temperature (K) and q is the eluent viscosity (poise).
The assumption in the derivation of the above bandwidth was that the 
solute migrated as an unique, conformationally rigid moiety. It is generally 
accepted that peptides and proteins can explore a variety of conformations in 
solutions. If it is assumed that these processes or any additional secondary 
equilibria are extremely rapid compared to the chromatographic separation time, 
then the ratio between the experimentally observed bandwidth ovexp, and the 
bandwidth determined by equation 8, avca,c, should approach unity over the 
normal operational range of retention values commonly used in optimization 
studies, i.e. 1 < k* < 10.
L is t  o f  s y m b o l s  u s e d :
a' Intercept of the 8 versus k* plot, taken to be 1.1.
B Knox equation constant, which arises from zone dispersion due to
longitudinal diffusion. 
b Gradient steepness parameter, as defined by equation 2.
b' Solute diffusion parameter, equal to the ratio at solute diffusion in
the stationary and mobile phases (D /D J .
C Knox equation constant, which accounts for mass transfer
contributions throughout the pore structure of the stationary phase. 
Dm Diffusion coefficient (cm2/s) of the solute in the mobile phase.
Ds Diffusion coefficient (cm2/s) of the solute at the stationary-phase
surface.
d Intercept of the [log K J '1 versus t  plot.
dp Mean particle diameter (cm),
e Slope of the [log Km]'1 versus t  plot.
F1t F2... Flow-rate of mobile phase at different values.
G Band compression factor, as defined by equation 9.
Km Michaelis constant.
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k' Capacity factor for the solute determined from isocratic retention 
data.
k* Median capacity factor for the solute determined from gradient 
retention data as defined by equation 4.
k'o Capacity factor for the solute determined or extrapolated at ip = 0.
L Column length (cm).
MW Molecular weight.
N Column plate number.
PCexp Peak capacity as defined by equation 7 from experimental values 
of tG and ovexp.
PC calc Peak capacity as defined by equation 13.
Ps Average resolution for gradient separation.s Slope of the plot log k' versus qj as defined by equation 6.
T Absolute temperature.
td Chromatographic dwell time.
te Gradient elapse time.
td> t(S2, Gradient times.
tgh tg2, Gradient elution times for the solute under two different gradient 
times.
to.1> tQ 2, Column dead times for different conditions of flow.
Vm Column void volume.
vmax Maximum velocity of enzyme-substrate reaction.
X Fraction of the column void volume in the interstitial spaces of the 
column bed.
a Gradient separation factor, as defined by the ratio of k* values for 
two adjacent solute zones.
(3 Ratio of the gradient times as defined by 13 = tG/ t G1.
A lfJ Change in the organic modifier mole fraction.
n Mobile phase viscosity at a defined temperature (poise).
p Restricted diffusion parameter.
®v,exp Peak bandwidth in volume units (mL), determined experimentally.
^v.calc Peak bandwidth in volume units (mL), calculated according to 
equation 8.
X Solute selectivity parameter (= In a).
V Organic solvent modifier mole fraction in isocratic system.
q j* Median organic modifier mole fraction as defined by equation 5.
X Hydrophobic retention coefficient.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix B
Decomposition Procedures for Secondary Structure Transitions from 
Amide Circular Dichroism Spectroscopy of B1-40 and Derived Analogs
The deconvolution of observed CD spectra was performed using 
Varselec (Manavalan and Johnson, 1987) and CCA (Perczel et al., 1991) 
analyses and from the observed mean residue molar ellipticity. The 
decomposition of spectral data was done as per Labhardt (1982), Kuwajima et 
al. (1987) and Ptitsyn (1987).
Using the reference spectra for a-helix rh(A), ra(h) for antiparallel 
ft-sheet, rp parallel ft-pleated sheets, r, for ft-turns and r0 for all other structures, 
all observed CD spectra were approximated at an interval of 5 nm for 11 different 
wavelengths between 210 and 260 nm to least-squares by a superposition of the 
form:
[0] = fhrh(k) + fara{k) + fprp(k) + f / t(k) + f0r0(k) (6)
The only constraint imposed on this equation was that
I f ,  = 1.0 (7)
Therefore, this was equivalent to approximating the measured difference 
spectrum a [ 6 ] '  = [©Leased - r0{k) to least-squares by a 2-parameter expression:
a[Q] = fa(ra - r0) + fB(ra - r0) (8)
where fa is the fractional a-helical content, fa is the sum of antiparallel and
parallel U-pleated sheets, r0 represents the basis spectra for all other structures
which are neither a-helical nor U-pleated sheets structures, which yields the 
individual /Tor the secondary structural elements, which are analytical solutions 
to the system of linear equations:
dldfa Z{a[0]' - a[0]} = 0 (9a)
d/dfa Z{a[0]' - a[0]} = 0 (9b)
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8ldf0 I { a[0]' - a[0]} = 0 (9c)
The difference spectra were orthogonal in the wavelength range from 260 to 195 
nm, i.e., J\ac<aIX • dA = 0.
The fractions of a-helical (fa) and fJ-pleated sheet (fB) were calculated 
from the measured difference spectrum for conformational change,
a [ 6 ] '  =  ^ m e a s u r e d  '  ^ ( A ) ,  b y  U S i n g
fh = (Z^a[0]' • aI3 • I AAaAf2> - I aa[0]' • Aa • I aaf32)/D, and 
fB = ( I aa[0]' • Aa • I aaOa(3 - I aa[0]' • a(3 • Xaao2)/D, 
where,
D = ( I a o  • a [3)2 - I aa o 2 • I aa [32, and 
a a  = rh{ A) - r0(A); a  IS = ra(K) - r0(A); etc.
The success in fitting the measured CD spectra of the native 
conformational state with the correct fh and fB fractions given by equation 5 
showed that in the range of wavelengths in the random-coil and the unordered 
structure (f0) CD spectra were not sufficiently orthogonal for both to be 
incorporated at the same time as reference spectra. The reference spectra of 
a-helical and 13-pleated sheet structures were, however, well decoupled in the 
wavelength region of 260 to 195 nm; i.e. rB{K) went through zero near 225 nm 
whereas rh(A) reached the maximum (of its absolute value) nearby.
Verification o ffh(rh(A) - r0(A)) and fB(rB(A) - rJA))
To verify if the reference spectra which were used provided satisfactory 
estimates, all three 'pure' spectra, a, B, and o, were abandoned and replaced 
with the measured spectra, J|(A), of mixed conformations of [31-40 and derived 
analogs. Native spectra (J,(A)), and 'denatured' spectra (J2(^) and J3(A)) at pH 
2 were included to expand the spectra [0] of the peptide(s) to
[B] = l g jJi(\) (10)1
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Assuming that each of the Jj(A) was only defined by 3 different types of 
secondary structure, according to equations 6 and 7, this implied that the three 
gs values add up to unity. Therefore, equation 10 can be reformulated in a way 
analogous to equation 8 as
[0] - J3 -  ST|(Ji - J3) + £2(^2_ ^3) (11)
The meaning of the g^  values can be discerned from equation 11: the deviation 
of the actual conformation, spectrum [0], from the conformation of folded peptide 
(J3) is measured by g, in terms of conformational transitions which are spectrally 
equivalent to the disappearance of the a-helix forming segment. This was 
presumed to dominate J, - J3), and by g2 in terms of the appearance of the 
conformation of completely denatured peptide (pH 2) given by (J2 - J3).
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Concentration of Aqueous Aluminum(lll): Metal-ion Buffers
Appendix C
The determination of available Al(lll) in aqueous solutions were taken 
from the concepts presented by Martin (1986), Crumbliss and Garrison (1988) 
and Martin (1988).
The control of metal ion concentrations in solutions is analogous to pH 
buffers, except that it is the free metal-ion concentration which is controlled in the 
presence of excess ligand. Most effective buffering takes place when the 
complexed ligand to total ligand molar concentrations lie between 0.15 and 0.85. 
Normally the ligand concentration exceeds the metal concentration, and the total 
metal-ion to total ligand ratio, R, must be maintained to have any metal buffering 
action.
The conditional stability constants, Kc, permits the formulation of 
equation for metal-ion buffering. For a AIL0 system at neutral pH, like Al-cit or 
AI-EDTA, the conditional stability Kc = [HOAIL-] / [AI(III)][HL2-], refers to the 
overall reaction Al 3+ + HL2" ^  HOAIL " + H * for which the total ligand 
concentration is given by:
CL = [HOAIL"] + [HL21 (1)
Since the ligand is in excess, the total metal concentration is given by:
CM = [HOAIL"] (2)
All A l3+ is assumed to be tightly bound so that free A l3+ is negligible. Substituting 
this equation for the conditional stability constant equation for a AIL0 complex at 
neutral pH, the following general equation is arrived:
[Al3+] = F? / (1 - R)KC (3)
where R = CM / CL. This equation gives the free [Al3+] and is applicable at the pH 
at which the conditional stability constant applies.
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In the case of EDTA, Kc was formally given by:
Kc = Ks(1 + Kbi  [H+])/(1 + [H+] / Kg) (4)
since most of the ligand appears as a species with a net charge of 2- at neutral 
pH. The [H+] / Ka term accounts for the protonated ligand, HL2', and the Kb / [H+] 
term for the deprotonated AI(lll)-bound water, [AI(H20 )5(0H)] 2+1 which are 
generated during complex formation.
The metal-ion buffer equations 3 and 4 gives the free metal ion as a 
function of the known equilibrium constants, pH, and the ratio of total metal ion 
to excess total ligand concentration, R, and not their absolute concentrations.
Varying R, affects the free metal ion concentrations at any given pH. At 
pH 7.4, for AI(III)-EDTA, pAI = 15.0, and at pH 7.0, pAI = 14.2. For an equivalent 
Al(lll)-cit system, the corresponding values are 12.4 and 11.7 respectively. The 
[Al(lll)] in both cases is low, but is controlled.
The situation where R = 1 or CM = CL was avoided because of wide 
variations in pAI due to unbuffering of the solutions. Since these ligands are 
prone to time-dependent reactions, i.e., the equilibrium with complexes was 
reached slowly, they were allowed to stand for at least 4 hours before any 
measurements were taken. When a wider range of R was required, the variation 
in pH was sufficient to achieve the desired free [A l3+]; although R = 1, and 
= CL situations were circumvented at all times during the spectroscopic 
investigations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Characterization of Mg2+, Zn2+ and Ca2+ Incubations with IJ1-40 and Derived 
Analogs
Appendix D
Fig. 1. R P -H P L C  elution profiles for 131-40 incubations with Mg2*, Z n 2*and  Ca 2* The 
incubations were performed at 35°C  for 24 h using the metal ion-peptide ratio as 10:1. 
The solutions were occassionally vortexed, and after 24 h, the samples were loaded 
directly on a 4.6 X 300 mm Beckman Ultrasphere ODS column. Chromatography was 
done using a AB gradient; solvent A was 0.1%  TFA  and solvent B was 0.1% TFA in 80%  
MeCN. The flow rate was 0.8 mL/min with a gradient time from 0-100% B in 60 min. The 
major hydrophobic fraction was collected, concentrated in vacuo, and characterized by 
automatic amino acid sequence analysis.
300
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Sequence analysis:
The major fraction eluting after RP-HPLC of the incubations were 
attached on PVDF membranes and Edman degradation performed. The 
sequence analysis is given in Table 1.
Incubation with Sequence assignment for the major fraction on RP-HPLC
Mg2*
Zn2*
C a2*
D/AEFRXXXGVEVHXQKLVFFAEDVGXNKGA...
DAEFRHXXGYEVHXXKLVFFAEDVGXNKGA...
DAEFRHDXGYEVHHXKLVFFAXXVGXNKGA...
The underlined italics indicate the repetitive yield of the PTH-amino acid was less than 0.25 relative 
to PTH -Phe4 or PTH -Leu17.
The "..." indicate that sequence analysis was not performed beyond this amino acid because the 
repetititve yield was significantly less than 0.10 relative to PTH-Phe4 or PTH -Leu17.
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